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Abstract 
 
Saturated (or at least sp3-enriched) molecules have acquired an increasingly important role 
in medicinal and organic chemistry. The architectural complexity of three-dimensional, 
saturated molecules often confers greater biological activity and makes these compounds 
more likely to succeed as drugs. The challenge associated with their synthesis and the lower 
degree of toxicity compared to flat, aromatic molecules makes them very attractive synthetic 
targets. 
 
Polysubstituted bicyclo compounds are found in many biologically active natural products. 
In particular, the bicyclo[3.3.1]nonane system constitutes the core of the PPAP 
(polyprenylated acylphloroglucinol) family, whose members have shown multiple beneficial 
medicinal properties. A main approach to the construction the bicyclo[3.3.1]nonane core 
involves the biomimetic dearomatisation of prenylated phloroglucinols. The initial aim of the 
thesis work was to use chiral epoxides to achieve the dearomatisation of these derivatives 
and a consequent enantiodivergent synthesis of the PPAP scaffold. Inspired by the 
enantioselective total synthesis of hyperforin, achieved by Shair’s group through 
desymmetrisation of a cyclohexadiene ring, the thesis study initially focused on investigating 
an epoxide-mediated ring closure using more readily available 1,3-diketones. However, this 
approach met with little success, instead the products of O-cyclisation often being obtained. 
 
As an alternative, the construction of functionalised bicyclo[3.n.1]alkanes by a Michael-aldol 
type annulation was investigated. This method has previously furnished bicyclic compounds 
but was limited in scope and/or stereocontrol. We thus aimed to develop a general, reliable 
route for the synthesis of a variety of polysubstituted bicyclo[3.3.1]nonane derivatives using 
a Michael-aldol annulation. A novel and effective one-pot process was achieved by the 
reaction of substituted 1,3-cyclohexanediones with enals. The desired bicyclic ketols were 
generally obtained in good to excellent yields, and often with appreciable stereocontrol. The 
possibility to further functionalize the bicyclo system with other electrophiles was shown to 
be effective for fluorine, and afforded a selection of novel fluorinated bicyclic scaffolds of 
relevance to medicinal chemistry. 
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Impact Statement 
 
Over the past century, the discovery and development of important life-saving drugs was 
greatly enabled by the outstanding advances made in synthetic organic chemistry. The 
invention of new synthetic methods provide access to diverse, extensive regions of the 
chemical space containing a large array of biologically active molecules, a necessity for all 
drug discovery programmes. One of the key challenges in synthetic organic chemistry is the 
achievement of a certain degree of complexity and stereochemical diversity together with 
the selective construction of highly functionalized saturated scaffolds; in this context, 
architecturally complex molecules like bridged bicyclo compounds possess great structural 
diversity and a high level of saturation, which has been shown to confer higher aqueous 
solubility and lower toxicity when compared to the unsaturated/aromatic counterpart. 
Many biologically active natural products and marketed drugs possessing multiple 
therapeutic effects including anti-bacterial, antidepressant, anti-viral and anti-cancer feature 
a bicyclic core in their chemical structure. These rigid, saturated frameworks can be 
decorated with multiple substituents whose orientations can cover multiple directionalities, 
with potential for efficient interactions with biological targets. 
Following on these key concepts, we developed an annulation methodology via a tandem 
Michael-Aldol reaction to provide a diverse range of [3.3.1] and [3.2.1]bicyclo compounds in 
good to high yield and stereoselectivity. Having devised a method that can efficiently build 
a complex bicyclic scaffold in one step, we also sought a concise route to fluorinated bicyclo 
compounds of defined stereochemistry since the introduction of fluorine can beneficially 
alter physicochemical properties. As a result, we synthesized the most extensive series of 
monofluorobicyclo[3.3.1]nonane derivatives, achieving high stereoselectivity and 
chemoselective introduction of fluorine. 
The shape of bicyclo compounds and the ability to control the spatial orientation of various 
substituents on these rigid structures is crucial in determining their chemical and biological 
properties. This study highlights the 3D-structure of a selection of bicyclo and fluorobicyclo 
compounds and paves the way for the exploration of new regions of the chemical space. 
The bicyclic molecules synthesized have also a great potential for use as bioisosteres and 
provide structural diversity suitable for use in medicinal chemistry and drug design 
programme. 
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CHAPTER 1 
 
1.1 Natural products; complexity, diversity and exploration of the chemical space 
 
The constant demand for new specific and potent therapeutic agents and the necessity for 
novelty in chemical patents has made the medicinal chemistry community increasingly 
aware of the limitation of classical systems such as (hetero)aromatic compounds; their low-
cost synthesis and structural flexibility often comes with poor solubility and toxicity, features 
that cannot be neglected in drug development. Thanks to the remarkable advances in 
synthetic organic chemistry the tendency to prepare more architecturally complex molecules 
has emerged and new and uncommon saturated scaffolds are now accessible and 
progressively considered in the drug development process.1 
 
Natural products have always been an essential source of bioactive compounds. From their 
use by indigenous and agrarian societies to the breakthrough discovery of Penicillin in 1928 
until the post-industrialised discovery of important molecules like Daunorubicin or 
Cephalosporin C, natural products’ contribution to the progress of anti-infective and anti-
tumoral agents after the second world war has been enormous. Nowadays, natural products 
constitute one third of the top marketed drugs worldwide, covering a variety of therapeutic 
application, from the immunosuppressive agent cyclosporin A, to cholesterol-lowering 
agents to Doxorubicin and Artemisinin for cancer and malaria treatment respectively.2 
 
The remarkable chemical diversity and complexity possessed by natural products leads to 
the concept of chemical space, which was created to group all possible organic molecules. 
The majority of molecules that are able to interact with high specificity with their biological 
targets are however confined in only few regions of the chemical space and this number is 
additionally limited to those compounds possessing key features i.e. aqueous solubility and 
non-toxic metabolites.3 The exploration of unknown regions of the chemical space is 
therefore becoming very important as it can lead to an increased number of molecules to 
choose from at the “hit” stage and consequently to a higher success rate in the later stages 
of drug development.4 In this context, Diversity-Oriented-Synthesis (DOS), a concept 
pioneered by Schreiber in 2000, which is “aimed at the collection of many compounds having 
structural diversity and complexity”, addresses the urgency to explore the uninvestigated 
regions of the chemical space by building libraries of small-molecule chemical probes with 
chemical complexity and diversity. In his work, Schreiber proposed the ideal synthetic plan 
to be an integration of complexity and diversity elements, as illustrated for the Ugi and 
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intramolecular Diels-Alder reactions which are able to generate complexity in one single 
sequence (Fig. 1.1 top). Products derived from one single transformation can be split and 
pooled in a collection of different scaffolds, leading to a large number of components with 
different complex scaffolds (Fig.1.1, bottom).5 This strategy can be combined with a certain 
degree of stereochemical diversity to efficiently access a full display of chemical information 
in the three-dimensional space.6 
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Fig.1.1: DOS ideal synthetic plans, combining complexity and diversity.5 
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1.2 The concept of saturation 
 
In 2009, Lovering7 introduced two central criteria for drug-likeness; the number of chiral 
centres and the sp3 character, i.e. the carbon bond saturation. The rationale behind this 
selection is the effect on the molecular shape; a higher level of saturation, defined by the 
sp3 hybridized carbons (Fsp3), allows the exploration of diverse, natural product-like regions 
of the chemical space. The proof of concept was the discovery of the direct correlation 
between the various stage of drug development (with the GSK BIO database of molecules 
taken as a source) and the level of saturation, with a 31% increase of Fsp3 from discovery 
to phase III of clinical trials. Additionally, the average saturation, chiral centres count and 
molecular weights were calculated for each stage of the drug discovery process and the 
same increase in the compound likelihood to become a drug was observed. Fsp3 was also 
found to be highly correlated with solubility and can be increased without causing any 
significant change in the overall molecular weight, both key elements in Lipinski rule of 5.7 
 
Lovering’s study paves the way for a deeper investigation of saturated, architecturally 
complex natural products and confirms the Fsp3 as an important factor, which does not only 
enhance the specificity and/or the potency of certain compounds but more importantly 
increase their probabilities to become a successful marketed drug. 
 
1.3 Bridged bicyclo compounds in medicinal chemistry  
 
In this context, bridged bicyclo compounds are highly valued as they feature key complexity 
descriptors, i.e. the number of sp3 hybridized carbon atoms and the presence of chiral 
centres. The presence of a bridged bicyclic scaffold in particular has increased in therapeutic 
and biologically active natural products (Fig. 1.2). For instance, the bicyclo[2.2.1]heptane 
mecamylamine, being a non selective antagonist of the nicotinic acetylcholine receptor, has 
been shown to have some efficacy in the treatment of nicotine addiction; 
bicyclo[3.2.1]octane derivatives were initially synthesised for the structural similarity with the 
anti-cancer family of ent-kaurenoid diterpene mimics and indeed the amide derivative shown 
was found to exhibit a IC50 value between 1.1 and 4.3 μM in 5 cancer cell lines.1, 8 Tricyclic 
pyrimidine derivative was patented instead as JAK inhibitor, highlighting the increased use 
of small strained ring systems like bicyclo[1.1.1]pentane or cyclobutane and azetidine as 
bioisosteres in medicinal chemistry.9 Two of the most famous and important marketed drugs 
known to possess a bicyclic scaffold are also highlighted in Fig.1.2; Taxol, a complex natural 
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product able to block mitosis through stabilization of the microtubule polymer, has been 
successfully on the market for over 30 years as a chemotherapeutic drug; Ingenol mebutate, 
thanks to its antibody-dependant cellular toxicity and its rapid lesion necrosis10, has emerged 
recently as the main treatment for actinic keratosis, a skin condition considered potentially 
precancerous.  
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Fig.1.2: Biologically active and marketed bridged bicyclo compounds. 
 
 
1.4 Biological relevance of the bicyclo[3.3.1]nonane and bicyclo[3.2.1]octane 
bridged scaffolds 
 
Amongst all the different types of bridged bicyclic frameworks that can be investigated for 
medicinal chemistry purposes and for a better understanding of the chemical space, 
systems containing the bicyclo[3.3.1]nonane and the bicyclo[3.2.1]octane scaffold have 
drawn attention from the synthetic community, particularly because of their involvement in 
many sesquiterpenoids and other natural products biosynthetic pathways.11 For instance, 3 
and 3,7-substituted bicyclo[3.3.1]nonanes are potential precursors of adamantanoid 
compounds whose framework is very common in nature and is found in many biologically 
active molecules.12 Fig. 1.3 showcases a few examples: huperzine A, an inhibitor of the 
central acetylcholinesterase, has been clinically evaluated as an anti-Alzheimer drug and 
marketed in few countries as a dietary supplement for memory loss. Hypatulin A and 
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Platensimycin exhibited remarkable antimicrobial and antibacterial activity, 13 respectively 
whereas a potent anti-influenza virus activity is shown by the diterpene Wickerol A14 
(Fig.1.3a). Densely prenylated bicyclo[3.3.1]nonane-2,4,9-trione or bicyclo[3.2.1]octane-
2,4,8-trione cores are also found within the family of polycyclic polyprenylated 
acylphloroglucinols (PPAP) natural products, considered intriguing because of their complex 
chemical structure and interesting biological activities. Hyperforin, the primary active 
constituent of the flowering plant Hypericum perforatum (St. John’s wort) and the main 
representative of this class of phloroglucinol derivatives possess potent antidepressant and 
anxiolytic properties along with in vitro and in vivo activity against several bacterial species 
and cancer cell lines. Additionally, in vivo studies showed that Hyperforin can also have a 
nootropic effect, improving cognitive functions by reducing biomarkers of Alzheimer's 
disease.15 The same anti-neurodegenerative, anticancer and antibacterial effect is 
possessed by several members of the PPAP family, including Garsubellin A, Nemorosone 
and Hyperibone K (Fig. 1.3c).  
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Fig. 1.3: a) Biologically active natural products featuring the bicyclo[3.3.1]nonane scaffold, b) Biologically active 
natural products containing  the bicyclo[3.2.1]octane core, c) Representative PPAP natural products. 
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1.5 Synthetic strategies towards the bicyclo[3.3.1]nonane framework 
 
This incredibly extended therapeutic range across natural products featuring the 
bicyclo[3.3.1]nonane scaffold encouraged the synthetic chemistry community towards the 
development of stereoselective routes for the synthesis of this framework. The synthetic 
strategies developed so far are summarized in four major reviews; the first two, reported by 
Peters16and Buktus12 either describe general approaches towards relatively 
unfunctionalised bicyclo[3.3.1]nonane systems or report selective examples towards the 
synthesis of 3,7-substituted derivatives. The other two reviews by Njardarson17 in 2011 and 
Richard18 et al. in 2012 analysed the synthetic advances towards this scaffold within the 
context of PPAP natural products, showcasing the latest total syntheses together with the 
most recent synthetic approaches and their limitations. The following discussion will be 
divided by chemical transformation, highlighting the synthesis of functionalised and 
unfunctionalised bicyclo[3.3.1]nonane and [3.2.1]octane cores, mostly in the context of 
natural products synthesis. 
 
 
1.5.1 Annulation Strategies 
 
1.5.1.1. Annulation of cyclohexanone derivatives featuring Michael, double Michael or 
Michael-aldol reactions 
 
In their detailed analysis of all the synthetic approaches towards bicyclo[3.3.1]nonanes, 
Butkus and Peters cite one main reaction that has been historically used to forge the 
bicyclo[3.3.1] skeleton; the annulation of cyclohexanone derivatives. Most of these reactions 
feature Michael, double Michael or Michael-aldol mechanisms so a major focus will be given 
to these powerful C-C bond forging reactions.  
 
The first synthesis of a substituted bicyclo[3.3.1]nonane was reported at the beginning of 
the 20th century19 and involved the annulation of terpene carvone 1.1 with ethyl acetoacetate 
under basic conditions (Scheme 1.4, left). The mechanism was not described but most likely 
involves a Michael-aldol-decarboxylation sequence to give bicyclo 1.2. This methodology 
and other related reactions were successfully applied for many years for the synthesis of 
bicyclo[3.3.1]nonanes;20 reaction of 6-dichloromethyl-6-methyl-3-oxo-cyclohexa-1,4-diene 
1.3 for example21 has been reported to give the bicyclo[3.3.1]nonane core albeit with two 
different mechanisms depending on the reagent used; bicyclo compound of type 1.4 arises 
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from a double Michael addition between 1.3 and dimethyl acetonedicarboxylate whereas the 
use of methyl acetoacetate gives rise to diene 1.5 following a Michael-aldol sequence 
(Scheme 1.4, right). 
 
 
Scheme 1.4: Left: First synthesis reported for the construction of bicyclo[3.3.1]nonane. Right; double Michael 
and Michael-aldol strategies to access bicyclo compounds 1.4 and 1.5.19a, 21 
 
In 1986 Dauben22 showed that cyclic β-keto ester 1.6 reacts with a variety of enones at 15 
Kbar in the presence of an excess of a tertiary amine as co-solvent yielding substituted 
bicyclic ketols of type 1.7 (Scheme 1.5, left). Noteworthy is the extension of the methodology 
to various ring sizes and the use of unreactive enones such as mesityl oxide. The same 
reaction conditions were extended to enals like acrolein and methacrolein to give 6-hydroxy-
8-methylbicyclo[3.3.1]nonane-2,9-diones of type 1.9; importantly this constitutes to date the 
only example of annulation involving the use of unsaturated aldehydes with this type of 1,3-
cyclohexanedione system (Scheme 1.5, right). 
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Scheme 1.5: Dauben’s use of high pressure in the synthesis of bicyclic ketols of type 1.7 and 1.9.22 
 
In his account for the conformational analysis of 9,9-dimethylbicyclo[3.3.1]nonane 
derivatives, Fetizon23 explored a double Michael addition of 4,4-dimethylcyclohexadienone 
1.10 with dimethyl acetonedicarboxylate; ketalisation of the resulting mixture of enolised 
stereoisomers 1.11 and subsequent decarboxylation under basic conditions gave 9,9-
dimethylbicyclo[3.3.l]nonane-3,7-dione-ethylene acetal 1.12. Noteworthy is the high 
stereoselectivity of both reductions; in the presence of LiAlH4, because of the likely chelation 
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of Al to the acetal motif, the hydride is delivered on the more accessible face of the molecule, 
providing exclusively to the endo-epimer 1.14; reduction in the presence of Na/EtOH (initially 
via a radical oxyanion) yields solely the thermodynamically preferred exo-isomer 1.13 
instead (Scheme 1.16).  
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Scheme 1.6: Fetizon double Michael addition for the synthesis of 9-disubstituted bicyclo[3.3.1]nonane-3,7-
diones.23 
 
In the case of the synthesis developed by Pennetreau,24 a combination of Michael addition 
and Robinson annulation led to a bicyclo[3.3.1]nonane skeleton fused with a 6-membered 
ring. Michael product 1.16 arising from reaction of 5,5-dimethyl-1,3-cyclohexane-1,3-dione 
1.15 with two equivalents of methyl vinyl ketone undergoes a double Robinson annulation 
with elimination of two molecules of water; noteworthy is the regioselectivity of the last 
annulation, which gives rise only to the 6-membered ring product 1.17 rather than 5 or 4 
membered ring (Scheme 1.7). 
 
Scheme 1.7: Michael addition-Robinson annulation for the synthesis of fused bicyclo 1.17.24 
 
Very recently, an interesting mechanistic rationale for the diastereoselectivity observed in 
the base-catalysed Robinson annulation for the synthesis of bridged bicyclo[3.3.1]nonanes 
was proposed by Yu et al.25 DFT calculation and a detailed analysis of the reaction energy 
profiles revealed in fact the anti-product 1.21 to be formed preferably (Scheme 1.8). 
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Scheme 1.8: Base-catalysed Robinson annulation of enones of type 1.18 to give bicyclo[3.3.1]nonanes 1.21.25 
 
Another example featuring cyclohexane-1,3-dione was showcased by Coates and co-
workers.26 During their study on the aldol cyclisation of cyclohexane-1,3-dione derivatives a 
similar aldol cyclisation from 2-methyl-2-(3-oxobutyl)-1,3-cyclohexanedione (1.22) and its 4-
methyl analogue was also observed leading to bicyclo[3.3.1]nonane derivatives. Base-
catalysed cyclisation may occur on both carbonyl groups in the ring leading to two types of 
bridged bicyclic ketols (1.23 and 1.24) as a mixture of exo and endo-diastereoisomers 
(Scheme 1.9). 
 
Scheme 1.9: Coates aldol cyclisation approach and different mode of cyclisation leading to ketol 1.23 and 1.24.26 
 
In 2000, Koo27 et al envisioned a one-pot reaction for the construction of the [3.3.1]nonane 
bicyclic skeleton en route to cyclic steroids. Two consecutive intramolecular Michael-aldol 
reactions starting from aldehyde 1.25 and ethyl acetoacetate 1.26 afforded 
bicyclo[3.3.1]nonane scaffold 1.29 in moderate to good yields, albeit with poor 
diastereoselectivity (Scheme 1.10). 
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Scheme 1.10: Michael-aldol sequence employed by Koo et al for the synthesis of fused ketol 1.29.27 
 
Camps et al applied a double Michael strategy for the synthesis of differently substituted 
bicyclo[3.3.1]nonane-3,7-diones 1.34. Their synthetic sequence involved oxidation of 
polysubstituted phenols 1.30 with phenyliodonium diacetate followed by a double Michael 
addition of the resulting 4-alkoxy-4-alkylcyclohexa-2,5-dienones 1.31 with dimethyl 1,3-
acetonedicarboxylate 1.32 under basic conditions. The bicyclo[3.3.1]nonane-3,7-diones 
obtained after subsequent hydrolysis and decarboxylation of 1.33 are the same, regardless 
of the face selectivity of the Michael addition (Scheme 1.11).28 
 
 
 
Scheme 1.11: Camp’s double Michael approach for the synthesis of 3,7-substituted bicyclo[3.3.1]nonanes.28 
 
In a related manner, Reddy et al developed a simple methodology for the enantioselective 
synthesis of functionalised bicyclo[3.3.1]nonanes via intermolecular alkylation of Michael 
donors with 10-bromocarvones 1.35 and subsequent intramolecular Michael addition.29 
Although the scope of the methodology wasn’t expanded further than the use of three 
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different Michael acceptors and only methyl substitution at position 7, the simplicity and the 
enantioselectivity of the approach paved the way for Porco’s transformation of 
Clusiaphenone B into the bicyclo[3.3.1]nonane precursor of the natural product Clusianone 
30 (Scheme 1.12). 
 
 
Scheme 1.12: Reddy’s alkylation/intramolecular Michael addition strategy.29 
 
More recently, bicyclo formation has been achieved by employing α-alkoxycarbonyl- and/or 
α-acyl-cycloalkanones. Two important related examples are the acid-catalysed annulation 
of substituted 2-acylcyclohexanone with methacrolein and the domino carbocyclization 
reactions of cyclic 1,3-dicarbonyl compounds with malonic acid derivatives catalyzed by N-
Heterocyclic carbenes. In the former described by Nicolaou31, addition of TfOH at ‒78 °C to 
a solution of diketone 1.39 and methacrolein in CH2Cl2 enabled the intermolecular 1,4-
addition to the α,β-unsaturated aldehyde followed by subsequent protonation and 
intramolecular aldol reaction which gave rise to bicyclic hydroxyl diketone 1.40 in 63% as a 
2:1 mixture of diastereoisomers. The scope was not studied and the relative configurations 
were not assigned, given that both stereogenic centres were destroyed in the following 
oxidation step, but are presumably as shown on scheme 1.13, with the 3-methyl group being 
assigned as exo to the bridgehead carbonyl group. The group subsequently applied the 
same strategy for the synthesis of bicyclo[3.2.1]octane scaffold in order to access the 
complex polycyclic skeleton of Perforatumone, a member of the PPAP family (Scheme 
1.13). 
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Scheme 1.13: Nicolaou’s Michael-aldol strategy in the synthesis of bicyclo[3.3.1]nonane and bicyclo[3.2.1]octane 
towards natural product perforatumone.31 
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Rodriguez proved the utility of N-heterocyclic carbenes (NHC) of type 1.45 in the Michael 
addition of 1,3-carbonyl compounds.32 As shown by the formation of enolate-imidazolium 
complex 1.46 in the catalytic cycle, the NHC catalyst has the unique role of acting as 
Brönsted base and Lewis acid on the same carbon atom; complex 1.47 would then activate 
the electrophile, acting as Lewis acid and generating Michael adduct 1.48. This method gave 
access to bridged bicyclic compounds in good to excellent yields, with either cyclic or acyclic 
nucleophiles (such as 1,3-keto esters, 1,3-diketones, 1,3-ketoamides) in combination with 
methyl acrylate, acrylamide, phenyl vinyl sulfone, acrylonitrile, methyl vinyl ketone, or 
acrolein. However, only [3.2.1]octane bicyclic scaffold could be accessed with this method 
with the only example of bicyclo[3.3.1]nonanol shown on Scheme 1.14, which proceeded in 
good yield but poor stereoselectivity (Scheme 1.14). 
 
Reaction outline Catalytic cycle 
 
 
Scheme 1.14: Rodriguez N-heterocyclic carbene-catalysed Michael addition of 1,3-carbonyl compounds.32 
 
A related Michael-aldol approach starting from β-keto esters was undertaken by two different 
groups at the same time33 in their effort towards the total synthesis of huperzine A. In both 
cases, β-keto ester 1.49 was reacted with methacrolein to furnish the bicyclic scaffold of 
huperzine A in 93% yield. This Michael-aldol sequence was later implemented with the use 
of a chiral Cinchona base34 or with a quinine-derived chiral thiourea organocatalyst35 to give 
the desired bicyclic scaffold in 64% and 94% ee respectively. Another powerful method for 
the construction of the bicyclo[3.3.1]nonane scaffold, which will be explored more in depth 
for the synthesis of PPAP natural products, is the Pd-catalysed annulation of β-keto ester; 
in this context, Kozikowski36 investigated a second generation synthesis of huperzine A by 
reaction of β-keto ester 1.51 with 2-methylenepropane-1,3-diol diacetate 1.52. The exocyclic 
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double bond at position 8 was isomerized with triflic acid and the synthesis of the natural 
product carried out using the same racemic sequence reported originally (Scheme 1.15).33a 
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Scheme 1.15: Access to huperzine A via Michael-aldol and Pd-catalysed annulation approaches.33, 36 
 
A similar bicyclic compound, featuring a cyclohexane ring fused to the bicyclo[3.3.1]nonane 
unit rather than the 2-pyridone ring of huperzine A was observed by Hassner et al during the 
development of a route for the construction of functionalized eight and seven-membered 
rings.37 LDA mediated alkylation of trans-methyldecalone 1.55 with pentadienoic ester 1.56 
followed by intramolecular Michael addition of the major isomer 1.57 with t-BuOK yielded 
exclusively endo-bicyclic ketol 1.58 in 49% yield (Scheme 1.16). 
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Scheme 1.16: Intramolecular Michael addition for the synthesis of fused bicyclo compound 1.58.37 
 
The PPAP class of natural products greatly benefited from Michael type reaction and in this 
context the first asymmetric total synthesis of (‒)-hyperforin, reported by Shibasaki in 2010, 
remains a milestone in this field.38 The synthetic sequence started with a Diels-Alder reaction 
pioneered by the same group39 between diene TIPS enol ether 1.59 and dienophile 
oxazolidinone acrylamide; the reaction, catalysed by a cationic iron-pybox complex, cleanly 
afforded cyclohexene 1.60 in high yield with simultaneous installation of the two vicinal 
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tertiary and quaternary centres in high enantiomeric excess. A long, however, well 
maneuvered sequence with several functional group manipulation of the ketone moiety and 
installation of prenyl and isopropyl groups at C-5 and C-1 respectively gave after 20 steps 
aldehyde intermediate 1.61; the latter underwent the key intramolecular aldol reaction in the 
presence of NaOEt furnishing the bicyclo[3.3.1]nonane scaffold to which followed DMP 
oxidation of the resultant alcohol. Installation of the enone moiety and of two additional 
prenyl substitutents via palladium enolate oxidation, π-allyl palladium chemistry and olefin 
cross-methathesis respectively was achieved in 4 steps and afforded intermediate 1.63.  
Conversion to the desired 1,3-ketone moiety however proved to be extremely difficult and 
the Shibasaki group had to turn to an unusual vinylogous Pummerer rearrangement of allylic 
sulfoxide 1.64 (highlighted in brackets) in the presence of the bulky base 2,6-di-tert-
butylpyridine; the resulting allylic alcohol 1.67, obtained in 65% yield, was subjected to a few 
more manipulations for the installation of the remaining functionalities and within 7 steps the 
first total synthesis of (‒)-hyperforin, the antipode of the natural occurring PPAP, was 
completed (Scheme 1.17). 
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Scheme 1.17: The first total synthesis of (‒)-hyperforin by Shibasaki’s group.38 
 
In their synthetic efforts towards Papuaforin A, a PPAP natural product featuring a 2H-pyran 
ring fused to the bicyclo[3.3.1]nonane core, Kraus et al developed an eight step 
methodology towards 1.72, a valuable intermediate in the synthesis of the above-mentioned 
natural product.40 A notable two step sequence involving Michael addition of cyclohexanone 
1.68 to methyl acrylate followed by subsequent cyclisation and Birch reduction forged the 
bicyclo[3.3.1]nonane scaffold 1.69 in 85% yield. The resulting diol was oxidised and 
transformed to the TIPS enol ether which was brominated under radical conditions to afford 
an α-bromoenone (not shown) which after a Sonogashira cross coupling reaction afforded 
tertiary alcohol 1.71. Stereoselective reduction of 1.71 alkyne group yielded pyran hemiketal 
1.72 in 35% overall yield (Scheme 1.18). 
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Scheme 1.18: Synthesis of Papuaforin A core via Michael addition/Birch reduction/cyclisation.40 
 
Michael addition followed by acid catalysed intramolecular cyclisation was also the strategy 
adopted by Takagi and co-workers towards the construction of natural product plukenetione 
A.41 The complex adamantane framework was built in only eight steps starting from 1.73. 
After two consecutive Michael additions to build the bicyclo[3.3.1]nonane core, LiBH4 
reduction of the bridge ketone and organometallic addition of two methyl groups afforded 
intermediate 1.76; two sequential oxidations, protection of the tertiary alcohol and 
introduction of the benzoyl functionality gave triketone 1.78 which upon treatment with TfOH 
underwent intramolecular cyclisation to afford the highly advanced intermediate 1.79 
(Scheme 1.19). 
 
O
EtO2C
OAc
CO2EtO
OEt
O
OEt
EtO2C OEtHK2CO3, TBAB
plukenetione A
92% 55%
, LDA
OHO
O
H
OHO
O
O
Ph
O
Ph
1) LiBH4, 100%
2) MeLi, CeCl3, 74%
1) Pd(OH)2/C, t-BuOOH, O2, 58%
2) CrO3·3,5-DMP then TMSCl, imidaz., 
                2 steps, 85%
OEtH
OH
LiTMP, BzCl OEtH
OOTMS
TfOH, 59%
OEtH
OOTMS
O
Ph
88%
O
O
O
H
HO H
O
Ph
O
1.73 1.751.74 1.76
1.771.781.79
HO H
 
Scheme 1.19: Takagi’s Michael addition/acid-catalised cyclisation strategy towards Plukenetione A.41 
 
Also of interest is the effort by Patir’s group towards the synthesis of Uleine and 
Dasycarpidone type-alkaloids.42 The tetracyclic compound 1.81 featuring a bridged 
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[3.3.1]azabicyclo unit was obtained from a multi-step reaction involving a Michael-type 
intramolecular cycloaddition, this time on a conjugated iminium species 1.80 (Scheme 1.20). 
 
 
Scheme 1.20: Patir’s synthesis of intermediate 1.81, a highly advanced intermediate in the synthesis of Uleine 
and Dasycarpidone alkaloids.42 
 
Lastly, a double Michael addition for the synthesis of 9-disubstituted bicyclo[3.3.1]octane-3-
ones was reported in 2013 by Richard and co-workers; reaction between 2,7-cyclooctadien-
1-one 1.82 with various carbon nucleophiles under basic conditions afforded a good array 
of substituted bicyclo[3.3.1]nonanes in 42–96% yield (Scheme 1.21).43 
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Scheme 1.21: DMA approach for the synthesis of C-9 substituted bicyclo[3.3.1]nonanes from cyclooctadienones 
of type 1.82.43 
 
In contrast, Ballini approached the synthesis of the bicyclo[3.3.1]nonane scaffold from 
acyclic reactants.44 Commercially available ethyl 2-(bromomethyl)acrylate undergoes a 
double alkylation in the presence of 1,3-dinitroalkanes with concomitant release of two 
molecules of HBr to give intermediate 1.87; the two electron-poor olefin moieties engage in 
a double conjugate addition to generate in one-pot and under mild basic conditions the 
bicyclic framework in a highly diastereoselective manner, forming the 3-exo-7-endo 
diastereoisomers 1.88 in 62-80% yield (Scheme 1.22). 
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Scheme 1.22: Ballini’s synthesis of highly functionalized bicyclo[3.3.1]nonanes.44 
 
1.5.1.2 Annulation of enamine cyclohexanone derivatives 
 
In his extensive study towards the enamine alkylation and acylation of carbonyl compounds, 
Stork reported for the first time the formation of bicyclo[3.3.1]nonane in the form of an 
hydroxyketone 1.90, which arises from a double enamine mechanism (Scheme 1.23).45 
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Scheme 1.23: Stork first reported use of enamines in the synthesis of bicyclo[3.3.1]nonanes.45 
 
Enamines of cyclohexanone can be converted into bicyclo[3.3.1]nonane by various 
condensation reactions. Bicyclo[3.3.1]-2,9-diones 1.95 for example were obtained by 
reacting enamine 1.91 and acyl chloride 1.92, through a sequence that has been reported46 
to involve N-acylation, a [3,3]-sigmatropic rearrangement and enamine-mediated ring 
closure (Scheme 1.24). 
 
 
Scheme 1.24: Synthesis of bicyclo[3.3.1]-2-9-diones via enamine acylation/sigmatropic rearrangment/ring 
closure sequence.46 
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Synthesis of 3-substituted derivatives could be achieved by a more general annulation 
method between enamine 1.96 with methyl 2,3-dibromopropanoate.47 The reaction 
proceeds via dehydrobromination of 1.97 followed by alkylation of the enamine with the latter 
and Michael annulation. Interestingly the less thermodynamically stable conformer 1.100 
was obtained as well as the more favored one 1.99 (Scheme 1.25). 
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Scheme 1.25: General method for the synthesis of 3-substituted bicyclic compounds via enamine annulation 
with halogenated esters.47a 
 
Almost 30 years later, Gravel in the process of developing a mild method for the γ-alkylation 
of β-keto esters, observed the formation of bicyclo[3.3.1]nonane 1.104 by reacting the 
enamino derivative of β-keto ester 1.103 with electrophilic olefins like acrolein and 
methacrolein.48 The rationale for the inverse mode of cyclisation was based on the higher γ-
reactivity of β-keto esters enamino derivatives, which was first observed by Colonna49 and 
demonstrates how the enamino form 1.103 was more reactive than the vinylogous 
carbamate 1.102 (Scheme 1.26).  
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Scheme 1.26: Gravel rationale for the enamine reactivity in the synthesis of bicyclo[3.3.1]nonane.48 
 
More recently, the power of enamine chemistry in the construction of bicyclo[3.3.1]nonane 
derivatives was elegantly demonstrated by Tang and co-workers.50 Optically active 2-
hydroxy-9-oxo-bicyclo[3.3.1]nonanes 1.111 were obtained in good to high yields and high 
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ee via a one-pot, formal [3+3] annulation reaction of enamines derived from cyclic ketones 
of type 1.105 and enones. In the presence of a catalyst like 1.106, cyclohexanone 1.105 is 
converted into enamine 1.107 first, which undergoes Michael addition followed by 
isomerization and final aldol reaction with regeneration of the catalyst. The high 
enantioselectivity is explained by the selective attack of the enamine to one of the two planar 
faces of the prochiral sp2-hybridized carbon of the enone, i.e. the si face, which is activated 
by the sulfonamide via hydrogen bond (Scheme 1.27). 
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Scheme 1.27: Tang’s use of enamine chemistry for the synthesis of optically active 2-hydroxy-9-oxo-
bicyclo[3.3.1]nonanes.50 
 
 
1.5.1.3 Biomimetic annulation and dearomatisation strategies  
 
The number of dearomatisation examples carried out in nature by microorganisms, mostly 
oxygenase and reductase enzymes, is quite significant and surprising at the same time, 
considering the high resonance energy of the benzene ring. Dearomatisation of aromatic or 
heteroaromatic substrates is a very powerful synthetic tool for the conversion of planar, 
aromatic substrates into sp3-enriched architecturally complex molecules.51  
 
One of the most important and compelling dearomatisation process in nature is the putative 
biosynthesis of ()-hyperforin, a PPAP natural product which features the 
bicyclo[3.3.1]nonane scaffold. The diprenylated ring of benzene intermediate 1.112 is 
suspected to be dearomatised in the presence of geranyl diphosphate, followed by a C-2 
enol attack; in the same step, the C-1,C-8 bond would be made and an additional prenyl 
group installed at C-7, leading to ()-hyperforin 1.114 (Scheme 1.28).15 
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Scheme 1.28: Putative mechanism for the biosynthesis of the natural product ()-hyperforin.15 
 
In this context and inspired by ()-hyperforin’s proposed biosynthetic pathway, Porco’s 
group pioneered most of the dearomatisation-annulation strategies known for the 
construction of the bicyclo[3.3.1]nonane scaffold, completing several total synthesis of 
PPAP natural products in the process. One important example is represented by the 
asymmetric total synthesis of (‒)-clusianone;52 alkylative dearomatisation of 1.115 with 
triflate 1.116 followed by the key formic acid-mediated cationic cyclisation (intermediate 
1.117) forged the bicyclo[3.3.1]nonane core affording intermediate 1.118; RCM with Grubbs 
second generation catalysts completed the total synthesis of the natural product, yielding (‒
)-clusianone in 81% yield (Scheme 1.29). 
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Scheme 1.29: Porco’s dearomatisation approach in the enantioselective total synthesis of (‒)-clusianone.52 
A domino alkylative dearomatisation-annulation was first developed in 2007 for the synthesis 
of racemic (±-clusianone;30 as depicted in Scheme 1.30 the use of an α-acetoxy enal led to 
a highly diasereoselective dearomatisation-annulation of substrate 1.119, which was 
followed by an intramolecular Michael reaction to give 1.121, an important intermediate 
towards clusianone’s synthesis. By changing the reaction conditions and cooling the 
reaction mixture to 0 °C the kinetic protonation product 1.124 was instead favoured and 
underwent an intramolecular aldol reaction giving the complex adamantane scaffold, whose 
structure is closely related to the PPAP natural product ()-hyperibone K (Scheme 1.30). 
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Scheme 1.30: Porco’s divergent synthesis of highly functionalized intermediates in the synthesis of PPAP 
derivatives.30 
Three years later, the same alkylative dearomatisation-annulation strategy was used for the 
enantioselective total synthesis of (-hyperibone K.53 Cinchona-alkaloids-derived phase 
transfer catalyst mediated the key dearomatisation-annulation step between phloroglucinol 
derivative 1.126 and heptanoate aldehyde 1.127, followed by a subsequent aldol reaction 
to give adamantane compound 1.129. A retro-aldol step triggered by LDA followed by 
addition of 2-methyl propenyl magnesium bromide afforded allylic alcohol 1.131; (-
hyperibone K was finally obtained through an intramolecular cationic cyclisation catalised by 
scandium triflate (Scheme 1.31). 
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Scheme 1.31: Porco’s dearomatisation/annulation strategy for the synthesis of ()-hyperibone K.53 
34 
 
To complete their studies towards the PPAP family, Porco and co-workers ultimately 
managed to access the highly substituted adamantane core of (±-plukenetione A, a C-3,C-
5 regioisomer of the previously synthesised (-hyperibone K.54 In this context, his group 
devised a synthetic route with a selective alkylative dearomatisation as the key step; 
treatment of 1.132 with α-acetoxy enal under strong basic conditions delivered the mono-
alkylated product where dearomatisation took place as planned, exclusively at C-3.  Direct 
access to the annulation product through a domino cascade was not possible due to a 
probable retro-Michael process; nevertheless, exposure to conc. HCl forged the 
adamantane scaffold, giving alcohol 1.135 in 75% as a single diastereoisomer. Two possible 
mechanistic pathways were proposed to rationalize the adamantane formation (Scheme 
1.32, path a and b); in path a the acid mediated protonation of the aldehyde in 1.133 can 
promote a demethylative aldol cyclisation followed by a second protonation of the alkene 
and subsequent cationic cyclisation to give 1.134; in path b the allylic resonance structure 
(1.136) derived from aldehyde 1.133 can undergo directly a cationic cyclisation to forge the 
bicyclo[3.3.1]nonane core which participates in a final aldol reaction to give the adamantane 
core. (±-plukenetione A was lastly accessed from 1.135 in 6 steps and in 74% yield 
(Scheme 1.32). 
 
 
Scheme 1.32: Selective alkylative dearomatisation for the access to (±-plukenetione A.54 
 
In the context of biomimetic approaches, another contribution was given by Couladouros’ 
work on the synthesis of the highly functionalised bicyclo[3.3.1]nonane framework.55 The 
same alkylative dearomatisation strategy pioneered by Porco was applied to substrate 1.138 
affording selective acetylated intermediate 1.141. Conversion of the tertiary alcohol into the 
corresponding mesylate led to spontaneous cyclisation to bicyclo[3.3.1]nonane (path a) 
albeit with concomitant formation of the O-alkylation product (path b) in 89% combined yield 
(1.143:1.144 ca 1.5:1) (Scheme 1.33). 
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Scheme 1.33: Couladouros’ alkylative dearomatisation approach for the synthesis of highly functionalized 
bicyclo[3.3.1] intermediates.55 
 
Another well-recognized annulation method for the rapid formation of carbon-carbon bond 
is the reaction of various nucleophiles with allylic substrates via Pd π-allyl intermediates. 
The reaction between cyclic enamines and allylic alkylating reagents to afford bridged 
bicyclic ketones was documented by Murahashi for the first time in 1973;56 later in 1998 
Tenaglia accessed bicyclo[3.n.1]alkanones through a palladium-catalyzed C,C-dialkylative 
cyclisation of monoalkylated β-diketones (Scheme 1.34).57 
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Scheme 1.34: Tenaglia’s palladium-catalyzed C,C-dialkylative cyclisation of monoalkylated β-diketones.57 
 
These two precedents remained little explored until very recently, with Porco’s report on the 
Pd-catalysed dearomative conjunctive allylic annulation (DCAA) between desoxyhumulone 
derivative 1.147 and bis-Boc-protected-methylenepropane-1,3-diol;58 this method 
represents a powerful domino strategy and depending on the mode of annulation both type 
A and type B PPAP analogs can be easily accessed in high yield (Scheme 1.35). 
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Scheme 1.35: Porco’s Pd-catalysed dearomative conjunctive allylic annulation strategy to access both type A 
and B PPAP.58 
 
 
1.5.1.4: Annulation of cyclohexanone derivatives featuring the Effenberger cyclisation  
The Effenberger cyclisation59, in which cyclohexanones derivatives 1.151 are annulated in 
the presence of malonyl chloride to give the bicyclo[3.3.1]nonane scaffold 1.152, also 
represents a powerful annulation method (Scheme 1.36). 
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Scheme 1.36: Mechanism for the Effenberger annulation. 
Although limited by the modest yield, the restrictive use of 2-unsubstituted malonyl 
derivatives and 6-membered rings, a few groups successfully applied this strategy to the 
synthesis of the bicyclo[3.3.1]nonane scaffold. The first application of the Effenberger 
annulation in the construction of this bicyclic scaffold was reported by Stoltz in 2002, who 
obtained bicyclo[3.3.1]nonane 1.154 via a one-pot reaction of TBS enol ether 1.153 and 
malonyl chloride under basic and phase-transfer conditions.60 This protocol was particularly 
attractive despite the modest yield as the annulation was completely stereoselective in 
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respect to the prenyl group, which was found to have an anti-orientation relative to the 1,3-
diketone moiety just formed (Scheme 1.37). 
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Scheme 1.37: Stoltz’ application of the Effenberger annulation for the synthesis of bis-prenylated 
bicyclo[3.3.1]nonanes.60 
A closely related Effenberger annulation was also used by Simpkins in his total synthesis of 
(±)-nemorosone in 2010.61 Bis-prenylated silyl enol ether 1.157 generated via prenylation, 
cuprate mediated conjugate addition and subsequent silylation from 1.156, was readily 
cyclised in the presence of malonyl chloride with in situ methylation of the resulting alcohol 
to afford intermediate 1.158. A challenging C-3 prenylation and acylation of the C-1 
bridgehead position completed the total synthesis of this PPAP natural product in 55% 
overall yield (Scheme 1.38). 
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Scheme 1.38: Simpkins’ total synthesis of (±)-nemorosone.61 
 
Marazano’s α,α-annulation of silyl enol ether 1.159 with malonyl chloride is also noteworthy 
and afforded the corresponding bicyclo[3.3.1]nonane-trione 1.160 in 35% yield.62 C-
acylation with benzoyl cyanide completed their total synthesis, giving (±)-clusianone in 65% 
yield (Scheme 1.39). 
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Scheme 1.39: Marazano’s α,α-annulation of 1.159 with malonyl chloride for the synthesis of (±)-clusianone.62 
38 
 
 
Lastly, Coltart and co-workers devised an Effenberger annulation strategy for the 
asymmetric synthesis of (+)-clusianone.63 The key optically enriched cyclohexenone 
intermediate 1.162, obtained in 3 steps from 1.161 as a 4:1 epimeric mixture at C-1, was 
converted into its methyl enol ether 1.163. This then underwent an Effenberger type 
cyclisation affording bicyclo 1.164 with concomitant methylation of the enolisable β-diketone. 
Introduction of the remaining prenyl and benzoyl substituents followed by demethylation 
gave ()-clusianone in 71% yield (Scheme 1.40). 
 
Scheme 1.40: Coltart’s asymmetric synthesis of clusianone via Effenberger type annulation.63 
 
 
 
1.5.2 Desymmetrisation Strategies 
 
Synthetic chemistry, especially in the field of natural product total synthesis, has greatly 
benefited from the application of desymmetrisation strategies. Through either enantiotopic 
or diastereotopic group discrimination, several transformations can be in fact carried out 
while efficiently controlling the outcome of a particular stereocenter, guaranteeing therefore 
a high level of stereochemical integrity.64 
 
A late-stage desymmetrisation was used by Njardarson’s group in their exploration of the 
Guttiferone PPAP family derivatives.65 Following dearomatisation of phenol 1.165 with 
(diacetoxyiodo)benzene and intramolecular radical cyclisation, the tricyclic intermediate 
1.168 was successfully desymmetrised through its lithium enolate. Formation of both chiral 
enol ester 1.169 and α-methyl ketone 1.170 illustrated the power of this strategy in accessing 
optically active substrates which can be subsequently carried forward in the synthesis of 
PPAP derivatives (Scheme 1.41). 
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Scheme 1.41: Njardarson’s desymmetrisation approach towards the synthesis of functionalized intermediates 
for the access to guttiferone PPAP family.65 
Perhaps the most elegant example of desymmetrisation was demonstrated by Shair in 2013 
in his enantioselective total synthesis of (+)-hyperforin.66 The 18-step route was based 
around a geraniol fragment closely related to that used in nature for the biosynthesis of 
hyperforin. In a similar manner, deprotonation of cyclohexadiene 1.171 with t-BuLi and 
subsequent prenylation and coupling with the enantio-enriched epoxide 1.173 gave 
cyclisation precursor 1.174. Exposure of the latter to the Lewis acid TMSOTf activated the 
epoxide towards nucleophilic attack; a careful analysis of the transition state showed how 
only one enol ether engaged the activated epoxide through a chair-chair transition state 
(1.175); epoxide ring-opening by the alternative enol ether would result in a boat-chair like 
TS (1.176) and in a 5-endo-tet cyclisation, both highly disfavoured. 6-(enolendo)-tet cationic 
cyclisation at the epoxide carbon atom via a more favourable chair-chair TS afforded an 
oxonium ion 1.178 that was trapped internally by the liberated oxygen atom, giving the 
bridged acetal 1.179 in 79% yield as single diastereoisomer. Vinylogous ester 1.180 was 
prepared via iodine(III)-mediated allylic oxidation which installed the last required carbonyl 
group. Final hydrolysis of the ketal and insertion of the three remaining prenyl chains yielded 
()-hyperforin (Scheme 1.42). 
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Scheme 1.42: Shair’s enantioselective total synthesis of ()-hyperforin through desymmetrisation of epoxide 
intermediate 1.174.66 
 
Later in 2015, Shair and co-workers applied the same desymmetrisation strategy in the 
synthesis of two other members of the PPAP family, Nemorosone and Secohyperforin.67 
This time their choice fell upon a Lewis acid featuring a larger trialkylsilyl group as they 
postulate the latter would prevent the formation of a cyclic ketal of type 1.179 (scheme 1.42); 
its subsequent cleavage would in fact require the use of Me2BBr (as previously employed in 
the total synthesis of ()-hyperforin) which was considered not practical for their purposes 
and difficult to scale up. Thus, addition of TIPSOTf and 2,6-lutidine at −78 °C to a solution 
of 1.182 followed by slow warming of the mixture to room temperature afforded the TIPS-
protected alcohol 1.183 in 95% yield. Allylic oxidation was rather challenging and was 
ultimately achieved with Pearlman’s catalyst (Pd(OH)2/C) and TBHP, despite the additional 
requirement of DBU to convert the undesired allylic peroxide also formed during the reaction 
(not shown). Keck allylation after thiocarbonylation of the secondary alcohol and subsequent 
olefin cross-metathesis afforded intermediate 1.186 that was used for the synthesis of both 
Nemorosone and Secohyperforin, depending on the use of benzoyl chloride or isobutyroyl 
chloride respectively in the bridgehead acylation step (Scheme 1.43). 
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Scheme 1.43: Application of a similar desymmetrisation method for the synthesis of Secohyperforin and 
Nemorosone.67 
 
Porco’s group applied a similar diastereotopic group differentiation strategy for the synthesis 
of garcinol and isogarcinol derivatives, two type B members of the PPAP family.68 
Intermediate 1.187 was obtained as a single enantiopure diastereoisomer via bis-alkylation 
of acylphloroglucinol (not shown) and subjected to diastereoselective oxycyclisation; 
depending on the reaction conditions the two pyranodienone products 1.188 and 1.189 were 
obtained in different d.r. and yields. The diastereoselectivity was rationalised as a result of 
an intramolecular protonation after the formation of a hexacoordinate tin complex in the 
reaction using SnCl4 or a tetrahedral BF2 complex when BF3•Et2O was used. The same three 
steps sequence was then used to complete the synthesis of (‒)-6-epi-and ()30-epi-13,14-
didehydroxyisogarcinol respectively (Scheme 1.44). 
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Scheme 1.44: Diastereoselective, Lewis acid-controlled oxycyclisation for the synthesis of (‒)-6-epi-and ()-30-
epi-13,14-didehydroxyisogarcinol.68 
 
A very different approach was pursued in the remarkably short total synthesis of (±)-
hyperforin by Maimone and deserves comment because it provides a very succinct access 
to the bicyclo[3.3.1]nonane core (Scheme 1.45).69 Maimone and co-workers were indeed 
able to access the highly prenylated bicyclo[3.3.1]nonane-1,3,5-trione scaffold in only 6 
steps, completing the total synthesis in a total of 10 steps. Their strategy was based upon 
the exploration of a polarity-reversed reactivity; as highlighted in the grey box on Scheme 
1.45, whereas PPAPs in nature are presumably formed by attack of a nucleophilic enolate 
to a carbocationic intermediate, the reverse mode of attack will instead lead to a hypothetical 
carbonyl addition product which can undergo a [1,2]-alkyl rearrangement with ring expansion 
to give the bicyclo[3.3.1]nonane core. After copper mediated conjugate addition of 1.190 
and two subsequent alkylations, LTMP mediated deprotonation gave rise to a highly 
hindered enolate which engages in a diketene annulation reaction to afford 1.193 as single 
diastereoisomer. Generation of the key cationic intermediate 1.196 was achieved after 
extensive experimentation with hypervalent iodine where simply stirring at room temperature 
in MeOH effected the desired ring expansion, affording the PPAP skeleton in 92% yield. 
Functionalisation of the C-1 bridgehead position and a last C-prenylation afforded (±)-
hyperforin in 56% yield (Scheme 1.45). 
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Scheme 1.45: Maimone’s total synthesis of (±)-hyperforin via diketene annulation/ring expansion strategy.69 
 
1.6 Synthetic strategies towards bicyclo[3.2.1]octane framework 
 
Many new, stereoselective methodologies for the construction of the bicyclo[3.2.1]octane 
have been developed, a few being used in the total synthesis of complex natural products.70 
Shair assembled the desired bicyclic core of the natural product ()-fastigiatine by hydrolysis 
of the acetal moiety in 1.198; the corresponding ketone 1.199 underwent a 
diastereoselective intramolecular Michael addition followed by a transannular aldol reaction 
to give aldol product 1.200 from which (+)-fastigiatine was obtained in 4 steps (Scheme 
1.46).71 
 
Scheme 1.46: Shair’s total synthesis of ()-fastigiatine through a Michael-transannular aldol reaction.71 
As part of their study towards the Hajos–Parrish–Eder-Sauer-Wiechert reaction, Stephen 
Davies catalysed the intramolecular aldol reaction of triketone 1.201 with amine 1.202 to 
provide bicyclo aldol product 1.203 with high diastereoselectivity (Scheme 1.47).72  
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Scheme 1.47: Davies’ aldol condensation of 1.201 catalysed by cispentacin tetrazole derivative.72 
Michael-aldol sequences have also afforded the bicyclo[3.2.1]octane system. In 1995 
Rodriguez reported the base-catalysed reaction between 2-oxocyclopentane-1-carboxylate 
1.204 and crotonaldehyde 1.205; despite the high yield obtained this sequence presented 
low diastereoselectivity as well as being limited to only five membered ring precursors.73 Ten 
years later Nicolaou described the acid-catalysed Michael-aldol sequence between 1.207 
and methacrolein 1.208 to give bicyclic diastereomeric mixture 1.209 in good yield although 
the diastereoselectivity was not rationalised or described as the alcohol functionality was 
readily oxidized in the subsequent step (Scheme 1.48).31 
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Scheme 1.48: Rodriguez’ and Nicolaou’s Michael-aldol approaches for the synthesis of bicyclo[3,2,1]octanes.31, 
73 
In the same year Lepore proved the synthetic utility of enamines in the stereoselective 
synthesis of the [3.2.1] bicyclic scaffold; reaction between morpholine derivative 1.210 and 
allenyl methyl ketone 1.211 afforded bicyclo[3.2.1]octane 1.215; the endo mode of 
cyclisation observed was attributed to a better charge stabilisation in the endo bicyclo 
zwitterionic intermediate 1.214 which is also thermodynamically favoured; the (E)-geometry 
of the alkene arose from the initial Michael-Stork addition occurring at the less hindered 
bottom face of allene 1.211 (Scheme 1.49).74 
45 
 
N
O BnO

O
NO
BnO
O
NO
BnO
OO
H
OBn
N
O
OH
H
OBn
O
Benzene
1 h, 25 C
1.210 1.211 1.212
1.2131.2141.215  
Scheme 1.49: Rationalisation for the endo-selectivity and the double bond geometry observed in the reaction 
between enamines and allene of type 1.211.74 
Barluenga was the first to describe the transition metal-assisted [3+3] carbocyclisation 
reaction of enamines with Fisher carbenes (Scheme 1.50).75 Chiral cyclopentanone 
enamines 1.216 undergoes β,β’-annulation with either chromium or tungsten alkenyl 
carbene complexes of type 1.217 to generate bicyclic metallated intermediate 1.220 via 
Michael adduct 1.218. The acid-induced elimination of methanol from 1.219 forms the 
stabilized carbene species 1.220 which undergoes β-elimination and reductive metal 
elimination to give enantiomerically enriched endo-cycloadduct 1.221 in very high yields and 
ee. However, the same transformation using cyclohexanone enamine gave much lower 
levels of diasteroselectivity and enantioselectivity (Scheme 1.50). 
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Scheme 1.50: Barluenga’s transition metal-assisted carbocyclisation reaction to give bicyclo[3.2.1]octanes.75 
Wright and co-workers investigated the Diels-Alder reaction of tetrahalocyclopropenes to 
access bicyclic skeletons of biological relevance.76 Beaudegnies’ group applied this strategy 
for the synthesis of bicyclo[3.2.1]octane-2,4-diones with the intent to access novel 
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precursors for 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors (Scheme 1.51).77 
Heating a mixture of cyclopentadiene 1.222 and tetrachlorocyclopropene 1.223 in toluene 
readily afforded the exo-adduct 1.224 which underwent a spontaneous torquoselective 
sigmatropic rearrangement to give bicyclic structure 1.225. Conversion into the desired 
diketone product 1.226 was then achieved in 5 steps, accessing three different bicyclo[3.2.1] 
compounds in good to high yield (Scheme 1.51). 
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Scheme 1.51: Beaudegnies’ Diels-Alder strategy for the synthesis of bicyclo[3.2.1]octane-2,4-diones.77 
 
 
1.7 Our synthetic plan and initial aim of the project 
 
As outlined in this chapter, the exploration of new regions of the chemical space is a priority 
for the discovery of new compounds with unique chemical and biological properties. In 
particular, saturated bridged carbobicyclo systems attracted our attention because of the 
recent emphasis on compounds with a higher fraction (approx. 50%) of sp3 carbon atoms 
per molecule for improved physicochemical properties (better ‘drug-likeness’) and because 
of the challenge of constructing such scaffolds with specific three-dimensional direction of 
multiple substituents. 
Our interest initially fell upon the class of polycyclic polyprenylated acylphloroglucinols 
(PPAPs), whose members display a diverse array of biological properties and whose 
structures feature a complex, densely prenylated bicyclo[3.3.1]nonane or [3.2.1]octane 
scaffold. Our first approach towards the PPAP framework investigated a dearomatisation 
strategy, the addition of a three-carbon chain across the carbon atoms derived from a 
benzene ring to create the bicyclo[3.3.1]nonane core (Scheme 1.52). The dearomatisation 
precursor 1.228 could be accessed from commercially available 1,3,5-trimethoxybenzene in 
three steps, i.e. Friedel-Crafts acylation, subsequent allylation and selective demethylation. 
The methyl ester groups at positions 4 and 6 would closely relate to Shair’s intermediate 
1.172 (Scheme 1.42) and would render the compound easier to handle. The key 
dearomatisation of 1.228 by two chiral epoxides would give a pair of diastereomers, 
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1.229/1.230 or 1.231/1.232, which following two possible modes of cyclisation would give 
the bicyclo[3.3.1]nonane skeleton of type A (C-1 cyclisation) and type B (C-3 cyclisation) 
PPAP. This enantiodivergent sequence has not, to our knowledge been investigated and 
could provide a short route to fully-substituted bicyclo[3.3.1]nonane systems (Scheme 1.52). 
 
 
 
Scheme 1.52: Enantiodivergent synthesis of type A and B PPAP via dearomatisation and epoxide-mediated 
cyclisation. 
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The second strategy we pursued relied upon a desymmetrisation approach, starting from 
simpler, readily available 1,3-diketones (dihydroresorcinol derivatives); after introduction of 
a similar epoxide functionality and subsequent ring opening cascade via a chair-like 
transition state (path A), the desired bicyclic scaffold with desymmetrisation of the diketone 
precursor would be accessed in just one step (Scheme 1.53). 
 
OO
H
O
Boat-like TS
OOX
O+
Chair TS
X O R O
HO
RR O R O
O+
XX
H
LA
cyclization favoured
O R O
cyclization disfavoured
dehydroresorcinol
precursor
H OH
AB
LA
 
Scheme 1.53: Access to the bicyclo[3.3.1]nonane scaffold via desymmetrisation of dehydroresorcinol 
precursors. 
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CHAPTER 2: APPROACHES TOWARDS BICYCLO[3.3.1]NONANE 
VIA EPOXIDE CYCLISATION 
 
2.1 Synthesis of the dearomatisation precursor 3,5-diallyl-2,4,6-trimethoxyphenyl 
methanone 
Allylated aromatic compounds constitute useful intermediates in organic synthesis and can 
be synthesised using palladium80 or other transition metal catalysts.78 Besides these 
methods a few Friedel Craft-type allylations have also been reported using Lewis acids 
although the yields of the desired allylated products are low due to side reactions or 
decomposition of the catalyst.79 For instance, Fukuzawa79 described a Sc(OTf)3 Friedel-
Crafts allylation where an allylic alcohol could be used directly as alkylating agent and the 
reaction could be run without specific dryness requirements. In this context, our investigation 
started with the synthesis of the unknown bis-allylated compound 2.3. We started with the 
acylation of the commercially available 1,3,5-trimethoxybenzene 2.1 with benzoyl chloride 
which provided 2,4,6-trimethoxyphenylmethanone 2.2 in 50% yield. We then sought 
allylation of compound 2.2 under the conditions reported by Fukuzawa79 and Tamaru80 as 
well as using two more Lewis acids SnCl4 and TfOH but unfortunately none of the conditions 
showed in Scheme 2.1 led to the desired product 2.3. 
No reaction
Unidentified mixture
Unidentified mixture
Unidentified mixture
Outcome
Pd(PPh3)4, 5 mol%, Et3B, THF, 25 C, 16 h
Sc(OTf)3, PhMe, 100 C, 24 h
TfOH, 1,2DCE, 80 C, 16 h
SnCl4, 1,2-DCE, 80 °C, 16 h
Conditions
MeO OMe
O
PhOMe
MeO OMe
O
PhOMe
MeO
OMe
OMe
PhCOCl, AlCl3
CH2Cl2, 0 to 25 C
16 h, 50%
2.1 2.2 2.3
OH
Table
 
Scheme 2.1: Conditions for the allylation of 2.2. 
Given the inability to achieve Friedel-Crafts allylation, bromine groups were introduced for 
an alternative strategy involving a subsequent cross-coupling reaction. Reaction of 2.2 with 
Br2 in CH2Cl2 gave 2.4 in only 12%; N-bromosuccinimide led to a slight improvement, giving 
the dibromo product in 21%. Eventually, an improved procedure was found; heating at 50 
°C in glacial acetic acid afforded 2.4 in 62% (Scheme 2.2). 
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MeO OMe
O
PhOMe
Br
Br
MeO OMe
O
PhOMe
2.2 2.4
Conditions
Table
12%
21%
62%
(%)
Br2, CH2Cl2, 25 °C
NBS, CH2Cl2, 25 C
Br2, glacial AcOH, 50 ?C
Conditions
Scheme 2.2: Optimisation conditions for the bromination of 2.2. 
When Stille coupling conditions were applied to the trimethoxy derivative 2.4, compound 2.5 
was obtained in 86%. Unfortunately, the reaction was successful only when a stoichiometric 
amount of Pd(PPh3)4 was used, limiting the practicality of the reaction. Moreover, the 
organotin byproducts and impurities were found to be quite difficult to remove, despite 
purification on column chromatography using 10% w/w potassium carbonate-silica, as 
reported by Harrowven and co-workers.81 Selective deprotection was attempted on coupling 
product 2.5; it was hoped that the presence of the carbonyl substituent would determine the 
regioselectivity of the deprotection, with AlCl3 chelating to the carbonyl group and directing 
the deprotection of the methoxy group next to it.  Both AlCl3 and BCl3 are known to be 
efficient for the deprotection of methoxy groups82 and were preferred over BBr3 as they are 
safer to handle on large scale. What we observed instead of the mono-deprotected 2.6 was 
either the loss of the two allyl groups or degradation of the product if the temperature was 
raised above 0 °C (Scheme 2.3). 
MeO OMe
Ph
OOMe
Br
Br
2.4
SnBu3
Pd(PPh3)4,
PhMe,110 °C
12 h, 86%
MeO OMe
Ph
OOMe
2.5
AlCl3 or BCl3
CH2Cl2
0 to 25 C
MeO OMe
Ph
OOH
2.6
Scheme 2.3: Stille coupling/selective demethylation sequence. 
A search for alternative conditions for allylation revealed Fu’s procedure83 employing P(t-
Bu)3 as the first general method for room temperature cross-coupling of aryl bromides 
(Scheme 2.4). 
MeO
OMe
2.7
Bu3Sn
1.1 mol% P(t-Bu)3
PhMe, 25 C
89%
MeO
OMe
2.8
Br 0.5 mol% Pd2(dba)3
 
Scheme 2.4: Fu’s reported conditions for the cross coupling of aryl halides of type 2.7.83 
51 
 
The use of Grignard or organocopper reagents was also considered as reported by 
Hiyama.84 We therefore started with direct bromination of 1,3,5-trimethoxybenzene 2.9, 
which was closely related to Fu substrate 2.7 and was lacking any carbonyl group that could 
interfere with Grignard reagents. Controlling the temperature for this reaction was critical; at 
25 °C only 31% of the desired 2.10 was isolated, along with 30% of the monobrominated 
product 2.11. Instead, dropwise addition of Br2 at ‒10 °C gave 2.10 in 85% yield (Scheme 
2.5). 
MeO
OMe
OMe
2.9
Br2, CH2Cl2,
10 ?C, 85% MeO
OMe
OMe
BrBr
2.10
dropwise
Br2, CH2Cl2,
one portion
25 °CMeO
OMe
OMe
BrBr
MeO
OMe
OMe
Br
2.11, 30%
+
2.10, 31%  
Scheme 2.5: Bromination of 1,3,5-trimethoxybenzene 2.9. 
As shown in Scheme 2.6, the dibrominated precursor 2.10 was completely unreactive 
towards Fu conditions (Table, entry 2) whereas some reactivity was observed when 
standard Stille conditions were used yielding however only the monoallylated product 
(Table, entry 1). After a few failed attempts, it was discovered that slow addition of 2.10 to a 
solution of dibutylcopperlithium at ‒48 °C and subsequent quenching with allyl bromide 
afforded the desired product 2.12, but in 17% yield (entry 7). Given the low yield and the 
poor mass recovery, it was decided to not attempt the subsequent Friedel-Crafts acylation 
and put aside this strategy. 
MeO
OMe
OMe
BrBr
2.10
MeO OMe
OMe
R
Table
Mono-allyl product
No reaction
Unidentified mixture
Unidentified mixture
Outcome
Pd(PPh3)4, 0.5 mol%, PhMe, 110 C, 12 h
0.5 mol% Pd2(dba)3, 1.1 mol% P(t-Bu)3
PhMe, 25 C
Pd(OAc)2, P(t-Bu)3, THF, 16 h
Mg, I2, Et2O, 45 C, 1 h
Conditions
SnBu3
MgBr
SnBu3
Br
Unidentified mixture
Unidentified mixture
Mg, LiCl, Fe(acac)3, THF, 25 to 0 C, 16 h
Mg, LiCl, THF, 25 to 0 C, 16 h
OAc
OAc
17%nBu2CuLi, THF, 48 C, 2 h Br
Reagent
2.12
Entry
1
2
3
4
5
6
7  
Scheme 2.6: Conditions screening for the synthesis of 2.12. 
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2.2 Revised Strategy: Synthesis of dearomatisation precursor Clusiaphenone B 
 
The use of unprotected phloroglucinol itself was considered as an alternative starting point 
for the synthesis of the proposed allylated derivatives. Two literature procedures58, 85 were 
adopted for the acylation/alkylation sequence showed on Scheme 2.7. The allylation was 
already reported to be low yielding85 (22%) and indeed the best result was achieved using 
allyl bromide, which gave 2.15 in 21% yield. Despite the low yield, the mass recovery was 
considered sufficient (1.5 g starting from 5 g of 2.13) for continuing the sequence (Scheme 
2.7). 
HO
OH
OH HO
OH
OH
PhO
HO
OH
OH
PhO
PhCOCl, AlCl3 X
KOH, H2O
0 to 25 C
16 h, 16-21%
CH2Cl2
0  to 25 C
16 h, 41%
X = Br, 21%2.142.13
clusiaphenone B
2.15
X = Cl, 16%
X = I, no reaction  
Scheme 2.7: Synthesis of clusiaphenone B 2.15. 
Prenyl bromide was chosen as first electrophilic option for the dearomatisation of 
clusiaphenone B. To our surprise there were only two precedents involving dearomatisation 
of substrate 2.15 with prenyl bromide; the first one was reported by Yang and co-workers 
and involved the synthesis of various trialkylated intermediates en route to desmosdumotin 
C analogues; triprenylated adduct 2.16 was obtained in very low yield (11%) along with a 
mixture of diprenylated and tetraprenylated product.86 The second one was used by Porco 
in his total synthesis of clusianone30 who applied a previously reported procedure87 for the 
synthesis of dearomatised intermediate 2.17 (Scheme 2.8). 
HO OH
O
PhOH
Br
aq. KOH, 0 C
40%
O O
O
PhOH
OHHO
OH
OAc
Br
KOH, H2O
11%
OHHO
O
OAc
Porco, Total Synthesis of Clusianone, 2007Yang, Desmosdumotin C-analogues, 2011
2.16 2.17  
Scheme 2.8: Yang’s access to triprenylated 2.16 and Porco’s dearomatisation of phloroglucinol derivative.30, 86 
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Inspired by these precedents, a few dearomatisation conditions were tested (Scheme 2.9) 
HO
OH
OH
PhO
2.15
O
O Ph
HO
OH
Br
Table
Rearomatisation
No reaction
Rearomatisation
Rearomatisation
Outcome
NaH, THF
LiHMDS, THF
NaOMe, MeOH
KOH-aliquat336, PhCl
Conditions
O-alkylation
New, isolated spot
K2CO3, DMF
Cs2CO3, DMF
Degradation
Cs2CO3, THF
Temperature
0 C
No reactionKOH, H2O
KOH-TBAI, THF
O-alkylation
20, 0 and 25 °C
0 C
25 to 65 C
25 °C
25 °C
0 to 25 C
0 to 25 C
25 C
2.18
Entry
1
2
3
4
5
6
7
8
9  
Scheme 2.9: Attempted dearomatisation of precursor 2.15. 
Whereas a few of these conditions gave exclusively O-alkylation (Table, entries 6 and 7) or 
no reaction at all (Table, entries 2 and 3), the pattern for entries 1, 4 and 5 was very similar; 
a new spot was formed on TLC and crude 1H NMR always indicated the presence of the 
prenyl goup and a new quaternary carbon; however, after purification on silica gel only 
starting material 2.15 was recovered suggesting that the product had the tendency to 
rearomatise and/or undergo decomposition due to the acidity of the silica; the use of eluents 
containing 1% Et3N did not resolve the issue. Surprisingly, when the reaction was run in the 
presence of cesium carbonate no decomposition or rearomatisation was observed; when 
the reaction was performed in DMF O-alkylation occurred whereas the use of THF led to the 
formation of a new spot on TLC, which was subsequently isolated. A comparison was then 
made between our crude 1H NMR spectrum and the 1H NMR spectrum of the isomer 
compound 13 isolated by George;85 like in their case, a mixture of tautomers was expected 
and their carbonyl pattern was found quite similar to ours (Fig. 2.10 and 2.11). 
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Fig. 2.10: Comparison between the crude 1H NMR spectrum of 2.18 (top) and and George’s isolated 
compound 13 (bottom). 
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Fig. 2.11: Comparison between crude 13C NMR spectrum of 2.18 (top) and George’s isolated compound 13 
(bottom). 
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Initial assessment of our NMR was based on a promising pattern in the carbonyl region; 
however, some key signals, more upfield methylenes for instance and very downfield ones 
(16-18 ppm) for the free OHs were missing, suggesting that the desired product was actually 
not present in the mixture.  
In order to solve the stability issues caused by the presence of the allylic position in our 
substrate, which renders it more prone to rearomatisation, epoxide 2.19 was chosen as 
electrophile instead of prenyl bromide, giving the additional advantage of a direct insertion 
of the desired epoxide functionality in our scaffold, and in principle, a more convergent 
synthesis. Accordingly, several conditions were screened (Scheme 2.11). 
2.15
O
O Ph
HO
OH
X
X = Br, 2.19
Table
Unidentified mixture
No reaction
Unidentified mixture
Outcome
NaH, THF, 25 °C
LiHMDS, THF, 0 to 65 C
Cs2CO3, THF, 25 C
NaOMe, MeOH, 25 C
Conditions
No reaction
Unidentified mixture
KOH-TBAI, THF, 25 C
KOH-TBAI, PhCl, 25 C
DegradationNaH, DMF, 25 C
X
O-alkylationCs2CO3, NaI, THF, 0 to 65 °C
KOH 3M, aliquat-336, 25 C
Unidentified mixture
2.20
O
O
OH
OH
HO
O Ph
O-alkylation
Br
Br
Br
Br
Br
Br
Br
Br
Br
NaH, DMF, 0 C DegradationI
Entry
1
2
3
4
5
6
7
8
9
10
X = I, 2.19a
 
Scheme 2.11: Attempted dearomatisation with epoxide 2.19. 
As shown in the last entry of the table, iodo derivative 2.19a was also synthesised and used 
instead of the bromo one hoping for an enhanced reactivity; as seen previously with bromo 
epoxide 2.19, a new spot was formed but rearomatisation occurred after column 
chromatography.  
George described the use of homoallylic iodide 2.21 for alkylative dearomatisation, the 
advantage being that the product is less likely to undergo deallylation by SN2’ attack.85 
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If the dearomatised precursor 2.22 could be accessed, it was envisioned that a 
regioselective epoxidation of the more substituted olefin and subsequent cyclisation of 2.24 
would give access to the type B PPAP core 2.26 (Scheme 2.12). 
 
Scheme 2.12: Proposed plan towards an epoxide-opening cyclisation strategy. 
Iodide 2.28, suspected to have a closer reactivity to 2.21, was prepared via Appel reaction 
and subsequently used in an attempted dearomatisation reaction but unfortunately O-
alkylation predominated (Scheme 2.13). A different approach to the synthesis of 
bicyclo[3.3.1]nonane core was then considered, and one also consistent with our efforts 
towards a biomimetic dearomatisation of prenylated phloroglucinols.  
 
O-alkylation
No reaction
O-alkylation
O-alkylation
Outcome
NaH, DMF, 0 °C
NaH, THF, 0 °C
Cs2CO3, THF
KOH 3M, aliquat-336, PhCl
Conditions
OH
OH
HO
Ph O
O
O Ph
HO
OH
2.28 Table
2.29
I
2.27
HO
PPh3, imidaz.
I2, CH2Cl2
25 C, 20 h
46%
2.15
 
Scheme 2.13: Attempted dearomatisation with iodo precursor 2.28. 
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2.3 Desymmetrisation of 1,3-diketones derivatives 
Over the past decade, advances in desymmetrisation strategies have delivered efficient 
syntheses, especially of natural products.88 Two examples are the total synthesis of natural 
products lycoperine A89 and maistemonine.90 As shown in Fig. 2.14, the synthesis of 
lycoperine A commenced by reacting dione 2.30 with acrolein affording hemiacetal 2.31 
which was desymmetrised with an aminoalcohol to yield vinylogous amide intermediate 2.32 
(Fig.2.14, A). Similarly, a desymmetrisation strategy was used in one of the key steps of 
Tu’s total synthesis of maistemonine; TiCl4-catalysed desymmetrisation of diketone 2.33 via 
an intramolecular Schmidt reaction afforded the desymmetrised azepine intermediate 2.34 
as a single diastereoisomer (Fig. 2.14, B). 
O
OO
O
OH
N O
Ph Ph
H
O
OH
PhPh
H2N
NH
N
N
H
HAc
Ac
2.30 2.31
Cu(OTf)2
MgSO4
O
O N3
N
O
O
TiCl4
2.32, 96%
dr. = 20:1
2.33 2.34, 72%
single diast.
N
O
O Me
OMe
H O
H
O
Me
O
Me
(-)-Lycoperine A ()-Maistemonine
A: Desymmetrisation strategy towards Lycoperine A B: Desymmetrisation strategy towards Maistemonine
O
 
Fig 2.14: Desymmetrisation strategies in the context of natural product total synthesis.89-90 
Another interesting example of desymmetrisation was demonstrated by Shair in his 
enantioselective total synthesis of (+)-hyperforin (Scheme 2.15, A).66 As previously 
highlighted in chapter 1, the requirement for a chair-like transition state for 2.38 enables only 
one ketone to attack the epoxide at its carbon atom giving oxonium ion 2.39 which was 
trapped internally by the liberated oxygen atom, leading to bridged acetal 2.40. Encouraged 
by Shair’s approach, we sought to investigate new desymmetrisation strategies using more 
readily available diketones of type 2.41 (Scheme 2.15, B); a base like KHMDS, previously 
reported91 to effectively convert a 2,2-disubstituted cyclohexane-1,3-dione into the ditriflate 
ester could be used instead of the hazardous t-BuLi to obtain epoxide intermediate 2.43; if 
alkylation could be achieved there will be much to be gained since the same step in Shair’s 
synthesis required BaI2, prepared from beaten barium rod and iodine (see Chapter 1, 
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Scheme 1.42). Finally an oxophilic Lewis acid like Et2AlCl should be sufficient to enolise the 
CO group as well as activating the epoxide toward cyclisation to give the [3.3.1]nonane 
bicyclic scaffold 2.45 (Scheme 2.15 B). 
OOOO
O
A) Shair's approach
OMO
O
OO
HO
M
R
2.42
O
2.41 2.43 2.45
B) Our approach
Lewis acidmild base
TESO Br
s-BuLi, THF, cHex
 78 to 30 C, 90 min
THF, ?30 C, 15 min
 78 to 40 C, 1 h
85%
OMe
OMe
O
OMe
OMe
O
MeO
OMe
R
OMe
OMe
R
OO
R =
TESO
R
chair-chair
TMSOTf
2.35 2.36 2.37
2.38
MeO OMe
O LAMe
R
2.40
prepared 
from t-BuLi
and BaI2
2.39
2.44
chair-chair  
Scheme 2.15: A) Shair’s desymmetrisation approach,66 B) our proposed strategy. 
 
2.3.1  Preparation of 2,2-disubstituted cyclohexane-1,3-diones  
The above epoxide cyclisation strategy required 2,2-disubstituted cyclohexane-1,3-diones, 
important building blocks in the synthesis of steroidal and terpene natural products.92 
Preparing this scaffold via alkylation has always been challenging; alkylation with activated 
sp3 electrophiles or -allyl electrophiles is the preferred method of synthesis 93 (Scheme 
2.16, a), while the use of non activated sp3 electrophiles is very limited due to the 
predominant formation of the O-alkylated product. (Scheme 2.16, line b). Methods that give 
selective C-alkylation with these types of electrophiles mostly refer to two main strategies: 
alkylation of cyclohexanediene derivative and subsequent hydrolysis, as reported by Piers94 
first and recently used by Shair66 (Scheme 2.16, line c), which is limited by the hazardous 
nature and toxicity of t-BuLi and HMPA, and the use of cyclic ketohydrazones (Scheme 2.16, 
line d) as pioneered by Enders95 and lately used by Johnson.96 
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Scheme 2.16: C-alkylation strategies of 2,2-disubstituted cyclohexane-1,3-diones.93a, 94-95 
Scheme 2.17 shows the first two steps of our initial strategy; alkylation of commercially 
available 2.46 with MeI following a literature method 97 gave 2-methyl-1,3-cyclohexanedione 
2.47 in 84%. Its synthesis was preferred over the commercially available sample which 
invariably contained impurities and was prone to decomposition. Significantly, the melting 
point of the freshly prepared sample was 204‒206 °C, very close to the literature reference 
of 206‒208 C, in contrast to 195‒203 °C recorded for the commercial material. Subsequent 
alkylation with prenyl bromide gave the 2,2-dialkylated product 2.48 in 33% yield (Scheme 
2.17). The moderate yield is explained by the concomitant formation of the mono and bis-
O-alkylated products (not shown) and it drops drastically to 5% if the temperature is raised 
above 0 °C. The only report for this alkylation was from the Zhurnal Obshchei Khimii which 
could not be accessed; two other related procedures start from 1,3-cyclohexanedione or 
5,5-dimethyl-1,3-cyclohexanedione (dimedone), not substituted at the 2-position, to give 
either the mono or the bis-prenylated derivative or a mixture of the two.98 
OO OO OO
Br
NaH, DMF
0 to 25 °C, 2 h
33%
MeI
NaOH 5M
42 °C, 17 h
84%
2.46 2.47 2.48
 
Scheme 2.17: Methylation and subsequent prenylation of 1,3-cyclohexanedione. 
Allylation of 2-methyl-1,3-cyclohexanedione was instead known but the 85% yield reported99 
could not be reproduced, obtaining 2.49 in 36%. Switching to NaH in DMF even lowered the 
yield to 27% (Scheme 2.18).  
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OOOO
Br
NaH, DMF
0 to 25 C, 1 h
27%
Br
NaOH 1M,
25 C, 16 h
36%
2.47 2.49
OO
2.49
 
Scheme 2.18: Different basic conditions for the allylation of 2.47. 
Since the first report by Enders,95 C-2 substituted hydrazones are known to give the C-
alkylated product regioselectively. Accordingly, monohydrazone 2.50 was synthesised and 
alkylation with prenyl bromide was then attempted but with no significant improvement in the 
yield (2.51, Scheme 2.19). 
NOOO
NH2-N(CH3)2
pTsOH, Benzene
80 C, 5 h
NO
N N
Br
NaH, DMF
0 to 25 C
98% 2 h, 32%
2.50 2.512.47
 
Scheme 2.19: Synthesis of monohydrazone 2.50 and subsequent C-alkylation. 
 
2.3.2  Epoxidation of 2-allylated and prenylated cyclohexanedione  
At this point the issues surrounding C-alkylation were set aside and attention was turned to 
the epoxidation step of the alkenes previously prepared. Dimethyldioxirane (DMDO) and m-
CPBA were the reagents selected to attempt this transformation. Shi’s conditions100 are 
known to work for terminal, cis, trans and tri-substituted alkene; however, this method has 
never been applied to 2-substituted cyclohexane-1,3-dione. A first attempt on substrate 2.48 
(Scheme 2.20) afforded a crude product whose mass and 13C NMR spectrum were as 
expected; however, subsequent attempts to repeat and/or scale up this reaction were 
unsuccessful, despite the accurate control of pH and the use of freshly prepared K2CO3 and 
OxoneTM solutions. The use of m-CPBA showed one new spot by TLC after 30 minutes but 
separation from benzoic acid and isolation of the pure product proved difficult. The same 
two conditions were repeated and tried on alkene 2.49, unfortunately without success. 
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THS, K2CO3 0.1 M
oxoneTM, K2CO3
acetone
CH3CN/DMM
30 min, 25 °C
OO
O
OO
2.48 2.52
0 °C, 2 h
m-CPBA, CH2Cl2
OO
O
2.52
not reproducible
difficult isolation
THS, K2CO3 0.1 M
oxoneTM, K2CO3
acetone
CH3CN/DMM
25 °C
OO
O
OO
2.49 2.53
0 °C
m-CPBA, CH2Cl2
OO
O
2.53  
Scheme 2.20: Attempted epoxidation of alkenes 2.48 and 2.49. 
A different way of forming DMDO in situ under biphasic conditions, as used by Dondoni101 
was then selected for a second epoxidation attempt using alkene 2.49 (Scheme 2.21). 
OO
oxoneTM, aq. sat. NaHCO3
(CH3)2CO, CH2Cl2
0 C, 1 h
OO
O
27%
2.49 2.53
 
Scheme 2.21: Dondoni’s biphasic conditions applied to alkene 2.49. 
Despite four equivalents of OxoneTM added, the yield obtained was modest although 30% of 
starting material could be recovered. The same biphasic conditions were then repeated on 
alkene 2.48 (Scheme 2.22); after column chromatography of the crude mixture, a new 
product was isolated in 14% as a crystalline solid but unexpectedly, the structure assigned 
was the complex acetal 2.54. 
 
Scheme 2.22: Unexpected formation of complex acetal 2.54. 
 
When it became clear that isolation of the desired epoxide was not trivial, a tandem 
epoxidation cyclisation was attempted on alkene 2.48. The starting material was completely 
consumed after 20 minutes stirring at 20 °C, with TLC showing a spot with the same Rf of 
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the epoxide previously isolated (2.52); at this point the reaction mixture was cooled to ‒78 
°C and 2,6-lutidine and TMSOTf were added. Scheme 2.23 shows the expected and actual 
transformations. 
OO
1) m-CPBA, DCM 
0 C, 30 min
2) 2,6-lutidine, TMSOTf
78 C, 2 h
OO
O
5% 2.542.48
OO
m-CPBA, DCM 
0 C
2,6-lutidine, TMSOTf
78 C
2.48
OO
O
OO
HO
OTMSO
O
TMS
Expected
2.52
Result
 
Scheme 2.23: Expected mechanism for the tandem epoxidation-cyclisation and formation of acetal 2.54. 
The TLC of the reaction showed three main spots which were separated; interestingly, the 
same complex acetal structure 2.54 previously obtained under biphasic epoxidation 
conditions was isolated in 5% yield. 
There are three requirements for such tandem cyclisations: 
 Generation of an enolic species so that the reaction occurs on the carbon instead of 
the oxygen. 
 Activation of the epoxide by a Lewis acid or Brönsted acid 
 Reaction of epoxide and enolic species via a low-energy chair transition state. 
 
In scheme 2.24 a new perspective is used to highlight in more detail Shair’s work (see 
Scheme 1.42 and 2.15 for a reminder) and his use of a preformed methyl vinyl ether and a 
Lewis acid to activate the epoxide and enable cyclisation to the bicyclo[3.3.1]nonane core. 
A chair transition state enables 2.55 to align and form 2.56 which cyclises via a boat 
conformation to give 2.57 (Scheme 2.24). 
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Scheme 2.24: Analysis of Shair’s epoxide mediated cyclisation. 
 
In our case one can rationalise the formation of acetal 2.54 starting from the oxonium ion 
2.59 (Scheme 2.25), the boat conformer of which (2.60) undergoes intramolecular attack via 
a low-energy trans-fused chair-like transition state, showing an axial interaction between the 
methylene and the epoxide. This mechanism has been reported before for the formation of 
2,7-dioxabicyclo[2.2.1]heptane leading to type 2.58 bicyclo.102 The acidity of the reaction 
mixture, due to either m-CPBA, the 3-chlorobenzoic acid produced after the epoxidation 
reaction or the silica gel, would then catalyse the ring closure that leads to 2.54. Notably, 
even the disfavoured high-energy chair-like TS of a cis-fused decalin-type (2.52 and 2.59 
shown in brackets) will lead to the same oxonium ion 2.59, revealing thus only one possible 
cyclisation product (Scheme 2.25). 
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Scheme 2.25: Cyclisation analysis leading to the formation of complex acetal 2.54. 
The analysis of acetal 2.54’s 13C NMR spectrum showed the absence of a second carbonyl 
group, evidence that O-alkylation has occurred. Cyclisation when X=H would be reversible 
thus formation of acetal 2.62 (Fig. 2.26) could also be excluded, in contrast to Shair’s 
intermediate 2.5766 which is formed after quenching the O-methylated oxonium ion. A 
thorough comparison of 13C NMR chemical shift values was carried out between acetal 2.54, 
compound 2.61103 and 2.58102 (whose signals have been assigned by analogy with 2.58). 
The data were found to be in fair agreement with those reported in the literature, with the 
exception of the peak at 70.9 ppm which was assigned to the bridgehead carbon atom 
bonded to one oxygen atom (Fig 2.26).  
 
Fig. 2.26:  Comparison between 13C NMR values for 2.54 with previously reported bicyclic acetal 2.58 and 2.61. 
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2.3.3   Direct C-alkylation with 1-bromoethyl-3,3-dimethyloxirane 
As an alternative to alkene epoxidation, the direct installation of the epoxide functionality 
onto the cyclohexanedione ring by direct C-alkylation with epoxy bromide of type 2.19 was 
considered. Its synthesis was achieved in high yield from both prenyl bromide and 
commercially available 2-methyl-3-buten-2-ol 2.63 (Scheme 2.27). 
Br
m-CPBA, CH2Cl2
25 °C, 3 h Br
O OH aq.KOH, Br2
5 °C, 20 h Br
O
81% 60% 2.192.632.19  
Scheme 2.27: Synthesis of bromo epoxide 2.19. 
 
2-Epoxy-substituted cyclohexane-1,3-diones are not known in the literature, with the only 
two related examples prepared by an aldol reaction of cyclohexanone with an epoxy 
aldehyde as shown by Yoshimura,104 and an attempted C-alkylation with epoxy bromide en 
route to the natural product angelmarin as carried out by Banwell (Scheme 2.28).105 
OBn
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ZnBr2, LDA
THF, 78 °C
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71%
OO OHO
O
LiOH, DMSO
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Scheme 2.28: Previous reports on the synthesis of 2-epoxy-substituted cyclohexane-1,3-ones.104-105 
 
Alkylation of 2-methyl-1,3-cyclohexanedione with 1-bromoethyl-3,3-dimethyloxirane was 
first attempted using NaH in DMF (Scheme 2.29); TLC analysis of the crude showed two 
products, with NMR analysis revealing that O-alkylation had occurred predominantly. The 
O-alkylated product was isolated after column chromatography in 10% yield along with a 
16% of a not identified second product. Although 13C NMR for this second product was 
consistent with the structure expected for the desired C-alkylated derivative, 1H NMR 
revealed a multiplet at 4.23 ppm which could not be assigned. 
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O
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Scheme 2.29: Attempted C-alkylation of 2.47 with bromo-epoxide. 
 
A brief screening of conditions (Scheme 2.30) did not lead to any improvement.  
OOOO
Br
Table
O
O
2.47 2.52
No reaction
No reaction
No reaction
O-alkylation
Outcome
K2CO3, acetone, 25 C
NaH, PhCH3, 118 C
t-BuOk, t-BuOH, 25 C
NaH, DMF, 155 C
Conditions
 
Fig. 2.30: Attempted C-alkylation of 2-methyl-1,3-cyclohexanedione 2.47. 
However, the monohydrazone previously synthesised (2.50, see scheme 2.19) could be 
alkylated with the bromo epoxide giving the corresponding 2,2-dialkylated hydrazone 2.64 
in moderate yield (Scheme 2.31). 
 
Scheme 2.31: Successful C-alkylation of hydrazone 2.50. 
Given the encouraging result on this direct alkylation with bromo epoxide, formation of 
bishydrazones of type 2.65 and 2.68 could give access to the functionalized 
bicyclo[3.3.1]nonanone 2.67 via cyclisation of epoxide 2.66 and subsequent hydrolysis 
(Scheme 2.32).  
68 
 
 
Scheme 2.32: Planned strategy for the formation of bishydrazones 2.68 and/or 2.70 and subsequent epoxide-
mediated cyclisation. 
Unfortunately, N,N-dimethylhydrazine could not be purchased in Singapore so we decided 
to use N,N-diphenylhydrazine to access the key hydrazone intermediates. As highlighted on 
scheme 2.33, monohydrazone enol form 2.69 could be obtained but could not be converted 
to the bis-derivative 2.70 by either addition of more equivalents or increase of temperature. 
Similarly, blocking the 2-position with an allyl group and treating the Tsuji-Trost product 2.71 
with N,N-diphenylhydrazine did not lead to the desired product 2.72 (Scheme 2.33). Indeed, 
1H NMR indicated only 10 aromatic protons and mass spectroscopy couldn’t confirm the 
structure, despite the fact that 1H and 13C NMRs were as expected, showing clearly a 
symmetrical product and no carbonyl signal present. A possible explanation could be that 
the phenyl groups are too bulky for the reaction to take place.  
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Pd(PPh3)4, THF
25 °C, 16 h
66%
NHO N Ph
Ph
uncertain 
outcome NN
N
Ph
Ph N
Ph
Ph
2.72
2.69
NH2-N(Ph)2
MeOH, 25 to 60 °C NH2-N(Ph)2
MeOH
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2.71
2.47
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NNN
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Scheme 2.33: Attempted formation of bishydrazone 2.70 and 2.72. 
 
2.3.4   6-endo-tet cyclisation strategy 
Given the simplicity and the high yield of the Tsuji-Trost reaction employed for the synthesis 
of compound 2.71, we thought that this reaction could represent a valid alternative to the 
difficult C-alkylation, en route to a subsequent epoxidation. Cinnamyl acetate 2.73 was 
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tested as the first allylic electrophile, giving 2.74 in 85% yield. Triton X-100 was chosen as 
surfactant over CTAB, which was tried first but gave alkene 2.74 in only 47% yield. 
Subsequent epoxidation with m-CPBA proceeded smoothly affording epoxide 2.75 in 88% 
yield as a crude product, which needed no further purification (Scheme 2.34). 
OO
Ph
OOPd(PPh3)4
Ph
OO
O Ph
88%
AcO
85%
m-CPBA, NaHCO3, CH2Cl2
0 to 25 C, 16 h
Triton X-100, K2CO3
H2O, 25 C, 30 min
2.74 2.752.47
2.73
 
Scheme 2.34: Tsuji-Trost epoxidation sequence. 
With the key precursor in hand, five different conditions were tested for the desired epoxide-
mediated cyclisation (Scheme 2.35).  
Unidentified mixture
Unidentified mixture
Unidentified mixture
Unidentified mixture
Outcome
LDA, THF, 78 C
t-BuOK, 25 C
Et3N, TMSCl, DMF, 0 to 135 C
LDA, TMSCl, THF, 78 C
Conditions
OO
O Ph
OO
OH Ph
2.75 2.76
6-endo-tet
cyclisation
2,6-lutidine, TMSOTf, DCM, 78 C Unidentified mixture
Table
 
Scheme 2.35: 6-endo-tet cyclisation attempts. 
Unfortunately, none of these conditions led to the formation of the desired 
bicyclo[3.3.1]nonane. A reasonable explanation could be that this type of ring closure is 
classified as a 6-endo-tet which is disfavoured according to Baldwin’s rules. 
 
2.3.5   6-exo-tet cyclisation strategy 
According to Baldwin’s rules the 6-endo-tet cyclization that was tried first (Scheme 2.35) 
was disfavoured. Seeking a potentially more favourable 6-exo-tet cyclisation, addition of one 
more carbon atom to the side chain of our cyclohexanedione was pursued and the synthesis 
of aldehyde 2.77 was therefore considered. The latter was known and easily accessible via 
Michael additions from 2-methyl-1,3-cyclohexanedione 2.47, with reported syntheses mostly 
carried out in water at room temperature.106 Accordingly, after 48 h stirring at 25 °C pure 
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2.77 was isolated but in only 35% yield. A major improvement of the yield (up to 95%) 
resulted when the reaction was carried out in CH3CN at reflux with the addition of 20 % mol 
of DABCO (Scheme 2.36). 
OO
O
2.77
OO
O
H2O, 25 °C
48 h, 35%
OO
O
2.77
O
20 mol% DABCO
MeCN, 95 °C
4 h, 95%
2.47
 
Scheme 2.36: Synthesis of 3-(1-methyl-2,6-dioxocyclohexyl)propanal 2.77. 
A Wittig reaction between aldehyde 2.77 and phosphonium salt of type 2.78 or phosphonate 
of type 2.81 was then attempted. Instead of the expected alkene 2.80, aldol product 2.79 
was formed exclusively and isolated in 33% after purification when 2.78 was used. Exclusive 
formation of the same aldol derivative was also observed in the crude 1H NMR when 
switching to phosphonate 2.81 (scheme 2.37). 
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PPh
Ph
Ph
n-BuLi, THF
0 to 65 C, 16 h OO
HO
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O
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O
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OMe
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2.77
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Scheme 2.37: Horner-Wadsworth-Emmons reaction on aldehyde 2.77. 
 
A milder base like DBU did lead to the desired unsaturated ester 2.82 although in low yield 
whereas complete elimination of the base source finally yielded compound 2.83 in 85%, as 
the only product of the reaction (Scheme 2.38).  
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Scheme 2.38: Synthesis and optimization of α,β-unsaturated ester derivatives. 
At this point, a few conditions were tested for the epoxidation of the unsaturated ester 
(Scheme 2.39). In all cases shown in the embedded table there was a clear formation of just 
one polar spot but isolation was particularly difficult. During work-up it was noticed that the 
TLC spot disappeared under acidic or neutral pH whereas if the solution was kept basic, 
decomposition probably due to fragmentation caused by H2O2, was observed in the form of 
colour change after concentration or after dissolving the crude product in deuterated 
solvents. 
OO
CO2Et
2.83
OO
CO2Et
2.84
O
Decomposition
Decomposition
Decomposition
Outcome
m-CPBA, 1,2-DCE, 25 C
H2O2 30%, NaOH 3M, 0 °C
TBHP, Triton B, THF
Conditions
Conditions
Table
 
Fig. 2.39: Attempted epoxidation of the α,β-unsaturated ester 2.83. 
Given the difficulties encountered we momentarily put aside epoxidation and thought about 
an alternative way to build the desired bicyclo[3.3.1]nonane scaffold. Considering the ease 
in which this unsaturated ester could be accessed, an intramolecular base-catalysed 
Michael reaction looked appealing and most importantly a catalytic asymmetric version had 
not yet been reported. We were particularly inspired by Dixon’s report on the catalytic 
asymmetric desymmetrisation of prochiral cyclohexanones 2.85 leading to 2-
azabicyclo[3.3.1]nonane 2.86 (Scheme 2.40).107 
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Scheme 2.40: Synthesis of 2-azabicyclo[3.3.1]nonane through catalytic asymmetric desymmetrisation of 
prochiral cyclohexanones.107 
We first ran preliminary studies with the guanidine base 1,5,7-triazabicyclo[4.4.0]dec-1-ene 
(TBD) (Scheme 2.41, highlighted in turquoise); in the case of a 20 mol% loading a new spot 
was formed within an hour on TLC; it was then decided to stop the reaction even though it 
had not reached completion, to identify the spot which was in fact the desired bicyclic product 
2.87. With the amount of base increased to 0.5 eq TLC showed complete consumption of 
starting material but crude 1H NMR revealed 11% of 2.83 still present. Following these 
promising results, screening of a few primary and secondary amine organocatalysts was 
pursued (highlighted in pink); unfortunately, with all the three bases chosen, no conversion 
was observed, even after 5 days or the aid of additives like benzoic acid. 
OO
CO2Et
2.83
base
OO
CO2Et
2.87
Identification
89% NMR yield, single diast.
No reaction
No reaction
Time
TBD (20 % mol)
TBD (0.5 equiv.)
(S)-(-)-methylbenzylamine
(S)-(-)-methylbenzylamine
Base
No reaction
No reaction
(+/-)-trans-1,2-diaminocyclohexane
(+/-)-trans-1,2-diaminocyclohexane
No reaction
L-proline
Additive
1 h
L-proline
No reaction
1 h
5 days
5 days
5 days
5 days
3 days
3 days
Solvent Outcome
PhCOOH
PhCOOH
PhCOOH
THF
THF
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
N
NH
N
TMG
N
H
N
N
TBD
Table
 
Scheme 2.41: Intramolecular Michael reaction to forge the bicyclo[3.3.1]nonane core. 
Given that our first results with chiral bases were not promising and that the novelty aspect 
was lessened because of the publication108 of the phosphoric acid-catalysed 
desymmetrising Michael cyclisation of 2,2-disubstituted-1,3-diketones (Scheme 2.42), such 
asymmetric desymmetrisations were not pursued further. 
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Scheme 2.42: Lam’s desymmetrising strategy of 2,2-substituted-1,3-diketones.108 
The original epoxidation strategy was revisited, this time using a pre-formed phosphonium 
precursor of type 2.89 for the Wittig reaction (Scheme 2.43). As previously reported, 109 
guanidine bases like TBD and TMG could promote Wittig and HWE reactions on enolisable 
aldehydes. Despite the promising precedents, aldol product 2.79 was obtained 
predominantly along with 11% of the desired alkene 2.90. Epoxidation of the latter afforded 
the desired epoxide 2.91 in 98% yield (Scheme 2.43). The low yield of the alkene precursor 
was considered not practical enough to continue the investigation of our 6-exo-tet cyclisation 
strategy; we thus turned our attention to the epoxidation of other α,β-unsaturated 
compounds. 
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Scheme 2.43: TMG-promoted Wittig reaction and subsequent epoxidation of alkene 2.90. 
 
2.3.6   Synthesis and epoxidation of more α,β-unsaturated compounds 
After the difficulties encountered in the synthesis of 2.90, other α,β-unsaturated compounds 
were evaluated with unsaturated thioester 2.92 (R=SEt) and aldehyde 2.93 (R=H) (Scheme 
2.44). These intermediates were proposed as versatile starting materials for either direct 
epoxidation or selective reduction to allylic alcohol 2.96, which in turn would allow Sharpless 
asymmetric epoxidation. 
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Scheme 2.44: Proposed strategy to access the bicyclic core through reduction or epoxidation of unsaturated 
carbonyl compounds. 
For the preparation of thioester 2.92,we started the synthesis of phosphorane precursor 2.99 
which was carried out in two steps from commercially available 2-bromoacetic acid, yielding 
2.99 in 67% yield. Wittig reaction with aldehyde 2.77 afforded the desired α,β-unsaturated 
thioester in 89% yield (2.99, scheme 2.45). 
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Scheme 2.45: Synthesis of thioester 2.92. 
Attempted epoxidation of the α,β-unsaturated thioester with three different set of conditions 
was troublesome in much the same way as before with ester 2.83 and the pattern revealed 
to be the same; formation of a new polar spot which decomposes upon work-up, drying in 
vacuo or solubilisation in deuterated solvents (Scheme 2.46). 
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Scheme 2.46: Attempted epoxidation of thioester 2.92. 
Selective reduction of the thioester over the ketones was then considered, a reaction usually 
achieved using Raney-Nickel.110 Unfortunately, no reactivity was observed after treatment 
of thioester 2.92 with Ra-Ni, either in methanol or toluene (Scheme 2.47). 
OO
COSEt
2.92
OO
2.96
OH
MeOH or PhMe
25 C, 48 h
Ra-Ni
 
Scheme 2.47: Attempted selective thioester reduction to allylic alcohol 2.96. 
We then turned to the synthesis of unsaturated aldehyde 2.93 which was prepared in 31% 
yield (Scheme 2.48). Despite the modest yield and the formation of the already observed 
aldol product 2.79, the mass recovery was sufficiently good to proceed to the next step.  
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O
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CHO
Br
H O
O
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O
CHCl3
61 C, 5 h 2.93, 31%
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2.79, 23%
HO
2.101
2.77
t-BuOK, Et2O
PPh3H3C
 
Scheme 2.48: Synthesis of unsaturated aldehyde 2.93. 
Encouraged by a few reported chemoselective reduction of aldehydes over ketones,111 a 
few reductive conditions were tried. In the case of NaBH4 in the presence of LiClO4, 
reduction of both ketones was unfortunately also observed. With NaBH(OAc)3 instead only 
starting material was recovered, even when the reaction was subjected to the addition of 
more equivalents of the hydride and/or higher temperature (Scheme 2.49). 
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Scheme 2.49: Attempted synthesis of allylic alcohol 2.96 via chemoselective reduction of aldehyde 2.93. 
Attempted epoxidation of the same unsaturated aldehyde with hydrogen peroxide led to the 
desired epoxide 2.102, albeit in low yield (13%, Scheme 2.50). In an attempt to synthesize 
more material and in the hope of optimising the yield, the reaction was run a second time; 
unfortunately, the result of the previous reaction could not be reproduced. 
H2O2, NaHCO3
MeOH
0 to 25 °C, 1.5 h
13%
OO
CHO
2.102
O
OO
CHO
2.93
 
Scheme 2.50: Synthesis of epoxy aldehyde 2.102. 
 
2.3.7 Alternative pathways towards epoxidation: the Corey-Chaykovsky reaction 
In the Corey-Chaykovsky reaction, a sulfur ylide reacts with carbonyl compounds or imines 
leading to the corresponding epoxides or aziridines, with high diastereoselectivity towards 
the trans product (where stereochemistry applies). Accordingly, this reaction was performed 
on the previously synthesised aldehyde 2.77; generation of trimethylsulfoxonium ylide 2.103 
after treatment of trimethylsulfoxonium iodide with NaH, subsequent nucleophilic addition 
and ring closing led to the formation of epoxide 2.104 in 33% yield (Scheme 2.51). 
Unfortunately, compound 2.104 decomposed after a week even if kept at ‒20 °C. 
OO
O
NaH, DMSO
10 C, 1 h
33%
S O
OO
O
2.77 2.104
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O
I
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O
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Scheme 2.51: Corey-Chayvkosky reaction for the synthesis of epoxide 2.104. 
Despite the modest yield, the Corey-Chaykovsky reaction held promise, since in one step 
process the result is the same as a Wittig olefination followed by an epoxidation. A report by 
Graham described the guanidine base TBD as very effective for in situ generation of 
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sulfonium salt of the type 2.105 (Scheme 2.52).112 The latter can then be reacted with a 
variety of aldehydes to give the corresponding oxiranes in high yield and trans 
stereoselectivity. This protocol is known to work for both enolisable and non enolisable 
aldehydes; however, the examples with aliphatic aldehydes were limited to two (80 and 36% 
yield respectively), as opposed to nine aromatic ones. Unfortunately, both TBD and TMG 
were found to be inefficient in delivering the desired epoxide 2.106 (Scheme 2.52).   
Br
S
(CH3)2CO
25 °C, 16 h
S
Ph
Br
TMG or TBD
(2.2 eq)
CH2Cl2, 25 °C
OO
O
2.105
OO
O
2.106
Ph
2.77
 
Scheme 2.52: Guanidine base-promoted Corey-Chaykovsky for the synthesis of epoxide 2.106. 
The Aggarwal group has a long-standing interest in the asymmetric synthesis of epoxides 
employing chiral sulfides. In 2013, the group published an extensive study on the application 
of chiral isothiocineole 2.107 to the asymmetric epoxidation of aldehydes extending the 
study to a wide range of aliphatic and aromatic aldehydes, all obtained in high yield, d.r. and 
ee (Scheme 2.53).113 
 
Scheme 2.53: Chiral isothiocineole for the asymmetric epoxidation of aldehydes.113 
Tempted by the simplicity of their protocol, we sought to apply these reaction conditions to 
our system. In a first attempt to apply the Aggarwal protocol, we decided to keep using the 
sulfonium salt 2.105 as isothiocineole 2.107 was not available in our laboratory. A mixture 
of protic and aprotic solvents was reported to be ideal for aliphatic aldehydes and a few 
conditions were tried but unfortunately none of them delivered the desired oxirane 2.106 
(Scheme 2.54). In two cases, the same observation as the Aggarwal group was made, 
namely the Sommelet-Hauser rearrangement, a 2,3-sigmatropic rearrangement of 
equilibrated ylide 2.105a (Scheme 2.54).114 
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Scheme 2.54: Attempted synthesis of epoxide 2.106. 
 
Scheme 2.55: Mechanistic details of the Sommelet-Hauser rearrangement. 
 
In Aggarwal’s case, the product of the Sommelet-Hauser rearrangement 2.108 arises when 
ketones and less electrophilic aldehydes are employed in the reaction. He postulated that 
ylide 2.105a has time to equilibrate because of the slow reaction rate of these carbonyl 
partners compared to more electrophilic substrates. He then applied Fava’s studies115 on 
the rate of deuterium exchange of the cyclic sulfonium salt’s protons and substituted 
tetrahydrothiophene with its 6-membered ring homologue (pentamethylene sulfide); this 
resulted in an increase of the epoxide yield from 15 to 69%, as the rate of exchange of α-
protons is much slower.  
Since the pentamethylene sulfide was not available in our laboratory, the conditions 
published by Aggarwal in 2003 were used,114 in which a variety of metalated tosylhydrazone 
salts derived from benzaldehyde in the presence of rhodium catalyst delivered epoxides in 
very good yield and d.r. (Scheme 2.56).  
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Scheme 2.56: Use of tosylhydrazone and rhodium catalyst for the epoxidation of aldehydes. 
 
Formation of the tosyl hydrazone of p-bromobenzaldehyde 2.109 proceeded in high yield. 
However, the desired epoxide 2.111 was not obtained, instead a range of decomposition 
products were detected (Scheme 2.57). Possibly the aldehyde was insufficiently reactive; 
indeed, Aggarwal noted that the reaction failed with hindered aliphatic aldehydes such as 
pivaldehyde. The use of the 5-membered tetrahydrothiophene rather than the suggested 6-
membered ring (pentamethylene sulfide) to avoid the Sommelet-Hauser rearrangements 
could be the solution to this reactivity problem. 
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Scheme 2.57: Synthesis of the metalated tosyl hydrazone 2.110 and its use in the attempted Corey-Chaykovsky 
epoxidation. 
2.4 Conclusion 
Unfortunately, we were not able to realize the synthetic plan presented in Scheme 1.52 for 
the construction of the PPAP core via a dearomatisation approach. We encountered many 
challenges during the dearomatisation step because of repeated rearomatisation pathways. 
The epoxide-mediated cyclisation of 1,3-dihydroresorcinol derivatives envisioned did afford 
some interesting intermediates but was limited by low product yields, epoxide decomposition 
and/or instability. However, observation and accurate NMR analysis of a side product 
deriving from a Wittig reaction prompted us to explore further another approach which will 
be described in details in the following chapter 3. 
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CHAPTER 3: MICHAEL-ALDOL TANDEM ANNULATION 
 
3.1 Introduction 
 
During the investigation of Wittig and HWE conditions in order to access various alkene 
intermediates, the persistent formation of bicyclo ketols 3.2 was observed (see also Scheme 
2.37 in Chapter 2), the product of an intramolecular aldol reaction of aldehyde 3.1. 
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3.2
3.2
OH
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Scheme 3.1: Bicyclic epimers 3.2 arising as side product of Wittig and HWE reactions on aldehyde 3.1. 
Given that this unexpected intramolecular reaction afforded the desired 
bicyclo[3.3.1]nonane scaffold, this process was studied in more detail for three main 
reasons: 
- The aldol product was readily formed under mild conditions 
- The diastereoselectivities observed were promising given that the reaction had not 
been optimised 
- An intramolecular aldol was not very well studied for cyclic 1,3-diketones 
Our main goal was to develop a short and efficient route towards the bicyclo[3.3.1]nonane 
scaffold. Having regard to various, mostly biomimetic, domino annulations that have been 
used in the synthesis of the PPAP bicyclic core, we proposed to develop a one-pot 
annulation process to functionalised bicyclo ketols. Accordingly, a Michael addition prior to 
the cyclisation observed above was considered. 
A detailed account of all the strategies used so far for the synthesis of bicyclo[3.3.1]nonane 
core, with their application in natural product total synthesis and their limitations, was given 
in Chapter 1 and is summarized in Fig.3.2. 
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Fig. 3.2: Summary of the main synthetic strategies to access the bicyclo[3.3.1]nonane scaffold. 
 
Given our first preliminary results on the construction of the [3.3.1]nonane scaffold via an 
intramolecular aldol (see Scheme 3.1) and inspired by domino-type annulations we 
considered the development of a Michael-aldol annulation reaction starting from readily 
available 2-methylcyclohexane-1,3-dione. Shair’s enantioselective total synthesis of ()-
hyperforin had already established the importance of dihydroresorcinol derivatives as key 
precursors for the formation of the bicyclo[3.3.1]nonane scaffold66-67 and we were intrigued 
by the very few annulation reports that used them as starting material. Bicyclic ketol 
formation has been achieved using mainly α-alkoxycarbonyl or acyl-cycloalkanones which 
bear an electron withdrawing group at the α-position of the cyclic ketone. For instance, 
Gravel reported that β-keto esters of type 3.3 can undergo Michael-aldol annulations via 
enamine formation at the less hindered carbon, thus positioning the resulting alcohol next 
to the β-keto ester unit (Scheme 3.3, 3.4).48 The yield achieved was moderate and the 
diastereoselectivity of the reaction was not examined. More recently, Rodriguez reported 
the same type of annulation in the presence of a NHC catalyst which gave bicyclo ketol 3.5 
in high yield but poor d.r.(Scheme 3.3).32 
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OMeO
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2)
1,4-dioxane
101 °C, 9 h
O
51%
O
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O
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OH
HO
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Gravel, 1984Rodriguez, 2011
d.r. not reported  
 
Scheme 3.3: Michael-aldol annulation sequence from β-keto ester 3.3. 
 
82 
 
A similar strategy was reported by Nicolaou in 2005;31 acid-catalysed annulation of 2-
acylcyclohexanone 3.6 with methacrolein afforded a 2:1 mixture of exo and endo-ketols 3.7 
in which the relative configurations were not assigned but the methyl group is presumably 
as drawn in the scheme below, i.e. exo to the bridgehead carbonyl group (Scheme 3.4). 
O
O
O
TfOH, CH2Cl2
78 to 20 °C
63%
O
O
O
O
OH
OH
exo-3.7 endo-3.73.6
Nicolaou, 2005 +
 
 
Scheme 3.4: Nicolaou’s annulation of acylcyclohexanone 3.6.31 
 
Only two cases of annulations where the cyclohexanone derivative lacks an electron 
withdrawing group at the α or β-position have been described (Scheme 3.5). While Tang50 
managed to react cyclic ketone 3.8 with various enones in the presence of pyrrolidine-
sulfonamide-derived catalyst to obtain the desired bicyclic scaffold 3.9 in good yields and 
ee, Marazano’s use of enals62 afforded the diprenylated bicyclic compound 3.1 in moderate 
yields and d.r. (Scheme 3.5). 
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20 mol%
4-MeOC6H4CO2H
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5 to 0 C then 25 C
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42%
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Scheme 3.5: Two Michael-aldol annulation approaches to the bicyclo[3.3.1] none scaffold.50, 62 
 
These few examples highlighted the limitations in scope and mainly in stereocontrol for the 
annulation of α-alkoxycarbonyl and acyl-cycloalkanones. To date, the only example of 
annulation involving 2-substituted-cyclohexane-1,3-diones of type 3.12 was reported by 
Dauben in 1983;22 a mixture of unassigned diastereoisomers of bicyclo ketol 3.13 was 
formed after 2 days reaction at high pressure (Scheme 3.6, left). With these considerations 
in mind, we sought a succinct and efficient method that could build the bicyclo[3.3.1]nonane 
scaffold 3.16 in just one step from dihydroresorcinol derivatives 3.14 and substituted enals; 
ideally this strategy would be flexible enough so that a diverse range of substituents could 
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be incorporated with high stereocontrol into the bicyclic scaffold, generating the maximum 
number of stereogenic centres at once, without being limited by the ring size (Scheme 3.6, 
right).  
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Scheme 3.6: Left: only example of Michael-aldol annulation featuring a 2-substituted-1,3-cyclohexanedione.22 
Right: our proposed annulation strategy. 
 
3.2 Synthesis of bicyclo[3.3.1]nonanes through a domino Michael-aldol 
annulation of cycloalkane 1,3-diones with α,β-unsaturated aldehydes 
 
3.2.1 Optimisation of the annulation conditions 
 
Our study began with the investigation of the reaction between 2-methyl-1,3-
cyclohexanedione 3.12 and acrolein 3.17 (Table 3.7). 
With inorganic bases like NaH or NaOMe (entries 1-4) the desired bicyclo ketol was never 
observed. The use of Et3N in THF did not lead to any promising results but the Michael 
adduct 3.1 was obtained in 62% when the reaction was run in acetonitrile (entry 6). A 
catalytic amount of the same base afforded mainly the aldol products in good 
diastereoselectivity (entry 7). The same outcome was observed when a base like DIPEA 
was employed; stochiometric amount afforded exclusively 3.1 whereas catalytic amount 
drove the equilibrium slightly towards the aldol products, which were detected in appreciable 
diastereoselectivity and yields (entries 9 and 10). Imidazole and pyridine both afforded only 
aldehyde 3.1 whereas a stronger base such as DBU led to a mixture of Michael and aldol 
products in a 1:1 ratio when used in stochiometric and catalytic amount (entries 11 and 13). 
The use of DABCO in dichloromethane provided the bicyclo ketols in very low yield but 
promising diastereoselectivity; switching to acetonitrile dramatically improved the yield, and 
complete conversion into the desired bicyclic products was observed (entry 19). Although a 
10 mol% loading of DABCO appeared to be too low, giving a 1:1 mixture of Michael and 
aldol adducts, 20 mol% led instead to the exclusive formation of the aldol products in 65% 
isolated yield and a 1:1 ratio between the two epimers (entry 21). Given the promising results 
with DABCO, a solvent screening was performed in the hope of improving the 
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diastereoselectivity; the use of a more polar solvent such as ethanol or dimethyl sulfoxide 
(entries 22 and 25) gave either exclusively 3.1 or a mixture of 3.1 with bicyclo compound(s) 
3.2. Conducting the reaction in toluene or THF gave high yields but with no improvement of 
the diastereoselectivity and aldehyde 3.1 could be detected in 7% yield (entries 26 and 27); 
the quantitative conversion into a 66:34 ratio of epimers was achieved when the reaction 
was heated at reflux in acetonitrile (entry 28). Prolonging the reaction time (48 h) led to high 
diastereoselectivity and quantitative yields (entry 29). A stochiometric amount of DABCO 
under the same conditions led to exclusive formation of the exo-adduct 3.2, the best result 
that could be achieved (Table 3.7) 
5025 50 : 50 (50)32
83Imidazole (1 eq.) 25 -16
1625 - -
-NaOH (4%) 25 -16
62DIPEA (1 eq.) 25 -16
4025 53 : 47 (60)16
traces25 -32
-25 -16
1625 30 80 : 20 (70)
6225 -16
2065 70 : 30 (80)16
42DIPEA (0.2 eq.) 25 66 : 33 (58)32
-25 -16
Base Solvent T ( C) Time (h) 3.01 (%) exo-3.02 (%):endo-3.02 (%)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
entry
-25 -16
Et3N (1 eq.)
Et3N (0.2 eq.)
Et3N (1 eq.)
Et3N (0.2 eq.)
50DABCO (0.2 eq.) 25 50 : 50 (50)16
7DABCO (0.2 eq.) 25 68 : 32 (93)16
16DABCO (0.2 eq.) 25 7 86 : 14 (93)
-DABCO (0.2 eq.) 95 90 : 10 (100)48
62DABCO (0.2 eq.) 25 traces16
83DABCO (0.2 eq.) 25 -16
95DABCO (0.2 eq.) 25 traces16
83 -
-25 -16
traces25 70 : 30 (95)16
1625 - 70 : 30 (12)
-25 50 : 50 (100)16
5025 50 : 50 (100)16
-DABCO (0.2 eq.) 25 50 : 50 (65)16
-DABCO (1 eq.) 95 100 : 0 (100)48
25 32
17
18
19
20
21
22
23
24
25
26
27
28
29
30
-DABCO (0.2 eq.) 95 66 : 34 (100)16
Pyridine (1 eq.)
Pyrroldine (1 eq.)
DMAP (1 eq.)
DABCO (1 eq.)
DABCO (1 eq.)
DABCO (0.1 eq.)
DBU (0.2 eq.)
DBU (0.2 eq.)
DBU (1 eq.)
NaH
t-BuOK
NaOMe
THF
MeCN
MeCN
MeCN
MeCN
MeCN
MeCN
THF
MeCN
MeCN
THF
t-BuOH
EtOH
MeOH
MeCN
MeCN
MeCN
CH2Cl2
MeCN
MeCN
MeCN
EtOH
CH2Cl2
DMF
DMSO
THF
PhCH3
MeCN
MeCN
MeCN
-- 95 100 : 0 (70)7231 MeCN
-- 135 100 : 0 (100)2432 DMF
OO
3.12
OO
O
3.1
O
base/acid
solvent OO exo-3.2
OH
OO
HO
+ +
endo-3.2
3.17
 
Table 3.7: Optimisation of the annulation reaction conditions. 
 
We later discovered that approximately 50% of pure isolated Michael product 3.1, if not 
stored at low temperature, spontaneously converts to the aldol product in almost a 1:1 
mixture of epimers (Scheme 3.8) over a 30-day period. 
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Scheme 3.8: Spontaneous intramolecular aldol reaction at room temperature. 
 
Accordingly, we tested the hypothesis that no base was needed for the aldol reaction to 
occur. Scheme 3.9 highlights a short screening of solvent, temperature and time for both 
aldol and domino Michael-aldol reactions. For the aldol reaction, after careful monitoring of 
the reaction at fixed intervals of time, 72 h was found to be the ideal time to reach complete 
selectivity towards exo-3.2, which could be isolated in quantitative yield (entry 1). Although 
quantitative yields were also achieved using DMF, complete stereocontrol was never 
achieved (entry 2 to 4). In contrast, for the domino reaction the use of DMF gave a better 
outcome as the reaction time could be shortened to 24 h and the desired bicyclo compound 
could be isolated in quantitative yield exclusively as exo-adduct 3.2 (entry 8). 
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OH
OO
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3.1 exo-3.2
OO
3.12
aldol
Domino Michael-aldol
7295 100 100 : 0
100130 81 : 1932
Reagent Solvent T (° C) Time (h) yield 3.2(%) exo-3.2(%) : endo-3.2(%)
1
2
3
entry
100130 78 : 2218
-
-
MeCN
DMF
DMF-
100130 81 : 19644 DMF-
7295 70 100 : 0
100155 100 : 024
Base Solvent T (°C) Time (h) yield 3.2(%) exo-3.2(%) : endo-3.2(%)
5
6
7
entry
80140 100 : 024
-
-
MeCN
DMSO
DMF-
100130 100 : 0248 DMF-
OO
OH
exo-3.2
OO
endo-3.2
+
HO
OO
endo-3.2
HO
+
Table
Table
Scheme 3.9: Solvent and temperature optimisation for the Michael-aldol annulation reaction. 
 
Although the above results were satisfactory, a few acidic conditions were also tested. 
Literature31 conditions using TfOH for cyclisations involving 2-methylcyclohexane-1,3-dione 
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with acrolein were unsuccessful (entry 1). In the same way, the use of TFA at ambient 
temperature was ineffective to deliver the desired aldol adduct (entry 2) although at 95 °C 
exo-3.2 could be isolated but in low yield (Scheme 3.10, entry 3).  
1625 80 -
-78 to 25 -16
Acid Solvent T ( C) Time (h) 3.1 (%) exo-3.2 (%) : endo-3.2 (%)
2
3
1
entry
-95 100 : 0 (36)16
TFA
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MeCN
MeCN
CH2Cl2TfOH
OO
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O
3.1
O
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solvent OO exo-3.2
OH
OO
HO
+ +
endo-3.2
3.17
 
Scheme 3.10: Initial screening of the Michael-aldol annulation reaction using acidic conditions. 
 
 
3.2.2 Scope of the reaction 
 
After the optimum conditions for the annulation were established the scope of the reaction 
was examined. Our approach relied on the incorporation of substituents at two of the three 
carbon atoms in the annulating unit, i.e. position-7 and -8, through reaction with 
commercially available substituted enals, and on the modification of the dihydroresorcinol 
scaffold to diversify position -1, -3 and -4. Reaction of each substituted dione with each of 
the enals selected would in principle give three analogs per substituent (Scheme 3.11). 
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OO R3
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OO R3
R4
R5
R1
R2
1
3
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R2 = Ph, cinnamaldehyde
R1 = Me, methacrolein
1
3
4 6
7
88
R3 = Me, prenyl, COPh
R4, R5 = -(CH3)2
7
6
-CO(CH3)2, -Ph
Me, crotonaldehyde
 18 examples
 
  
Scheme 3.11: Determination of the scope for the Michael-aldol annulation. 
 
 
3.2.2.1 Substitution at position -6,-7 and -8 
Our investigation of the scope of the reaction started with the use of methacrolein 3.18; 
heating in acetonitrile overnight with 20 mol% loading of DABCO gave predominantly the 
endo-isomer 3.19 in almost quantitative yield. Extending the reaction time to 48 h led to a 
lower diastereomeric ratio (65:35) instead (Scheme 3.12). 
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Scheme 3.12: Synthesis of 6-hydroxy-1,7-dimethylbicyclo[3.3.1]nonane-2,9-dione. 
 
Neutral conditions were then tested to see if stereocontrol could be further enhanced. 
Surprisingly, heating for 72 h in DMF led to the predominant formation of exo-3.19 although 
in very low isolated yield. Several conditions in DMF were then tested and the formation of 
the exo-3.19 was predominant in all cases, with its exclusive formation when the reaction 
was heated for 48 h with 1 eq of DABCO (Scheme 3.1). Unfortunately, the crude product 
contained several other unidentified impurities; the reaction always required purification and 
exo-3.19 was never obtained in satisfactory yield (Scheme 3.13). 
OO
3.12
OO
exo-3.19
OH
OO
OH
+
endo-3.19
exo : endo, 80:20
6% of pure exo recovered
exo : endo, 75:25
exo : endo, 63:37
Outcome
95 C, 72 h
130 C, 16 h
20 mol% DABCO,130 C, 16 h
Conditions
DABCO (1 eq), 130 C, 24 h exo : endo, 70:30
DMF
predominant
DABCO (1 eq), 130 C, 48 h
32% of pure exo recovered
exo-3.19
32% NMR yield
O
3.18
 
Scheme 3.13: Optimisation of the reaction conditions for exo-isomer 3.19. 
 
 
After installing the methyl group at the 7-position, substitution at position -8 was examined 
using crotonaldehyde 3.20. Whereas 20 mol% loading of DABCO failed to deliver any 
annulation product, treatment of 3.12 with 1 eq of DABCO led to the desired exo and endo-
3.21 adducts in a 50:50 diastereomeric ratio. Together with the aldol products, a significant 
amount of unreacted 2-methylcyclohexane-1,3-dione was also present in the crude mixture; 
unfortunately, any attempt to separate it from the desired mixture of aldol isomers was not 
successful and the crude mixture seemed to degrade during column chromatography on 
silica gel (Scheme 3.14). 
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Scheme 3.14: Synthesis of 6-hydroxy-1,8-dimethylbicyclo[3.3.1]nonane-2,9-dione and its attempted isolation. 
 
As shown in scheme 3.15, prolonging the reaction time and using DMF as solvent seemed 
to lead to better results in terms of NMR yield and diastereoselectivity. However, unreacted 
dione 3.12 was still present in the crude mixture and, as described before, purification was 
not possible. 
Solvent T (° C) Time (h) exo-3.21:endo-3.21 NMR yield (%) recovered. 3.12
OO
3.12
O
DABCO (1 eq) OO
OH
OO
HO
+
DMF, 130 C exo-3.21 endo-3.21
30
130 16
DMF
DMF
130
42:53
58:42
60
38
40
62
time
 
 
Scheme 3.15: Attempted optimisation of the synthesis of 6-hydroxy-1,8-dimethylbicyclo[3.3.1]nonane-2,9-dione.   
 
We therefore decided to derivatise the mixture of the free alcohols as the acetate ester or 
methyl ether in order to avoid a possible retro-aldol process, most likely catalysed by the 
acidity of silica. As shown on scheme 3.16, attempted derivatisation as either the TBS ether 
or the methyl ether failed. In both cases no reaction occurred and a mixture of exo and endo-
3.21 was recovered. Reaction with acetic anhydride and DMAP however afforded, after 
separation on column chromatography, two products, the desired 3.22 and the dimethyl 
ester 3.23, both as single diastereoisomers but unfortunately in very low yield (Scheme 
3.16). 
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Scheme 3.16: Derivatisation of bicyclo ketol mixture as methyl ester 3.22. 
 
A one-pot strategy was then devised to improve the efficiency of the derivatisation and the 
yield of 3.22. The Michael-aldol annulation was first run under the conditions that gave the 
best results in terms of diastereoselectivity and starting material vs product ratio (see 
Scheme 3.15). When TLC showed that the annulation reaction was completed, DMF was 
evaporated at reduced pressure, the crude mixture redissolved in dichloromethane and 
acetic anhydride and DMAP were added. This strategy slightly improved the yield (8% to 
16%), probably owing to a more efficient work-up; however, the best result was obtained 
when the reaction was heated at reflux in the presence of pyridine and the crude product 
chromatographed on neutral alumina, giving 3.22 in 23% yield. Interestingly, only the major 
endo-isomer of the crude product could be recovered to give the desired product as a single 
diastereomer (Scheme 3.17). 
OO
3.12
O
DABCO (1 eq)
OO
H3C(O)CO
3.22
DMF, 130 C, 30 h
16%
single diastereoisomer
1)
2) Ac2O, DMAP
CH2Cl2
25 C, 16 h
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O
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DMF, 130 C, 30 h
1)
2) Pyridine, Ac2O
CH2Cl2, DMAP
40 C, 16 h
OO
H3C(O)CO
3.22
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Scheme 3.17: One-pot strategy for the synthesis and isolation of the derivatised bicyclo 3.22. 
 
The substitution of position -8 was further explored using cinnamaldehyde 3.24. No reaction 
was observed with a catalytic amount of DABCO whereas the use of stochiometric quantities 
drove the reaction to completion, with 95% conversion observed by crude 1H NMR and 
satisfactory d.r. (exo:endo, 37:63). Unfortunately, the crude product could not be freed from 
cinnamaldehyde impurities, either by evaporation or distillation. In the attempt to separate 
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the desired aldol adducts from the aldehyde residues on column chromatography it was 
observed that the products were also unstable on silica even when the solvent was 
neutralised or neutral Al2O3 was used instead, and at best only 10% of a mixture of the exo 
and endo-3.25 products could be isolated (Scheme 3.18). 
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O
20 mol% DABCO OO
exo-3.25
OH
OO
HO
+
endo-3.25CH3CN
Ph
25 or 95 C, 16 h
Ph Ph
30:70
10% after purification
3.24
 
 
Scheme 3.18: Synthesis and difficult isolation of 6-hydroxy-1-methyl-8-phenylbicyclo[3.3.1]nonane-2,9-dione. 
 
Derivatisation was again attempted but the esterification that was successful for bicyclo 3.21 
could not be achieved. Scheme 3.19 shows how only reaction with benzoyl chloride and 
triethylamine led to a pure adduct (3.26, R = Bz) as a single diastereoisomer, although in 
only 5% yield. Oxidation of the alcohol was considered as a means of making the bicyclo 
system more stable but unfortunately all oxidation attempts were unsuccessful (Scheme 
3.19). 
Py, Ac2O, DMAP, CH2Cl2, 40 C, 16 h No reaction
RO O
Degradation
No reaction
Promising crude, unstable on silica
Degradation
Outcome
DMP, NaHCO3, CH2Cl2, 25 C, 16 h
PCC, CH2Cl2, 25 °C, 16 h
IBX, EtOAc
NaH, MeI, THF
Conditions
OO
HO
3.25
Ph
OO
Ph
or
OO
Ph
3.26 3.27
Et3N, BzCl, CH2Cl2, 25 C, 16 h R = Bz 3.26, 5%
R = Me, OAc, Bzendo:exo mixture
Table
 
 
Scheme 3.19: Derivatisation to ester analogue 3.26 and attempted oxidation to triketone 3.27. 
 
Limitations to install an 8-substituent was shown when 3.12 was reacted with 3-methyl-2-
butenal 3.28 using the same conditions previously employed for crotonaldehyde. No bicyclo 
product was observed, only no reaction or degradation (Scheme 3.20). 
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OO
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Scheme 3.20: Limitation on substitution at the 8-position. 
 
3.2.2.2 Substitution at position -1,-3 and -4 
With the idea of synthesizing a bicyclo compound that more closely resembled the PPAP 
scaffold, replacement of the methyl group at the C-1 bridgehead position by a prenyl group 
was attempted. 2-prenyl-1,3-cyclohexanedione 3.31 was obtained by alkylation of 1,3-
cyclohexanedione 3.30 with prenyl bromide in water (Scheme 3.21).62 Reaction of this 
precursor with a catalytic amount of DABCO under optimal conditions (acetonitrile, 95 °C) 
yielded the desired bicyclic adducts 3.32 in high d.r. but only in 22% yield. Simply increasing 
the reaction time to 48 h dramatically improved the efficiency of the reaction (80% yield) and 
the diastereomeric mixture (d.r. = 90:10). Surprisingly, only traces of the aldol product could 
be detected if the same reaction was run in DMF under neutral conditions. 
OO OO
HO
OO 3.30
exo-3.323.31
DIPEA, H2O
0 to 25 °C
3 days, 41%
OO
OH
endo-3.32
20 mol% DABCO
CH3CN, 95 C
time
+
O
Br
16 h, d.r.  = 87:13, 22%
48 h, d.r. = 90:10, 80%  
Scheme 3.21: Reaction sequence for the synthesis of 6-hydroxy-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-
2,9-dione. 
 
With precursor 3.31 in hand, its reaction with methacrolein and with crotonaldehyde was 
then tested. In both cases catalytic loading of base afforded unsatisfactory yields; however, 
use of a stochiometric amount of DABCO led to good to high isolated yields and satisfactory 
d.r. For bicyclo 3.34 the crude product was not pure enough and column chromatography 
had to be performed, affording the pure compound in 44% yield (Scheme 3.22). Reaction 
with cinnamaldehyde was not attempted given the instability issues encountered with the 
methylated precursor 3.12. 
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Scheme 3.22: Michael-aldol annulation of 2-prenyl-1,3-cyclohexanedione with methacrolein and crotonaldehyde.  
 
A simple variant to the prenyl precursor 3.31 was the synthesis of 2-allyl-1,3-
cyclohexanedione 3.35 for use in the Michael-aldol annulation. Reported allylation 
conditions in aq. KOH in the presence of Cu 116 could not be repeated while a Tsuji-Trost 
reaction under standard or modified117 conditions both provided the diallylated adduct 3.36 
instead of the desired monoallylated product 3.35 (Scheme 3.23). 
 
OOOO 3.30OO
3.353.36
Cu, 5 % KOH
Br
Bu4N Br
PdCl2
K2CO3, H2O
100 °C, 7 h
OAc
Pd(PPh3)4
THF, 25 °C, 4 h
OO
3.35
OAc
 
Scheme 3.23: Attempted monoallylation of 1,3-cyclohexanedione 3.30. 
 
Determined to install more functional groups at position-1 of 3.30 and expand the scope 
behind the prenyl group, the possibility of installing an acyl group or an aromatic ring at this 
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position was considered. The preparation of 2-phenyl-1,3-cyclohexanedione (3.37) has 
been previously described;118 after an initial unsuccessful attempted synthesis through a 
palladium-mediated arylation, reaction of 1,3-cyclohexanedione with iodobenzene in the 
presence of CuI and L-proline119 gave dione 3.37 in 65% yield. The crude product was not 
stable on silica for purification but was found to be sufficiently pure to attempt the cyclisation 
step. Treatment of 3.37 with 20 mol% of DABCO in acetonitrile over the course of 16 or 24 
h both led to a complex mixture from which only 8% of Michael adduct 3.38 could be isolated 
(Scheme 3.24). The outcome was the same when a stochiometric amount of DABCO was 
used so this route was abandoned. 
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Scheme 3.24: Synthesis of 2-phenyl-1,3-cyclohexanedione 3.37 and its use in the Michael-aldol annulation. 
 
Attention was then turned to preparing a 1-acyl precursor. The synthesis of the 
monoacylated 1,3-dione has been scarcely described, and the best procedure120 afforded 
the key precursor 3.40 in 11% yield. Treatment of 3.40 under the optimum onditions led to 
the equilibrium depicted on Scheme 3.25. As the reaction was monitored by crude 1H NMR 
at regular intervals of two hours it was observed that Michael adduct 3.41 was the major 
product after 2 h and then gradually decreased at the expense of the formation of hemiacetal 
3.42 which after 16 h was almost the sole identified product. The products were well 
distinguished on NMR but unfortunately they co-eluted on column chromatography and 
could not be separated (Scheme 3.25). 
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Scheme 3.25: Aldehyde-hemiacetal equilibrium for the annulation of 2-acyl-cyclohexanedione 3.40. 
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In case the steric hindrance caused by the phenyl group at position -1 was preventing 
cyclisation of the Michael product, the cyclisation of 2-isobutyrylcyclohexane-1,3-dione 
(3.43) was examined. Following a patent application121 cyclohexane-1,3-dione was heated 
at reflux with 2-methylpropionyl chloride in toluene in the presence of DMAP to give trione 
3.43 in 28% yield. Reaction of the latter with acrolein under neutral reaction conditions at 
room temperature afforded an inseparable mixture of starting material and aldehyde 3.44, 
whereas heating at 130 °C led unexpectedly to the formation of spiro compound 3.45 in high 
yield and as the only product of the reaction. However, in the presence of DABCO the yield 
was only 31%. To the best of our knowledge, such unsaturated spirocyclic diones have not 
been previously described and a detailed account of its formation will be given in chapter 4 
(Scheme 3.26). 
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Scheme 3.26: Synthesis of 2-isobutyrylcyclohexane-1,3-dione and unexpected formation of enal 3.45. 
 
Moving to the functionalization of position -4 and -5, we considered two commercially 
available diones, 5,5-dimethyl-1,3-cyclohexanedione 3.46 and 4,4-dimethyl-1,3-
cyclohexanedione 3.47 respectively (Fig. 3.27). 
 
 
Fig. 3.27: Structure of gem-dimethyl 1,3-cyclohexanediones. 
 
Starting from the 5,5-dimethylated precursor 3.46, methylation97 with MeI in a freshly 
prepared 3M solution of NaOH yielded 3.48 in 36% yield. Treatment of the latter with acrolein 
and a catalytic amount of DABCO gave aldehyde 3.49 in nearly quantitative yield. The 
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desired bicyclo compound exo-3.50 could be obtained as a single diastereoisomer from 
isolated Michael adduct 3.49 in 55% yield upon heating in acetonitrile in the presence of 
DABCO for 30 h. Unfortunately, most of the attempts to trigger the domino Michael-aldol 
sequence by either prolonging the reaction time or changing the reaction conditions were 
unsuccessful and exo-3.50 was obtained only in the presence of 2 eq of DABCO in an 
unsatisfactory yield of 12% (Scheme 3.28).  
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CH3CN, 95 °C, 4 h
OO
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O
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3.46
NaOH, MeI
100 °C, 24 h
36%
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Conditions Table OO
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DMF, 130 °C, 24 h
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CH3CN, 95 °C, 16 h
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OO
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Scheme 3.28: Stepwise access to bicyclo compound 3.50 and attempted optimisation of domino Michael-aldol 
from 5,5-dimethyl-1,3-cyclohexanedione. 
 
Interestingly, heating in DMF at 135 °C led to a faster conversion of the Michael adduct to 
the desired bicyclo product, in the exact same yield and diastereoselectivity as before. A 
one-pot strategy was then devised; once 3.49 was formed from the reaction in acetonitrile, 
the solvent was evaporated at reduced pressure and replaced with DMF; the resulting 
mixture was heated at 135 °C for 24 h which allowed the intramolecular aldol to take place 
giving exo-3.50 in an improved yield of 66% over 2 steps (Scheme 3.29). 
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Scheme 3.29: Improved stepwise sequence for the synthesis of exo-3.50 in which no work-up is required. 
 
With 4,4-dimethyl-1,3-cyclohexanedione 3.47 as starting material instead, addition of 1 
equivalent of DABCO to a solution of 3.51 and acrolein in acetonitrile led to the formation of 
the desired mixture of bicyclic products 3.52 in nearly quantitative yield and satisfying d.r. 
(Scheme 3.30). The reaction could not be driven to completion when dione 3.51 was heated 
in DMF, affording a mixture of aldol 3.52 and Michael product 3.53; the aldol products were 
predominant in case of overnight heating (16 h) whereas the Michael adduct was favoured 
when the reaction time was prolonged to 24 h (Scheme 3.31). It is worth noting that the 
purity of dione 3.51, synthesised from 3.47 via methylation in aq. NaOH, was critical; being 
highly unstable at room temperature (although it can be stored at -20 °C for several weeks) 
it was crucial to use it as soon as it was prepared; the use of the stored sample, even after 
few days, made the yield of the annulation drop significantly (from 98 to 59%) (Scheme 
3.30). 
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endo-3.52
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stored batch: d.r. = 53:47, 59%
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OO OO
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Scheme 3.30: Michael-aldol annulation for the synthesis of bicyclo 3.52 bearing a gem-dimethyl group at the 4-
position. 
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3.3 Domino Michael-aldol annulation of cycloalkane 1,3-dione with α,β-
unsaturated aldehydes to give bicyclo[3.2.1]octanes derivatives 
 
At this point it was reasoned that the same methodology adopted for the construction of the 
bicyclo[3.3.1]nonane core could be applied to the synthesis of bicyclo[3.2.1]octane by 
employing 3.54, the 5-membered ring analogue of 2-methyl-1,3-cyclohexanedione. To test 
our hypothesis, the reaction between commercially available dione 3.54 and acrolein with 
both catalytic and stochiomentric amount of DABCO was carried out and delivered the 
desired annulation products exo- and endo-3.55, albeit in only 30% yield. Both d.r. and yield 
of the domino Michael-aldol were improved under neutral conditions (DMF at 130 °C), 
although a prolonged reaction time was detrimental for the yield. Interestingly, by reducing 
the temperature to 95 °C Michael product was obtained exclusively in 91% yield (Scheme 
3.31). Isolation of the Michael product 3.56 was also achieved after overnight stirring of a 
solution of 3.54 and acrolein in water. Subsequent cyclisation of 3.56 to the desired bicyclo 
compound was surprisingly successful under acidic conditions, affording 3.55 in 61% yield 
with the exo-isomer favored over the endo (Scheme 3.31). 
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Scheme 3.31: Application of our methodology to 2-methyl-1,3-cyclopentanedione for the construction of the 
[3.2.1]bicyclic scaffold. 
As highlighted in scheme 3.32, the extension of the methodology to methacrolein delivered 
the desired bicyclic ketols in 50% yield and good d.r.. Similarly to the bicyclo[3.3.1]nonane 
scaffold, isolation of bicyclo compounds exo- and endo-3.58 arising from the reaction with 
cinnamaldehyde was particularly difficult. Even if crude 1H NMR showed 95% conversion 
and only residual amounts of cinnamaldehyde, the product was found unstable on silica gel 
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and could be isolated in only 10% yield (Scheme 3.32). The mixture resulting from the 
reaction with crotonaldehyde was isolated as a mixture of three diastereoisomers, the third 
one being most likely endo-3.59b, bearing the methyl group in axial position at C-8, a trend 
already observed for the reaction with 2,4,4-trimethylcyclohexanedione (Scheme 3.32). 
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Scheme 3.32: Annulation reaction with methacrolein, cinnamaldehyde and crotonaldehyde. 
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3.4 Trends in the mode of cyclisation and stereochemical assignment 
 
A summary of bicyclo ketols synthesised with our Michael-aldol annulation is depicted on 
Table 3.33 
 
Table 3.33: Summary of bicyclo[3.3.1]nonanes and [3.2.1]octanes synthesised, with yields and 
diastereoselectivity. 
 
Since the beginning of our investigation, it became clear how the configuration of the alcohol 
at the 6-position could be controlled through modification of the reaction conditions or the 
type of substituent present in the annulating unit and in the cycloalkane dione. For instance, 
the use of neutral conditions with DMF as solvent was found to be optimal in terms of yield 
only for annulations involving acrolein; in terms of diastereoselectivity, it seemed that the 
absence of substituents in the enals (i.e. acrolein) led to the formation of the exo-adduct 
predominantly (entries 2, 4 and 8) or exclusively (entries 1 and 3) in both the 
bicyclo[3.3.1]nonane and [3.2.1]octane series. As previously mentioned, whereas neutral 
conditions gave the best results only for unsubstituted bicyclo ketols 3.2 and 3.55, the use 
of stoichiometric amount of DABCO in acetonitrile was found to be ideal for all other bicyclo 
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compounds, with the successful use of catalytic amount of base only for entries 2 and 5. 
The use of α-methyl substituted enals led to the predominant formation of the endo-adduct; 
this can be rationalised by the substituent effect on the Michael adduct conformation and 
consequently on the mode of cyclisation; in case of an α-methyl group, the endo-mode of 
cyclisation would in fact be preferred because of one less synclinal interaction, compared to 
when the exo-adduct is formed (Scheme 3.34).  
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Fig.3.34: Michael adducts containing α-substitutents. 
 
An exception to this is represented by the annulation involving 2-prenyl derivatives, where 
the exo-ketol is formed predominantly where both α and β-substitutents are present. At the 
same time, a β-methyl or phenyl group present on the annulating unit does not exert the 
same effect as an α-group, although preference for the exclusive formation of the exo-adduct 
is smaller (entries 7, 10, 11 and 12).  
Substituents on the cyclohexane-1,3-dione system also have a profound effect on the 
Michael adduct conformation and therefore on the stereochemical outcome. The placement 
of the gem-dimethyl group at position -3 (entry 4) causes the dione ring to adopt a boat 
conformation, a peculiarity that will be discussed in detail in paragraph 3.5, rather than a 
chair-chair; in this way, the non-bonding interactions with the aldehyde carbonyl group are 
minimized leading mostly to the formation of the endo-isomer. When the gem-dimethyl group 
is located at position-4, the 1,3-diaxial interaction between the carbonyl and the equatorial 
methyl group completely suppress the endo mode of cyclisation, giving exclusively the exo-
isomer (entry 3). A detailed assignment of the first bicyclo ketol obtained, exo-3.2, revealed 
two small coupling constants (3.1 and 2.6 Hz) for δ 4.28, assigned as the H-6 proton; these 
couplings make this in theory a doublet of triplets, with the 2:1 and 1:2 regions close but not 
superimposed (which would give 1:3:3:1), with the peak height found to be about 1:2.5:2.5:1, 
consistent with partial overlap of the 2 and 1 regions. Importantly, the values of the coupling 
constant suggested that the H-6 adopted an equatorial position, the C-OH being in an axial 
orientation. Additional proof for this assignment came from the 1H NMR analyses of the 
endo-3.2 ketol (never isolated pure but whose crude 1H NMR was clear enough to allow 
stereochemical assignment) which showed a big, trans-diaxial coupling constant of 11.5 Hz 
for its H-6 proton. HMQC and HMBC established the location of all the other peaks in the 1H 
NMR where general trends were observed; for instance the multiplets at δ 2.32 and 2.60 
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cleanly coupled with the peak at 38.2 in 13C NMR, identified through HMBC correlation and 
DEPT as the 3-CH2; J values for the multiplet at δ 2.32 was found to be 9.4 Hz indicating a 
trans-diaxial coupling, identifying therefore that multiplet as the 3-Hax and the higher δ 2.60 
as the 3-Heq. This chemical shift trend for the axial/equatorial protons was generally found 
throughout the bicyclo series and was used to assign axial/equatorial 3-CH2 in other chair-
chair structures (Fig. 3.35).  
 
 
Fig. 3.35: Details of the NMR assignment of ketol 3.2 
 
The stereochemical assignment was unequivocally confirmed by the X-ray crystal structure 
obtained for the 3,5-dinitrobenzoyl derivative of exo-3.2, previously assigned by NMR, which 
showed the C-OH moiety occupying the axial position (Fig.3.36). 
 
  
 
Fig.3.36: NMR assignment and X-ray crystal structure of the ester derivative of bicyclo 3.60. 
 
Assignment of 3.19 was based on a few key observations; the value for the H-6 coupling 
constant was found to be at 10.5 Hz, clearly indicating a trans-diaxial relationship with H-7, 
positioning at the same time the C-7 methyl group in equatorial position. The second 
coupling constant for H-6 matched with the same value found for H-5 (4.8 Hz), confirming 
the axial-equatorial relationship between H-6 and the bridgehead proton. Although 
assignment for the H-6 of the exo-isomer was troublesome as the 1H NMR showed only 
complex multiplets, its synthesis and isolation confirmed the presence of two distinct 
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diastereoisomers rather than equilibrating conformers. Noteworthy is the chemical shift for 
C-8 at 44.5 ppm and C-3 at 38.4 ppm; the effect of the 7-C-Me group is in fact to deshield 
C-8 by about 10 ppm, which is consistent with the effect seen on cyclohexanone and its 4-
Me derivatives (Fig. 3.37, left). 
In the prenylated series it is interesting to highlight that the 7-CH2 signals are found to be 
the most shielded, which was almost always the case for the H-4 protons in other bicyclo 
compounds. It was also noticed that there was little separation in chemical shift between 
axial and equatorial protons as shown for instance in ketol 3.32 by the region at δ 2.2-2.0, 
which contains 4 and 8-CH2, both equatorial and axial, as well as the 3-Hax; those 
separations were usually bigger in non-prenyl analogs. The presence of a prenyl chain was 
confirmed by the presence of the olefinic peak at δ 5.05, which featured an allyl/vinyl 
coupling constant of 5.0 Hz and a multiplicity of a triplet of septets, consistent with its 
coupling to the neighbouring -CH3 and -CH2. Stereochemical assignment of H-6 was 
confirmed by the coupling constant of the endo-isomer, whose values (11.5 and 4.6 Hz) 
clearly indicated a trans-diaxial coupling with H-7 (Fig. 3.37, right). Assignment for exo,endo-
3.33 and exo,endo-3.34, containing a methyl group at the 7 and 8-position respectively, was 
complicated by unclear integration and unresolved couplings in some regions of the 1H 
NMR, which sometimes contained 4 or 5 protons all together. However, some trends were 
noticed; whereas increase in the chemical shift values were expected for the carbon directly 
substituted with the methyl group, as clearly shown by comparison of C-7 for exo-3.2 and 
endo-3.19, a difference in the chemical shift value of the vicinal 6-CH-OH was also observed, 
showing an increase of about 3 ppm when the Me groups was located at position -7 and a 
decrease of about the same range when C-8 was substituted instead. The same difference 
was also observed in the bicyclo[3.2.1]octane series. 
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Fig.3.37: Details of the NMR assignments of ketol 3.19 and 3.32 
 
 
Relatively to the bicyclo[3.2.1]octane series, HMBC and HMQC confirmed the consistency 
observed for all the other bicyclic compounds relative to carbon 3 and 4, having values of 
26.5 ppm and 40 ppm respectively. A coupling constant of 5.4 Hz was found for the 
bridgehead proton at C-1 of exo-3.55 and it was especially puzzling, given the fact that there 
was no evidence for a –O-H-O=C hydrogen bond and it was too large for a W coupling. 
However, this value could be explained on the basis of the dihedral angles being different, 
and giving rise to unequal J values. 
Additionally, the cyclopentane-1,3-dione ring is much flatter than a cyclohexane-1,3-dione 
ring with models showing the (pseudo) axial 7-CH being at 90 ° to the bridgehead 1-CH so 
that J = 0; this information was particularly useful in the interpretation of exo,endo-3.57 as it 
explains why only J-geminals of 19 Hz are seen for the 7-CHax, and at δ 2.9; however there 
is also a vicinal coupling for 7-CHeq, so that a doublet of doublets at δ 2.5 is also observed. 
A straightforward distinction was also made for the 2-CH multiplet, which showed a J of 9.6 
Hz for the major endo-isomer and a W-coupling of 2.3 Hz for exo-3.57. As mentioned before, 
trends in the chemical shift adopted by the substituted carbon were also particularly 
noticeable in this series (Fig. 3.38). 
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Fig.3.38: Details of the NMR assignments of bicyclo[3.2.1] ketols 3.55 (left), 3.57 (centre) and 3.59 (right). 
 
For exo-3.50, the carbon at position -4 bears two methyl groups so 3-CH2 was 
unambiguously identified as at δ 52.6; coupling with 3-Hax (δ 2.45) and 3-Heq (δ 2.72), both 
having a gem-coupling of 18 Hz, was subsequently confirmed by HMQC. A small coupling 
was also noticed in the COSY NMR between the 3-Heq at δ 2.72 and the methyl group at δ 
0.91, which could have supported the equatorial assignment, but no splitting was seen on 
this signal. Conversely, a small splitting was also seen on the δ 2.45 signal belonging to 3-
Hax, but it was negligible as a W conformation is not generally adopted for some 4- or 5-
bond couplings. Chemical shift values for C-8 and C-7 were also found to match previous 
values of the bicyclo series (Fig. 3.39). As will be discussed extensively in the next 
paragraph, the position of the gem-dimethyl group in exo,endo-3.52 forces the molecule to 
adopt an unusual boat-chair conformation. This is confirmed in the chemical shift values of 
4-CHax which are much more shielded (δ 1.48 in exo-3.52 and δ 1.70 in endo-3.55) 
compared to the rest of the series. Additionally, the delta value for 8-Hax is much lower (δ 
1.41-1-26) in the endo isomer compared to exo-3.52 (δ 2.12-2.00) since the latter 
experiences a severe 1,3-diaxial interaction with the axial OH group (which is also strongly 
deshielding). The carbon pattern is however unchanged, although actual delta values 
slightly differ (Fig. 3.39). 
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Fig.3.39: Details of the NMR assignment of bicyclo 3.50 (left) and 3.52 (right). 
 
 
3.5 Oxidation product and conformational studies 
 
Given that the annulation methodology was found to be particularly effective using the gem-
dimethylsubstituted cyclohexane-1,3-diones, their reaction with methacrolein was studied, 
the expected epimers exo- and endo-3.61 being obtained in almost the same amount 
(Scheme 3.40). A small amount of what looked like a third and a fourth diastereoisomer was 
also observed by 13C NMR. Oxidation with pyridinium chlorochromate converted the 
complex ketol mixture into trione 3.62. It was however noticed that a second product was 
formed in 15% yield; the epimer at C-7 could be excluded as it would suffer severe non-
bonding Me-Me interaction between the gem-dimethyl group at C-3 and the axial methyl 
group at C-7. The 85:15 ratio observed could have been an evidence that trione 7-exo-3.62 
existed as chair and boat form and that in reality we were observing conformers, not 
diastereisomers. Molecular models indeed suggested that the steric hindrance brought by 
the presence of the gem-dimethyl would result in an alternative boat-chair conformation 
compared to the usually observed chair-chair conformation of bicyclo[3.3.1]nonanes 
(Scheme 3.40). 
O
OO
3.51
DABCO (1 equiv.)
CH3CN, 95 C exo-3.61
+
endo-3.61
OO OO
OH
OH
d.r. = 43:41:14
(+ traces visible only by 13C)
OO
O
PCC, CH2Cl2
25 C, 16 h
94% 3.62
O
O
O
unusual
conformation
16 h, 65% 7-exo-3.62
7 6 7
6
3
 
Scheme 3.40: Michael-aldol annulation for the synthesis of 3.61, oxidation to 3.62 and observation of an unusual 
boat-chair conformation. 
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At this point we wanted to test whether the placement of other substitutents in different 
position of the scaffold would exert this same conformational effect; 3.51 was thus reacted 
with crotonaldehyde under the same reaction conditions giving a complex mixture of four 
diastereoisomers (Scheme 3.41). Despite the complex spectrum, the fact that the chemical 
shift for the major diastereoisomer peak was comparable with previously assigned exo-
isomers (4.25 ppm), the identification of a coupling constant of 4.3 Hz and the absence of 
any trans-diaxial coupling, suggested that also in this case the major isomer possessed an 
exo-configuration (at carbon 6). The mixture was then readily oxidized yielding 
approximately a 70:30 mixture of 8-endo-3.64:8-exo-3.64. 8-H was assigned via COSY and 
HMQC but being a complex multiplet no J could be deduced from it; however, 7-Hax, 
assigned as a doublet of doublet, showed a big coupling constant of 15.5 Hz with 8-Hax, 
suggesting a trans-diaxial interaction and establishing that 8-CH3 was equatorial. Moreover, 
the multiplicity observed for the peak at 3.71 ppm, assigned to the bridgehead H-5, is a 
doublet of triplets, as expected given the presence of the W-coupling from 5-CH to 7-CHeq; 
this is in contrast to 7-exo-3.61, where the 7-Me group is present, in which the peak for H-5 
(found at 3.69 ppm) is only a doublet of doublet because no W-coupling is possible. 
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+
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49%
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Scheme 3.41: Michael-aldol annulation for the synthesis of ketols 3.63 and subsequent oxidation reactions. 
 
The same oxidation reactions were also performed on all the previous ketol derivatives with 
very good results, as summarized on scheme 3.42. 
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Scheme 3.42: Left: chair-chair triketone derivatives, Right: boat-chair triketone derivatives synthesised. 
*On standing for 2 weeks 7-exo-3.62 was converted into a single diastereomer. 
 
With a series of triketone derivatives in hand, computational experiments using the 
Schrödinger software package were performed on all the triketones containing the gem-
dimethyl group at C-3 as well as the annulation product 3.52. Minimization and 
conformational analyses using the OPLS3 force field showed that the boat-chair was always 
the more stable conformation adopted (Table 3.43). The values are energy penalties from 
the zero value (which indicates the most stable conformer) for adopting a less than optimum 
conformation. Less favourable chair-boat, twistboat–twistboat and boat–boat conformations 
could be detected but never the usual chair–chair conformation. The results obtained in 
Table 3.44 were confirmed by quantum mechanics calculations using Jaguar and the B3LYP 
6-31g** hybrid functional (see Table 3.44) which gives the same lowest energy conformer 
as OPLS3- GB/SA. 
 
Compound 7-exo-
3.62 
8-endo-
3.64 
3.68 endo-3.52 exo-3.52 
Boat-Chair 0 0 0 0 0 
Chair-Boat 16.2 - 10.0 35.6 28.4 
Twistboat-Twistboat 23.9 27.7 19.2 34.2 33.1 
Boat-Boat 27.4 - 21.0 - - 
Twistboat-Twistboat2 - - - 41.3 - 
Chair-Chair - - - - - 
- Conformation not found during conformational search 
 
Fig.3.43: Conformational energies (kJ mol-1) of C3-gem-dimethyl-bicyclo compounds (relative to boat-chair 
conformer). 
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Compound 7-endo-
3.62 
8-endo-
3.64 
3.68 endo-3.52 exo-3.52 
Boat-Chair 0 0 0 0 0 
Chair-Boat 20.1 15.0ǂ 12.3 32.6 29.1 
Twistboat-Twistboat 20.7 18.8 13.7 23.0 29.4 
Boat-Boat * * * * * 
Twistboat-Twistboat2 17.1 13.4 9.7 21.4 19.2 
Chair-Chair - - - - - 
* Conformation minimized to Twistboat-Twistboat2, ǂ Conformation minimized to Twistchair-Twistboat 
 
Fig.3.44: Gas-phase conformational energies (kJ mol-1) of C3-gem-dimethyl-bicyclo compounds (relative to 
boat-chair conformer). 
The assistance of Dr. Anders Poulsen (Experimental Therapeutic Centre (ETC), A*STAR, Singapore in performing 
computational calculations is gratefully acknowledged. 
 
The unusual boat-chair conformation predicted by the above calculations was confirmed by 
a single crystal X-ray structure of 7-endo-3.62. The commonplace chair-chair conformation 
is excluded because of the severe non-bonding interactions that would arise between the 
C-3 axial methyl group with the 7-methylene unit. Additionally, the bridging carbonyl group 
(as distinct from an sp3 carbon atom) is able to accommodate a boat structure, the ring 
containing the gem-dimethyl group not suffering any significant flagpole interactions (Fig. 
3.45). In cases where such a non-bonding interaction is absent, as for triones 3.65, 3.66 and 
3.67, the usual chair-chair conformation for saturated, substituted bicyclo[3.3.1]nonanes is 
preferred (Scheme 3.42).  
 
 
 
Fig. 3.45: a) X-ray crystal structure of trione 7-exo-3.62, b) representation of the lowest energy conformer 
obtained by using OPLS3-GB/SA force field. 
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3.6 Additional Reactions 
 
3.6.1 Formation of enone derivatives 
 
While investigating the Michael-aldol annulation, a side product was observed at the 
expense of the bicyclo ketol, particularly when the reaction solvent was not dry, or without 
an inert atmosphere. This compound was also detected when 1,3-cyclohexanedione 3.30 
was used instead of the 2-methyl derivative (Scheme 3.46, blue) and during attempted 
methylation of the 3-position (Scheme 3.46, red) but it was obtained exclusively and isolated 
in near-quantitative yield when the reaction was heated in water (Scheme 3.46, magenta). 
OO
OH
H2O, 95 °C
24 h
72 h
OO
DABCO, CH3CN
95 °C, 16 h
with wet solvent
or no inert atmosphere
O
O
OO
OO
O
CH3CN, 95 C
16 h, 14%
OO
O
LDA, MeI
THF, 78 C
3.30
3.65 exo-3.2 3.12
3.12
97%
Side 
Product
3
 
 
Scheme 3.46: Highlight of a few reactions leading to a common side product. 
 
 
The product displayed both a carboxylic acid and a ketone function, as shown by the 13C 
NMR (202.0 ppm and 177.9 ppm) and by the IR spectrum (1600 cm-1). It could only have 
been formed by attack either at the bridge carbonyl group (C-9) giving cycloctanone of type 
3.70, or at the C-3 carbonyl group, leading to cyclohexenone of type 3.72 (Scheme 3.47); 
however, which reverse Claisen reaction had occurred was not clear. Dehydration was 
observed which might be expected in the six-membered ring, rather than the more 
conformationally flexible eight-membered ring.  
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Scheme 3.47: Mechanistic hypothesis for the formation of the carboxylic acid product observed. 
 
Selected 13C chemical shift data26, 122 were then collected which showed that the ketone 
signal at 202.0 ppm was in agreement with other related cyclohexenone derivatives, but did 
not fit with cycloctanone related structures (Fig. 3.48). 
 
 
Fig. 3.48: A few reported literature values for the chemical shift of cycloctanone and cyclohexanone derivatives.26, 
122 
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The above tentative assignment was unambiguosly confirmed by HMBC analysis of 3.72 
which showed no correlation between the olefinic proton and the carboxylic acid signal 
whose shift is instead correlated with the linear side chain, confirming the formation of 
cyclohexenone 3.72 over cycloctanone 3.70. 
There are examples of attack on bicyclo[3.3.1]octane-2,9-diones by oxygen nucleophiles in 
the literature. Initially, it was thought that the cycloctanone derivative 3.70 might have been 
formed, on the basis that the bridging carbonyl group could have been more prone to 
nucleophilic attack than the carbonyl at position-2. This reasoning was used to account for 
a 7-membered ring being formed as a result of a metal/proton-catalyzed Conia–ene 
reaction, as recently reported by Zhu.123 However, while 1,2-addition at the 9-CO group 
could be faster, because more angle strain is relieved, the major consideration may be the 
relief of diaxial interactions during the fragmentation. As previously shown on scheme 3.47, 
both reverse Claisen processes go through stereoelectronically favoured trans-diaxial 
eliminations, but the breaking of the 1,2-bond, as shown in Scheme 3.47, removes the 
severe 1,2-/4,5-diaxial interaction, providing a driving force that is not present in case of C-
9 attack because the breaking 1,9-bond is not in a 1,3-diaxial configuration. Additionally, the 
H/OH being 1,3-diaxial might render the attack at C-2 even slower than at C-9 (Scheme 
3.47). 
 
While the above is only a partial analysis, it led us to reconsider the literature data. As 
mentioned above, Zhu recently reported the formation of differently substituted 
cycloheptanones derivatives arising from nucleophilic attack on the bridged carbonyl group 
of bicyclo[3.2.1] 3.73, which led, after ring opening and isomerization, to the more stable 
unsaturated methyl ester 3.74 (Scheme 3.49).123 
Given the higher chemical shift value for the ketone 7-membered ring reported in the 
literature (Fig. 3.48), the value of 201.3 ppm reported by Zhu was not consistent. He 
suggested that bicyclo[3.2.1]octanes possess a higher ring strain and therefore are more 
prone to ring-open at the bridgehead position; however, this line of reasoning was simply 
adopted from an earlier paper 57 in which no further literature reference or justification was 
given. Overall, few comments and little analysis of such reverse Claisen reactions in bicyclo 
systems, especially bicyclo[3.3.1]octanediones, have been given.  
Noteworthy is the recent report by Lepore who documented a Grob-type fragmentation of 
bicyclo[3.3.1]nonane of type 3.75 to give highly functionalized 8 and 9-membered rings.122a 
Attack of the nucleophile on the carbonyl bridge gives a tetrahedral intermediate 3.76; 
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subsequent breaking of the C2-C9 bond forms carbanion 3.77, which is stabilised by the 
sulfone group and rapidly protonates to give the desired monocyclic products 3.78 and 3.79, 
notable for the keto groups being at 209.0 ppm (as depicted in Fig. 3.48). However, the 
presence of the sulfone group is a special case, enabling anion stabilisation, so conclusions 
concerning bicyclo[3.2.1]octanediones and/or bicyclo[3.3.1]octanediones cannot readily be 
drawn from this study. Interestingly, when the reaction is run in the presence of TBAF·3H2O 
instead of methanol, decarboxylation is followed by a double bond shift to give the more 
stable, conjugated vinyl sulfone 3.79 (Scheme 3.49).  
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Scheme 3.49: Zhu’s and Lepore’s approaches to diversely substituted cycloalkanones and a few reported 
literature values for cycloheptanone derivatives.118a, 118e, 119,124  
 
To our knowledge, there is no precedent for bicyclo[3.2.1]octane ring-opening. However, for 
bicyclo[3.3.1]nonane, a reliable account by Butkus describes the acid-mediated ring opening 
of bicyclo of type 3.80 leading to cyclohexanone of type 3.81.125 Perhaps the only precedent 
for a bridgehead nucleophilic attack on bicyclo of type 3.82 is that of Tenaglia57 but no 13C 
NMR data were given in support of the structure of cycloctanone 3.83 (Scheme 3.50). These 
weak precedents together with our detailed NMR analysis suggest that a deeper 
investigation of the ring opening of bicyclo[3.3.1]nonanes and [3.2.1]octanes would be 
113 
 
desirable. 
 
 
Scheme 3.50: Butkus’ and Tenaglia’s reports on bicyclo[3.3.1]nonane ring opening.57, 125 
 
 
3.6.2 Reaction of 1,3-cyclohexanedione 
 
Whereas heating 3.30 with acrolein in acetonitrile afforded cyclohexenone derivative 3.72 
as depicted in scheme 3.51, heating at 130 °C using DMF as solvent led to spiro compound 
3.45 when acrolein was used as electrophile and to fused bicyclic compound 3.84 when 
methacrolein was used instead. This set of results can be rationalized by the absence of the 
methyl group at the 2-position (Scheme 3.51). The alkyl chain added during the Michael 
reaction of a 2-substituted cycloalkane-1,3-dione adopts an axial position about 50% of the 
time (leading to the bicyclo ketols) in contrast to a > 95% adopting the equatorial position 
when position 2 is not further substituted, the axial hydrogen having only small 1,3-diaxial 
interactions compared to a methyl or a chain when axial. Since an equatorial mode of 
cyclisation (3.86) is kinetically faster than a small concentration of axial chain cyclising to 
the bicyclo ketol, the fused bicyclo of type 3.84 is formed. Enal formation instead is the result 
of axial attack to give the dialkylated derivative 3.85. The rate of cyclisation of an aldehyde 
enolate is faster than a ketone enolate as it lacks the inductively-deactivating effect of a 
second alkyl group attached to the C=O carbon atom so that one aldehyde group is attacked 
by the other aldehyde enolate to give the spiro system. Cyclisation to the desired bicyclo is 
possible but evidently much slower than the alternative aldol involving the aldehyde enolate. 
In this case, compared to when the same enal was obtained from reaction of 2-acyl-
cyclohexanedione 3.43 with acrolein, and isolated in 80% yield (paragraph 3.2.2.2, Scheme 
3.26), a lower yield was observed and the efficiency of the reaction seems to be dependent 
on the amount of acrolein added.  
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Scheme 3.51: Cyclisation of cycloalkane-1,3-diones and some mechanistic rationales. 
 
3.6.3 Construction of more stereogenic centres 
 
In the attempt to extend the scope of the reaction to electrophiles other than unsaturated 
enals, the unsaturated pyruvate 3.88 was prepared by Wittig reaction of the phosphonate 
3.87 with benzaldehyde. Following addition of cyclopentane-1,3-dione 3.54 and a 
stochiometric amount of DABCO to a stirring solution of 3.88, a mixture of bicyclo ketols 
3.89 was obtained in modest yield, the d.r. favouring the larger ester group being equatorial. 
However, in the reaction with 6-membered ring 3.12 the desired 3.90 could only be detected 
in the 1H NMR to the extent of 18% conversion, traces being isolated (Scheme 3.52). 
Attempts to optimize the formation of the bicyclo[3.2.1]octane dione 3.89 using various 
combinations of base and solvents were not promising, although triethylamine increased the 
extent of conversion (by 1H NMR spectroscopy) to 33% (Scheme 3.52). Although these 
highly functionalised scaffolds obtained were of interest, the poor yields could not be 
improved and so no further work using the pyruvate acceptors was undertaken.  
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 Scheme 3.52: Michael-aldol annulation with an unsaturated pyruvate. 
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CHAPTER 4: Scaffold functionalization and synthesis of new 
fluorinated substituted bicyclo compounds 
 
4.1 Synthesis of alkene 4.1 and its reactions 
 
Having demonstrated the efficiency of the domino annulation to access quickly and 
stereoselectively bicyclo[3.3.1]nonane and [3.2.1]octane cores, their further 
functionalisation by halogenation was investigated. Halogens can be used in increasing 
diversity by displacements. Additionally, fluorinated scaffolds often show improved 
physicochemical properties and are often key compounds in medicinal chemistry 
programmes. The secondary alcohol at position-6 in bicyclo[3.3.1]nonanones, e.g. 3.2, 
could in principle be dehydrated to the corresponding alkene (e.g. 4.1) which could be 
transformed into a variety of functionalised derivatives, a selection of which is shown in 
Scheme 4.1. 
OO
4.1
OO
O
O
OO
OHOH
OO
X
X
OO
OO
O
Cyclopropanation
Dihydroxylation
Addition of halogen
Epoxidation
Oxidative
X=Br, Cl
cleavage
OO
3.2
HO
 
Scheme 4.1: Dehydration of the alcohol functionality in bicyclo 3.2 leads to alkene intermediate 4.1, which can 
undergo a variety of different transformations. 
 
We therefore sought to access alkene 4.1 first to then proceed with the desired scaffold 
functionalization. Dehydration of the simplest bicyclo ketol 3.2 proved to be challenging, 
either with traditional methods or more harsh conditions. Various acid-catalysed conditions 
(Scheme 4.2) were unsuccessful. Polyphosphoric acid (PPA) gave some reaction, but the 
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NMR spectra were inconclusive, and indicated that product(s) other than the alkene had 
been formed. 
 
OutcomeConditions
HBr, AcOH, 25 C No reaction
10% H2SO4, AcOH, 25 C No reaction
TsOH, 25 C No reaction
PPA, 70 °C New spot, NMR inconclusive
OO
OH
3.2 4.1
OO
Acidic conditions
Table
 
Scheme 4.2: Attempted dehydration of alcohol 3.2 under acidic conditions. 
 
Non-acidic methods were then examined. Reaction of ketol 3.2 with phosphoryl chloride 
using an excess of pyridine afforded three products, of which only the chloro derivative 4.2 
could be isolated and identified, although characterisation was not possible as it rapidly 
underwent a retro-aldol reaction followed by ring opening. Triflates are known to undergo 
rapid elimination in the presence of a base hence ketol 3.2 was reacted with triflic anhydride 
and the crude triflate subjected to dehydration with DBU; unfortunately, no elimination 
reaction was observed at both room and reflux temperature. Burgess’ reagent, a mild and 
selective N-(triethylammoniumsulfonyl)carbamate known to work well for secondary 
alcohols126 was also found to be ineffective. Lastly, a Mitsunobu reaction to install an azide 
(4.3) and hence obtain the corresponding amine by reduction, also failed (Scheme 4.3). 
 
(PhO)2PN3, DIAD Burgess reagent
Tf2O, Py
POCl3, Py
CH2Cl2
0 to 25 °C
CH2Cl2, 10 °C
THF, 60 C
4.2 4.1
OO
OH
3.2
OOOO
Cl
4.1
OO
then DBU, 25 °C
4.3
OO
N3
 
Scheme 4.3: Attempted dehydration and Mitsunobu reaction. 
 
Given the above difficulties in achieving elimination of the alcohol group, this problem was 
temporarily put aside and other functionalisations were explored, in particular fluorination. 
Fluoro compounds are of paramount importance today in drug design. Some 20-25% of 
pharmaceuticals contain at least one fluorine atom.127 The electronegativity and the size of 
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fluorine usually enhance lipophilicity and metabolic stability but fluorination can also lead to 
a different preferred conformation.128 However, because of the reactivity and hazards of 
elemental fluorine and hydrogen fluoride, introduction of fluorine into organic molecules 
presents particular challenges and has led to the development of specialised fluorination 
technologies and reagents. Amongst them, diethylaminosulfur trifluoride (DAST), a reagent 
derived from sulfur tetrafluoride, is convenient to handle and quite selective, being especially 
useful for the conversion of alcohols into alkyl fluorides, carboxylic acids to acyl fluorides, 
and carbonyl compounds to gem-difluorides.129 Treatment of alcohol 3.2 with DAST at ‒78 
°C did afford the fluorinated bicyclo compound 4.4 but also a surprisingly high yield of the 
previously sought alkene 4.1 (Scheme 4.4). 
OO
OH
3.2
DAST, CH2Cl2
78 °C, 1 h
4.1, 60%
OO
4.4, 20%
OO
F
+
 
Scheme 4.4: Reaction of bicyclo ketol 3.2 with DAST to afford alkene 4.1 and fluorinated bicyclo 4.44. 
 
Complete conversion of alcohol 3.2 was only observed using 5 equivalents of DAST, making 
this reaction hardly practical. Attempted optimisations involved using polar aprotic solvents 
like DMF and THF which in theory should favor SN2 substitution over E2 elimination but in 
fact afforded a mixture of unidentified products. The best results were obtained in 
dichloromethane, however, the yield of isolated alkene was quite inconsistent and variable 
(Scheme 4.5). 
OO
OH
3.2
conditions
4.4
OO
4.1
OO
F
+
% conversion 4.1Conditions
DAST (1.2 eq), CH2Cl2, 78 °C 15
50DAST (2.5 eq), CH2Cl2, 78 °C
DAST (5 eq), CH2Cl2, 78 to 25 C
% conversion 4.4
DAST (5 eq), DMF, 78 °C
DAST (5 eq), THF, 78 °C
16
50
53 47
- -
- -
table
 
Scheme 4.5: Optimization of the yield of fluoro and unsaturated bicyclo compounds 4.1 and 4.4. 
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Dihydroxylation/oxidative cleavage and epoxidation were then attempted on the small 
amount of material prepared. An improved procedure reported by Jin130 using 2,6-lutidine to 
suppress unwanted side reactions did not afford the desired dialdehyde 4.5. Epoxidation 
using m-CPBA instead led to the formation of a new compound (single spot by TLC) which 
was isolated and identified as the bicyclic lactone 4.6, arising from a Baeyer-Villiger 
oxidation. As expected, migration of the C1-C9 bond was favored and the structure 
confirmed by HMBC, which clearly correlates the carbonyl lactone signal at 171.9 ppm with 
both the C-H bridgehead and the CH2 next to it. Moreover, the quaternary carbon was 
identified at 87.6 ppm; this high shift was considered consistent with the expected value for 
a carbon next to an oxygen as in 4.6, and unlikely for a carbon placed next to a carbonyl 
group, as would be in the not favoured structure (Scheme 4.6). Surprisingly the desired 
epoxide was never detected nor could an oxidative cleavage be achieved (Scheme 4.6). 
OsO4, 2,6-lutidine
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Scheme 4.6: Attempted oxidation cleavage on alkene 4.1 and synthesis of a novel bicyclic lactone 4.6. 
 
4.2 Selective fluorination and further scaffold functionalization 
As an alternative to the nucleophilic fluorine source DAST, the electrophilic Selectfluor was 
considered because of its ability to fluorinate silyl enol ethers.131 For their formation, triketone 
3.62 and 3.68 were immediately considered. Indeed, stereocontrol by approach on the face 
opposite the hindered gem-dimethyl ring could have been expected and bridgehead protons 
are notoriously hard to abstract132 leading, in theory, to the formation of only one silyl enol 
ether (Fig. 4.7). 
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Fig. 4.7: Rationale for the selective functionalisation of triketones 3.62 and 3.68. 
 
Addition of 3.6 eq of Et3N at 0 °C to a stirring solution of trione 3.68 in dry dichloromethane 
followed by quenching after 5 minutes with either TMS or TBS triflate cleanly afforded 4.7 
and 4.8 (Scheme 4.8). For derivatives 4.7 and 4.8, with no 7-substituent, the yields were 
higher (72% for the TBS derivative and 95% for the TMS derivative) whereas the yield of 
derivative 4.9, obtained from reaction of trione 3.62, was lower (49%). 
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Scheme 4.8: Synthesis of the TBS and TMS silyl enol ethers derived from triketones 3.62 and 3.68. 
 
Reaction of both TMS derivatives 4.8 and 4.9 with Selectfluor afforded the expected fluoro 
compounds 4.10 and 4.11 in 57% and 58% yield respectively, and both as single 
diastereoisomers (Scheme 4.9). Analysis of the coupling constants revealed that the fluorine 
atom was placed on the axial position; the J value of 12.4 Hz for one of the H-7 coupling 
constants conclusively established a trans-diaxial interaction of H-7 with H-8ax, which was 
confirmed by the value of J = 7.6 Hz for H-7 (axial) with equatorial H-8. Interestingly, the use 
of NFSI did not lead to 4.10, nor could the bridgehead hydrogen atom be removed to give 
4.12 with a strong base such as LiHMDS (Scheme 4.9). 
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Scheme 4.9: Synthesis of fluorinated bicyclo compounds 4.10 and 4.11. 
 
Having successfully introduced the fluoro functionality into the scaffold via silyl enol ethers, 
it was hoped to introduce other halogen atoms and to achieve oxidations. However, reaction 
of 4.8 with N-bromosuccinimide or peroxidants (Rubottom oxidation) did not lead to the 
desired functionalised products (Scheme 4.10). 
NBS, NCS, NIS
4.8
DMSO or THF CH2Cl2, 0 C
m-CPBA or DMDO
O
O
O
4.14
X
O
O
O
4.13
OH
X=Cl, Br, I
O
O
OTMS
 
Scheme 4.10: Attempted Rubottom oxidation and halogenation of TMS-silyl enol ether 4.8. 
 
Formal dehydrogenation of trione 3.68 to enone 4.15 could be a powerful way of 
functionalising position 8 by means of Michael additions. IBX oxidation afforded enone 4.15 
in modest yield, which however was found to be unreactive towards all the standard Michael 
additions attempted (Scheme 4.11). In order to improve the yield of the oxidation step, 
Saegusa oxidation of silyl enol ether 4.8 was also tried, but without success (not shown).  
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Scheme 4.11: Preparation of enone 4.15 and attempted Michael addition. 
 
Analogous to ketol 3.2, the epimeric mixture of ketols 3.52 also underwent 
fluorodehydroxylation upon treatment with DAST at ‒78 °C to give exo- and endo-4.19 in 
38% yield (Scheme 4.12). 
O
O
O
O
OH
CH2Cl2, –78 C
DAST
F
1 h, 38%
endo:exo, 36:64
3.52 endo-4.19
O
O
+
F
exo-4.19
d.r. = 35:65  
Scheme 4.12: Fluorodehydroxylation of the mixture of ketols 3.52 to give fluoro derivatives 4.19. 
 
 
Triketone 3.67 had been selected as the first compound to be studied for functionalisation 
because of the gem-dimethyl group blocking the reaction at position-3, thereby simplifying 
the number of potential products. Having established several efficient functionalisation 
reactions, it proved timely to investigate the transformation of trione 3.65, for which reaction 
at position-3 was an additional possibility. The relatively accessible chair-chair conformation 
gave the possibility of functionalisation at positions-3 and -7, and, via additions to the 
corresponding enone, also at positions-4 and -8 (Fig. 4.13). Moreover, Michael addition on 
4.15 could have been difficult due to the particular boat-chair conformation, a difficulty that 
might not apply to 3.65. 
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Fig.4.13: Rationale for the functionalization of bicyclo 3.65. 
 
Most of the reactions performed on scaffold 3.65 are shown in scheme 4.14. A mixture of 
the bis (4.22) and mono (4.25) silyl enol ethers was formed; separation by column 
chromatography afforded both derivatives in low yield but sufficient mass recovery to 
proceed with the desired subsequent transformations. Dihalogenation of the bis-silyl enol 
ether was not possible, and reaction with either Selectfluor or NIS led to complex mixtures 
of unidentified products. However, fluorination of the mono silyl enol ether 4.25 gave the 
fluorinated 7β-fluorotrione 4.27 as a single diastereoisomer in 90% yield. The mono 
iodinated product 4.26, arising from reaction with NIS, was identified in the crude 1H NMR 
spectrum but it could not be isolated pure. Rubottom and/or Saegusa oxidation were likewise 
unsuccessful. Whereas oxidation of triketone 3.68 with IBX had afforded the corresponding 
enone, the desired 4.20 could not be obtained using the same procedure. Treatment of 3.65 
with m-CPBA gave bicyclic lactone 4.21 through Baeyer-Villiger oxidation, although it could 
not be separated by column chromatography from the 2-methyl-1,3-cyclohexanedione 
starting material (Scheme 4.14). 
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Scheme 4.14: Summary of the halogenation and oxidation reactions attempted on triketone 3.65. 
 
Fluorination and bromination were also tried on triketone 3.65 without success. Interestingly, 
in an early attempt to add a 3-methyl group to the scaffold, the use of the strong base LDA 
afforded cyclohexenone 3.72, which was also obtained from other reactions as highlighted 
on Scheme 3.47 in paragraph 3.6.1 (Scheme 4.15). 
OO
O
3.65
Selectfluor
LDA, MeI
THF, - 78 C
Br2
CH3CN
0 to 95 C, 16 h
0 C, 6 h
OO
O
F
F
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4.30
4.32
O
3.72
COOH
3
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Scheme 4.15: Initial attempts to synthesise α-halogenated and methylated ketones. 
 
With the introduction of fluorine at position-7 in both the chair-chair and boat-chair 
conformers, our attention was turned to the functionalisation of the 3- and 4-positions. One 
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way to achieve selectivity was to block the 7-β-position; scaffold 3.66, previously prepared 
in 77% yield, was used to test our hypothesis (Fig. 4.16). 
 
to position 3 and 443
OO
O
3.66
Selective accessSilyl enol ether
at position 2 and 3
favored
Selective
functionalisation
 
Fig. 4.16: Strategy for the selective access to positions-3 and -4 of the bicyclic scaffold. 
 
Silylation was unselective, as small amount of the disilyl-derivatives 4.34 and 4.36 were 
obtained. TBS derivative 4.33 was obtained in higher yields (43% c.w. 36% of the TMS 
derivative) although it did not react with the chosen electrophiles (Selectfluor and NIS) thus 
4.35 was used instead (Scheme 4.17). 
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Scheme 4.17: Silylation of triketone 3.66. 
 
Reaction of silyl enol ether 4.35 with selectfluor gave a mixture of the 3-fluoro epimers 4.37 
in 81% yield, the major isomer having fluorine in axial position. To our delight, reaction with 
NIS afforded iodo-derivative 4.38 and in excellent yield. Unfortunately, neither a Rubottom 
reaction, nor a Saegusa oxidation, nor reaction of triketone 3.66 with IBX (not shown) gave 
the respective desired products (Scheme 4.18). 
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Selectfluor
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Scheme 4.18: Preparation of a 3-fluoro- and a 3-iodo-bicyclo compound, and their attempted transformations. 
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As we were intrigued by the formation of bicyclic lactone 4.6 and 4.21 previously formed, 
triketone 3.66 was reacted with m-CPBA; indeed, the desired complex lactone 4.41 was 
obtained but in low yield. A brief attempt at optimization was made (not shown) using other 
peroxides (t-BuOOH) and oxidants (Oxone) or with the aid of Lewis acids (BF3•Et2O) but it 
gave no improvements. Through reaction of ketol 3.19 with DAST in dichloromethane at ‒
78 °C alkene 4.44 and the 6-β-fluoro derivative 4.43 were additionally obtained (Scheme 
4.19).  
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+
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Scheme 4.19: Synthesis of bicyclic lactone 4.41 and fluorinated and unsaturated derivatives 4.43 and 4.44. 
 
Lastly, functionalisation of dimedone derivative 3.67 attracted our attention in the same way 
as the boat-chair conformer did, for the possibility of selective functionalisation at the 8-
position via conjugate addition to the corresponding enone. (Fig. 4.20). 
 
Fig. 4.20: Strategy for the C-7 and C-8 functionalization of scaffold 3.67 
 
 
Unlike all other scaffolds investigated, reaction of bicyclo ketol 3.50 with DAST afforded no 
fluorination products, but instead alkene 4.49 in nearly quantitative yield, nor did iodination 
occurred with NIS. Silyl enol ether derivative 4.45 was obtained from trione 3.67 in 60% but 
no reaction was observed when reacted with either Selectfluor or NFSI. In contrast, Saegusa 
oxidation applied to the silyl enol ether 4.45 afforded enone 4.47 in 46% yield (Scheme 
4.21). 
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Scheme 4.21: Attempted fluorination of silyl enol ether 4.45 and synthesis of enone 4.47 and alkene 4.49. 
 
The same conjugate addition reactions previously attempted on the boat-chair enone 4.15 
were applied to enone 4.47 but unfortunately here also no reactions occurred (Scheme 
4.22) 
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Scheme 4.22: Attempted conjugate addition reactions on enone 4.47. 
 
 
4.3 Conclusions, summary and future work 
 
The aim of this project was to develop new synthetic methodologies towards the synthesis 
of nearly saturated bicyclic compounds. The construction of architecturally complex caged 
sp3-enriched molecules is synthetically challenging and new methods are needed in order 
to access these promising scaffolds and explore new regions of chemical space.  
 
Our interest initially fell on a specific class of molecules, the polycyclic polyprenylated 
acylphloroglucinols (PPAPs) because of their remarkable range of biological activity. 
Although other groups have recently made considerable progress in their synthesis, 
difficulties remain in the efficient construction of such highly congested scaffolds, which 
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require densely prenylated bicyclo[3.3.1]nonanes. The first approach towards a new 
synthetic route for the construction of the PPAP core was based on the dearomatisation of 
a phloroglucinol with an epoxide moiety, in the hope of triggering a ring-opening reaction to 
give the [3.3.1] bicyclic skeleton. This strategy, as shown on chapter 2 (Scheme 2.11) faced 
many difficulties due to the challenge of the dearomatisation step and the tendency of the 
C-alkylated precursor 2.20 to undergo rearomatisation (Scheme 4.30). 
OH
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Ph
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MeO OMe
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Scheme 4.30: Difficulties encountered in the epoxide-mediated dearomatisation-cyclisation of phloroglucinols 
derivatives 
A possible alternative was depicted on Chapter 2 (Scheme 2.12) and could be represented 
by the use of iodo derivative 2.21, which was used successfully by George85 for the 
dearomatisation of our same substrate 2.15. If the dearomatised precursor 2.22 could be 
obtained, and a chemoselective epoxidation of the most electron-rich, terminal olefin 
achieved, then a subsequent cyclisation of epoxide 2.24 would give access to the type B 
PPAP core (Scheme 4.31). 
 
 
Scheme 4.31: Proposed alternative pathway towards the synthesis of PPAP-like bicyclic compounds. 
The second strategy pursued was intended to use the same epoxide functionality for the 
desymmetrisation of more readily available 1,3-diketone dihydroresorcinol derivatives 2.47-
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3.12. Scheme 4.32 summarizes the pathways explored and highlights the alkene and 
epoxides intermediates synthesised, although an epoxide-mediated ring closure to the 
desired [3.3.1] bicyclic scaffold was never achieved.  
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Scheme 4.32: Summary of epoxide intermediates obtained from 2-methylcyclohexane-1,3-dione 3.12. 
Of these pathways, exploration of the 6-exo-tet cyclisation seemed the more promising 
owing to the high accessibility of the epoxide 2.91; however, the poor yield of the alkene 
precursor 2.90 was a synthetic bottleneck. Alternative precursors could be obtained by 
synthesis of dibromoalkene 4.53 from which substituted [3.3.1] bicyclic scaffolds might be 
obtained (Scheme 4.33).  
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Scheme 4.33: Proposed alternative synthesis of dibromo intermediate 4.53 as versatile intermediate to access 
[3.3.1] bicyclic scaffolds. 
 
During the exploration of our desymmetrisation strategy we noticed that under Wittig and 
Horner-Wadsworth-Emmons conditions the formation of the desired olefination product was 
in most cases prevented by the formation of the product of an intramolecular aldol reaction 
on aldehyde 2.77-3.1, which featured the desired [3.3.1] bicyclic scaffold (see chapter 3, 
Scheme 3.1). Exploration of this side reaction led us to a third strategy and to the 
development of a general method for the synthesis of 6-hydroxybicyclo[3.3.1]nonane-2,9-
diones and 2-hydroxybicyclo[3.2.1]octane-6,8-diones. This one-pot Michael-aldol annulation 
enables stereoselective incorporation of different substituents at three positions, in which 
the relative configurations can be partly controlled through appropriate choice of solvent, 
temperature and reagent. The scope of the reaction was explored and oxidation of the 
annulation products to the corresponding bicyclo triketones led to the discovery of an 
unusual boat-chair conformation adopted by 2,4,4-trimethylcyclohexane-1,3-dione 
derivatives (see chapter 3, Table 3.33 and Fig. 3.45). 
An enantioselective cyclisation, with the aid of Cinchona alkaloids or MacMillan catalysts 
would be a natural evolution of this promising study (Scheme 4.34).  
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Scheme 4.34: Proposed enantioselective Michael-aldol annulation. 
 
Preliminary fluorination and derivatisation studies were performed on the bicyclic scaffolds 
synthesised in order to access unique aliphatic fluorinated bicyclo compounds. Optimisation 
of the reaction conditions to access enones of type 4.15 and 4.47 and synthesis of enone of 
type 4.42 would permit functionalisation of positions-8 and -4 respectively, allowing the study 
of facial selectivity toward addition reactions and providing access to other fluorinated and 
functionalised bicyclo compounds (Scheme 4.35).  
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Scheme 4.35: Synthesis of additionally functionalised bicyclo compounds via enone formation and conjugate 
addition. 
 
The bicyclic compounds synthesised in this study (Fig. 4.36), with their high level of 
saturation and complexity, have good potential for use in medicinal chemistry and in drug-
design programmes. The structural diversity provided by the different configurations and 
conformations adopted and the specific directionalities of the various substituents pave the 
way for a more extensive exploration of bicyclo chemical space. 
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Fig. 4.36: Summary of all the bicyclic compounds synthesised. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133 
 
CHAPTER 5: EXPERIMENTAL 
 
General. All moisture-sensitive reactions were performed under an atmosphere of argon 
and using glassware pre-dried in an oven (100 °C). Thin-layer chromatography was 
performed on Merck 0.2 mm aluminium-backed silica gel 60 F254 plates and visualised by 
UV (254 nm) or by staining with potassium permanganate with subsequent heating. Flash 
column chromatography was performed using Merck 0.040-0.063 mm, 230-400 mesh silica 
gel. Evaporation refers to the removal of solvent under reduced pressure. Melting points 
were determined using a Büchi B-540 apparatus. Infrared (IR) spectra were recorded on a 
Perkin−Elmer Spectrum One FT-IR spectrometer; absorptions are quoted in wavenumbers. 
1H and 13C NMR spectra were recorded respectively at 300 MHz/75 MHz on a Bruker AMX-
300 spectrometer, at 400 MHz/100 MHz on a DRX-400 spectrometer, at 500 MHz/125 MHz 
on a Bruker Advance 500 spectrometer and at 600 MHz/151 MHz on a Bruker Advance 600 
spectrometer and calibrated using residual undeuterated solvent as an internal reference; 
chemical shifts are in parts per million (ppm) and coupling constants (J) are given in Hertz 
(Hz). The following abbreviations were used in signal assignments: singlet (s), broad singlet 
(br s), doublet (d), triplet (t), quartet (q), and multiplet (m). High-resolution mass spectra 
(HRMS) were obtained using either an Agilent ESI TOF (time of flight) mass spectrometer 
at 3500 V emitter voltage, or using a VG7070H mass spectrometer with Finigan Incos II data 
system at University College London.  
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Phenyl(2,4,6-trimethoxyphenyl)methanone (2.2) 
 
A literature procedure was adapted.133 To an ice-cooled stirring mixture of AlCl3 (5.95 g, 44.6 
mmol, 1.5 eq) in dichloromethane (60 mL) benzoyl chloride (3.45 mL, 29.7 mmol, 1 eq) was 
added dropwise at 0 °C. After being stirred at the same temperature for 1 h, the reaction 
mixture was slowly poured into a stirring solution of 1,3,5-trimethoxybenzene (5.00 g, 29.7 
mmol, 1 eq) in dichloromethane (50 mL) at 0 ºC. The reaction was then allowed to warm to 
25 ºC over the course of the night and stirred at the same temperature for further 12 h. The 
resulting suspension was then quenched with ice water and conc. HCl was added until a 
clear solution was formed. The organic layer was diluted with dichloromethane, washed with 
saturated NaHCO3, water and brine, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (petroleum ether:ethyl acetate, 
80:20) afforded phenyl (2,4,6-trimethoxyphenyl)methanone 2.2 (4.00 g, 50%) as white solid, 
m.p. 110‒116 °C (lit.133 m.p 108‒111 °C); IR (film): 3707, 3681, 2973, 2865, 1597, 1455, 
1054, 1012, 750 cm-1; 1H NMR (400 MHz, Acetone-d6) δ ppm 7.79–7.74 (2H, m, aryl), 7.58 
(1H, tt, J = 7.2, 1.6 Hz, aryl), 7.46 (2H, dd, J = 8.4, 7.1 Hz, aryl), 6.34 (2H, s, aryl), 3.89 (3H, 
s, -OCH3), 3.68 (6H, s, 2xOCH3).13C NMR (101 MHz, Acetone-d6) δ ppm 194.7 (Ph-CO), 
164.0 (C-OCH3), 160.1 (C-OCH3), 140.0 (aryl), 134.0 (aryl), 130.2 (aryl), 129.8 (aryl), 112.3 
(aryl), 92.3 (aryl), 56.7 (1xO-CH3), 56.4 (2xO-CH3). 
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(3,5-Dibromo-2,4,6-trimethoxyphenyl)(phenyl)methanone (2.4) 
 
To a stirred solution of phenyl (2,4,6-trimethoxyphenyl)methanone 2.2 (0.200 g, 0.72 mmol, 
1 eq) in glacial acetic acid (5 mL), bromine (0.23 g, 1.44 mmol, 70 µL, 2 eq) was added 
dropwise at 25 ºC. The reaction mixture was heated at 50 ºC for one hour and then quenched 
with a 5% Na2S2O3 solution. The aqueous phase was extracted with dichloromethane 
(3x30mL), the combined organic layers washed with brine, dried over Na2SO4 and 
evaporated under reduced pressure. Column chromatography (petroleum ether:ethyl 
acetate, 95:5) afforded 3,5-dibromo-2,4,6-trimethoxyphenyl)(phenyl)methanone 2.4 (0.19 g, 
62%) as white crystalline solid, m.p 135‒139 °C, Rf = 0.44 (hexanes:ethyl acetate, 80:20); 
IR (film): 3707, 2981, 2973, 1275, 1260, 1054, 1033, 764, 750 cm-1;  1H NMR (600 MHz, 
CDCl3) δ ppm 7.85−7.80 (2H, m, aryl), 7.60 (1H, t, J = 6.4 Hz, aryl), 7.50−7.45 (2H, t, J = 
6.4 Hz, aryl), 3.97 (3H, s, O-CH3), 3.74 (6H, s, 2xOCH3); 13C NMR (151 MHz, CDCl3) δ ppm 
192.7 (Ph-CO), 156.6 (C-OCH3), 154.6 (C-OCH3), 136.8 (aryl), 134.0 (aryl), 129.6 (aryl), 
128.7 (aryl), 126.8 (aryl), 109.4 (aryl), 62.4 (2xOCH3), 60.8 (-OCH3); HRMS (ESI-TOF) 
[M+H]+ C16H15Br2O4 calcd. 428.9332, found 428.9344. 
 
2,4-Dibromo-1,3,5-trimethoxybenzene (2.10) 
 
A literature procedure was adapted.134 A solution of bromine (17.8 mmol, 0.92 mL, 3 eq) in 
dichloromethane (20 mL) was added dropwise to a stirred solution of 1,3,5-
trimethoxybenzene (1.00 g, 5.9 mmol, 1 eq) in dichloromethane (20 mL) at ‒10 ºC. After one 
hour stirring at this temperature, the reaction mixture was quenched with a 5% Na2S2O3 
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solution, the organic layers separated, washed with brine, dried over Na2SO4, filtered and 
evaporated under reduced pressure. Recrystallization from dichloromethane afforded 2,4-
dibromo-1,3,5-trimethoxybenzene 2.10 (1.65 g, 85%) as white crystalline solid, m.p. 
128−131 °C (lit m.p. 129−130 °C); 1H NMR (600 MHz, CDCl3) δ ppm 6.36 (1H, s, aryl), 3.92 
(6H, s, 2xOCH3), 3.88 (3H, s, OCH3), 13C NMR (151 MHz, CDCl3) δ ppm 156.6 (2 x -C-
OCH3), 155.7 (C-OCH3), 99.0 (C-Br), 93.2 (-C-H), 60.5 (-OCH3), 56.6 (2xOCH3). 
 
2,4-Diallyl-1,3,5-trimethoxybenzene (2.12) 
 
A literature procedure was adapted.84 n-Butyllithium (7.2 mL, 5.6 mmol, 8 eq) was slowly 
added under an atmosphere of argon over a period of 10 minutes to a suspension of 
copper(I) iodide (1.13 g, 6.0 mmol, 8.5 eq) in tetrahydrofuran (20 mL) at ‒48 ºC. After 10 
minutes, 2,4-dibromo-1,3,5-trimethoxybenzene (0.250 g, 0.70 mmol, 1 eq.) was dissolved 
in tetrahydrofuran (5 mL) and cannulated into the lithium dibutylcopper solution. The 
resulting mixture was stirred for further 30 minutes and then treated with an excess of allyl 
bromide (5.6 mmol, 0.48 mL, 8 eq). After 30 minutes stirring at −48 ºC, the reaction mixture 
was quenched with methanol (1 mL), diluted with sat. NH4Cl and the aqueous phase 
extracted with Et2O (2x20 mL). The combined organic layers were washed with sat. NH4Cl 
and brine, dried over Na2SO4, filtered and concentrated under reduced pressure. Column 
chromatography (petroleum ether:ethyl acetate, 95:5) afforded 2,4-diallyl-1,3,5-
trimethoxybenzene 2.12 (0.034 g, 18%) as colorless oil, 1H NMR (600 MHz, CDCl3) δ ppm 
6.32 (1H, s, aryl), 6.05‒5.94 (2H, m, CH2=CH), 4.99 (1H, m, CH2=CH), 4.97‒4.93 (4H, m, 
CH2=CH, CH2=CH), 3.82 (-OCH3) 3.72 (3H, s, -OCH3), 3.37 (4H, dt, J = 6.0, 1.6 Hz, 
CH2=CH-CH2). 13C NMR (151 MHz, CDCl3) δ ppm 158.0 (=C-OCH3), 157.4 (2x=C-OCH3), 
137.9 (2xCH=CH2), 114.2 (2X=C-CH2-CH=CH2), 114.0 (2X=C-CH2-CH=CH2), 92.0 (=C-H), 
62.2 (-OCH3), 55.9 (2xOCH3), 28.2 (2xCH2-CH=CH2). 
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Phenyl(2,4,6-trihydroxyphenyl)methanone (2.14) 
 
A literature procedure was adapted.85 A 25-mL flame-dried round-bottom flask was charged 
with phloroglucinol (dried for two nights in the oven at 200 °C) (0.500 g, 3.96 mmol, 1 eq) 
and AlCl3 (1.00 g, 7.5 mmol, 2 eq) under an atmosphere of argon. Dichloromethane (7.2 mL) 
was added and the reaction vessel was submerged in an ice bath. Once at 0 °C, benzoyl 
chloride (0.55 g, 0.46 mL, 1 eq) was added dropwise over a period of 2 min. The syringe 
was rinsed with dichloromethane (5 mL) and the reaction was left to slowly warm to room 
temperature overnight. After the allotted reaction time, crushed ice was added and the 
quenched reaction mixture was then transferred to a separatory funnel containing ethyl 
acetate (50 mL) and extracted with 1M HCl (2x20 mL) followed by brine (1x20 mL). The 
combined organic layers were dried over MgSO4, filtered and evaporated. The crude residue 
was purified by flash chromatography (petroleum ether:ethyl acetate, 80:20 → 70:30) to give 
2.14 (0.38 g, 41%) as a yellow solid, m.p. 158‒166 °C, (lit. m.p. 164‒167 ºC); Rf 0.1 
(petroleum ether:ethyl acetate, 70:30); 1H NMR (500 MHz, Acetone-d6)  ppm 9.76–10.11 
(3H, br. s, OH), 7.60‒7.56 (2H, m, aryl), 7.45 (1H, tt, J = 7.4, 2.2 Hz, aryl) 7.37 (2H, t, J = 
7.6 Hz, aryl), 5.85 ppm (2H, s, aryl); 13C NMR (DMSO-d6,125 MHz)  ppm 199.8 (Ph-CO), 
165.5 (3xC-OH), 142.8 (aryl), 131.7 (aryl), 129.0 (aryl), 128.3 (aryl), 105.3 (aryl), 96.0 (aryl).  
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(3,5-Diallyl-2,4,6-trihydroxyphenyl)(phenyl)methanone (2.15)  
 
A literature procedure was adapted.85 To a solution of phenyl(2,4,6-
trihydroxyphenyl)methanone 2.14 (0.140 g, 0.60 mmol, 1 eq) in H2O (2 mL), was added 
potassium hydroxide (0.07 g, 1.20 mmol, 1.2 eq) at 0 ºC. Allyl bromide (1.2 mmol, 0.140 mL) 
was then added dropwise over a period of 5 minutes. The reaction mixture was allowed to 
slowly warm to room temperature over 16 h. The mixture was then quenched with saturated 
NH4Cl and extracted with ethyl acetate. The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified by 
flash chromatography on silica gel (petroleum ether:ethyl acetate,  90:10 → 75:25 → 65:55) 
to give 2.15 (0.036 g, 21%) as yellow oil, IR (film); 3497, 1742, 1601, 1450, 1257, 1128, 
1062, 706 cm-1; 1H NMR (600 MHz, CDCl3) δ ppm 8.94 (1H, s, OH), 7.67–7.63 (2H, m, aryl), 
7.58 (1H, tt, J = 0.8, 4.8 Hz, aryl), 7.51 (2H, m, aryl), 5.96 (2H, ddt,  J = 13.6, 6.8, 4.0 Hz, 
CH=CH2), 5.17 (1H, q, J = 1.2 Hz, CH=CH2), 5.13 (3H, app ddt, J = 6.8, 2.4, 1.2 Hz, CH=CH2, 
CH=CH2), 3.41 (4H, m, CH2-CH=CH2); 13C NMR (151 MHz, CDCl3) δ ppm 198.1 (Ph-CO), 
160.9 (C-OH), 158.2 (C-OH), 140.1 (aryl), 136.2 (CH2=CH), 132.4 (aryl), 129.3 (aryl), 128.0 
(aryl), 115.9 (CH2=CH), 104.8 (aryl), 104.7 (aryl), 27.1 (CH2=CH-CH2). 
 
1-Bromoethyl-3,3-dimethyloxirane (2.19) 
 
A literature procedure was adapted.135 To a stirred solution of aqueous potassium hydroxide 
(14.5 g, 258 mmol, 4,4 eq) was added bromine (14.0 g, 4.5 mL, 87 mmol, 1.5 mmol) via 
syringe pump at 5 ˚ C. The mixture was kept stirring at 5 °C for 15 min. and 2-methyl-3-buten-
2-ol 2.63 (5.00 g, 6.0 mL, 58 mmol, 1 eq.) was then added. The mixture was stirred for 5 h 
at 5 °C. The mixture was extracted with hexane (3x30 mL), the organic layers separated, 
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dried over MgSO4 and evaporated to give 2.19 as colorless liquid (5.60 g, 60%), which was 
used in the next step without further purification, IR (film): 2965, 1379, 1218, 1127 883, 648, 
495 cm1; 1H NMR (600 MHz, CDCl3)  ppm 3.47 (1H, dd, J = 7.2, 4.0 Hz, CH2-CO, CH-O), 
3.22 (1H, dd, J = 6.8, 4.8 Hz, CH2-CO, CH-O), 3.04 (1H, dd, J = 5.0, 4.4 Hz, CH2-CO, CH-
O), 1.27 (3H, s, -CH3), 1.13 (3H, s, -CH3); 13C NMR (151 MHz, CDCl3)  ppm 61.6 (-C(CH3)2), 
60.0 (CH2-CO), 29.7 (CH2-CO), 24.0 (-C(CH3)2), 17.8 (-C(CH3)2). 
 
3-(Iodomethyl)-2,2-dimethyloxirane (2.19a) 
 
A literature procedure was adapted.136 To a solution of bromo epoxide 2.19 (0.100 g, 0.6 
mmol, 1 eq) in dry acetone (5 mL) NaI (0.13 g, 0.9 mmol, 1.5 eq) was added and the reaction 
heated at 80 °C for 1 h. The solution was then allowed to cool to room temperature and the 
organic portion extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4, filtered and evaporated under reduced pressure to give 3-(iodomethyl)-2,2-
dimethyloxirane 2.19a as brownish oil (0.050 g, 40%) which was used in the next step 
without any further purification, 1H NMR (400 MHz, CDCl3) δ ppm 3.32 (1H, dd, J = 10.0, 6.0 
Hz, CH2-CO), 3.09 (1H, dd, J = 8.4, 5.6 Hz, CH-O), 2.99 (1H, dd, J = 10.0, 8.4 Hz, CH2-CO), 
1.34 (3H, s, CH3), 1.29 (3H, s, -CH3). 13C NMR (101 MHz, CDCl3) δ ppm 63.4 (CH2-CO), 
61.8 (-C(CH3)2), 24.5 (-C(CH3)2), 18.0 (-C(CH3)2), 2.5 (CH2-CO). 
 
4-Iodobut-1-ene (2.28) 
 
A literature procedure was adapted.137 PPh3 (3.81 g, 14.5 mmol, 1.05 eq) and imidazole 
(0.990 g, 14.5 mmol, 1.05 eq) were stirred for 5 minutes in dry dichloromethane at 25 °C. 
The reaction was then brought to 0 °C and I2 (3.60 g, 14.5 mmol, 1.05 eq) was added in 4 
portions. After stirring at the same temperature for 15 minutes, 3-buten-1-ol (1.17 mL, 13.8 
mmol, 1 eq) was added dropwise. The solution was left stirring overnight at 25 °C. The 
solvent was then evaporated under carefully controlled reduced pressure (800 mbar, the 
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product is extremely volatile). The residue was dissolved in pentane and filtered through a 
pad of celite. Pentane was then evaporated at 40 °C and 850 mbar to afford 4-iodobut-1-
ene 2.28 (1.70 g, 46%) as colorless liquid, 1H NMR (400 MHz, CDCl3) δ 5.76 (1H, ddt, J = 
12.8, 10.8, 6.4 Hz, CH2=CH), 5.14−5.09 (2H, m, CH2=CH), 3.18 (2H, t, J = 7.2 Hz, CH2-I), 
2.62 (2H, qt, J = 7.2, 1.3 Hz, =CH-CH2). 13C NMR (101 MHz, CDCl3) δ 137.0 (CH2=CH), 
117.1 (CH2=CH), 37.8 (=CH-CH2), 4.6 (CH2-I). 
 
2-Methyl-2-(3-methylbut-2-enyl) cyclohexane-1,3-dione (2.48) 
OO
2.48  
Sodium hydride (60% dispersion in mineral oil, 0.100 g, 2.5 mmol, 4.3 eq) and dry 
dimethylformamide (6 mL) were placed in a dry flask under an atmosphere of argon and 
stirred at 20 °C for 5 min. 2-Methyl-1,3-cyclohexanedione 2.47 (0.200 g, 1.6 mmol, 1 eq) 
was added and the mixture was stirred at 20 °C for 30 min. The solution was then cooled to 
0 ˚C and prenyl bromide (0.4 mL, 3 mmol, 1.5 eq) was added dropwise via a syringe pump 
over 25 min. The cold bath was removed and the mixture stirred at 20 °C for 2 h. Water (10 
mL) was then added at 0 °C and the mixture extracted with diethyl ether (3x20 mL). The 
combined organic layers were washed twice with brine, dried over MgSO4, filtered and 
evaporated to give a crude colorless oil (1.20 g). TLC (hexane:ethyl acetate, 60:40),  
revealed 4 spots with Rf 0.7, 0.4, 0.3, 0.2 respectively. Column chromatography 
(hexane:ethyl acetate, 90:10→ 80:20 → 70:30) afforded 2.48 (0.100 g , 33%), Rf 0.14 
(hexane:ethyl acetate, 80:20); IR (film): 2966, 2914, 1724, 1452, 1381, 1025 cm-1; 1H NMR 
(600 MHz, CDCl3)  ppm 4.83 (1H, m, CH=C(CH3)2), 2.63 (2H, ddd, J = 16.0, 10.2, 5.7 Hz, 
CO-CH2), 2.54 (2H, ddd, J = 16.0, 6.3, 5.0 Hz, CO-CH2),  2.45 (2H, d, J = 6.0 Hz, CH2-CH=) 
2.04‒1.95 (1H, m, CO-CH2-CH2), 1.85‒1.75 (1H, m, CO-CH2-CH2), 1.62 (3H, s, -CH3), 1.55 
(3H, s, -CH3), 1.16 (3H, s, CH3); 13C NMR (150 MHz, CDCl3)  ppm 210.3 (CO), 135.8 
(CH=C(CH3)2), 117.6 (CH=C(CH3)2), 65.4 (C-CH3), 38.0 (2 x CO-CH2), 36.5 (CH2-CH=) 25.8 
(C(CH3)2), 18.5 (C-CH3) 17.5 (C(CH3)2), 17.2 (C(CH3)2) ; HRMS (ESI-TOF) [M+] calcd. for 
C12H18O2 194.1307, found 194.1302. 
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2-Methyl-2-(3-propenyl)-1,3-cyclohexanedione (2.49) 
 
A literature procedure was adapted.99 To a solution of 2-methyl-1,3-cyclohexanedione 2.47 
(1.00 g, 8 mmol, 1 eq) in aqueous sodium hydroxide (1M, 8 mL) was added 3-bromopropene 
(1.90 g, 1.4 mL, 16 mmol, 2 eq). The mixture was stirred for 16 h, and then extracted with 
dichloromethane (3x10 mL). The combined organic layers were washed with saturated 
aqueous sodium chloride, dried over MgSO4, filtered and evaporated to give a crude yellow 
liquid (1.10 g). Column chromatography (hexane:ethyl acetate, 80:20) afforded 2-allyl-2-
methylcyclohexane-1,3-dione 2.49 (0.390 g, 29%) as colourless liquid. The same compound 
was also obtained via Tsuji Trost reaction, procedure follows: to a solution of 2-methyl-1,3-
cyclohexanedione 2.47 (0.501 g, 4.36 mmol, 1 eq) in dry THF (10 mL) was added Pd(PPh3)4 
(0.050 g, 0.43 mmol) and allyl acetate (0.75 mL, 1.5 eq). The solution was stirred at 25 °C 
for 30 minutes. After this time the solvent was removed under reduced pressure to afford 
crude 2-allyl-2-methylcyclohexane-1,3-dione 2.49 (0.560 g, 66%) which was used in the 
subsequent step without any further purification, Rf 0.5 (hexane:ethyl acetate, 50:50); 1H 
NMR (600 MHz, CDCl3)  ppm 5.52 (1H, ddt, J = 14.4, 9.6, 7.2 Hz, CH=CH2), 4.95−4.93 
(2H, m, CH=CH2), 2.62−2.56 (3H, m, CO-CH2), 2.49−2.45 (2H, dt, J = 7.2, 1.2 Hz, CH2-
CH=CH2), 2.01−1.92 (1H, m, 1xCO-CH2-CH2), 1.89−1.78 (1H, m, 1xCO-CH2-CH2), 1.18 (3H, 
s, -CH3); 13C NMR (150 MHz, CDCl3) δ ppm 209.6 (2xCO), 131.9 (CH=CH2), 118.9 
(CH=CH2), 64.9 (-C-CH3), 41.0 (2xCO-CH2), 37.8 (CH2-CH=CH2), 19.1 (C-CH3), 17.2 (CO-
CH2-CH2). 
 
2-Methylcyclohexane-1,3-dione dimethylhydrazone (2.50) 
2.50
N
H
O N
 
A literature procedure was adapted.95 A solution of 2 methyl-cyclohexane-1,3-dione 2.47 
(1.26 g, 10 mmol, 1 eq), N,N-dimethylhydrazine (0.720 g, 0.9 mL, 12 mmol, 1.2 eq) and p-
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TsOH (0.100 g, 0.52 mmol) in benzene (50 mL) was heated at reflux for 5 h while water was 
removed with a Dean-Stark apparatus. The solvent was then evaporated to give a crude 
orange oil (1.75 g) which was recrystallized from hexane, to give 2.50 (1.55 g, 98%) as 
yellow needles, m.p. 105‒109°C (lit.95 m. p. 112‒114 °C); Rf  0.57 (ethyl acetate); 1H NMR 
(600 MHz, CDCl3) δ ppm 5.05 (1H, s, -NH), 2.65 (2H, t, J = 4.0 Hz, N-C-CH2), 2.53 (6H, s, -
N(CH3)2), 2.34 (2H, t, J = 4.0 Hz, CO-CH2), 1.91 (2H, m, CO-CH2-CH2), 1.66 (3H, s, -CH3); 
13C NMR (150 MHz, CDCl3) δ ppm 195.5 (CO), 160.8 ((CH3)C=C-NH), 128.6 ((CH3)C=C-
NH), 48.9 (-N(CH3)2), 31.6 (CH2-C(N)=C(CH3)), 24.7 (CO-CH2), 21.3 (CO-CH2-CH2), 7.4 (-
C(CH3)). 
 
2-Methyl-2-(3-methylbut-2-enyl)-cyclohexane-1,3-dione dimethylhydrazone (2.51) 
NO N
2.51  
To a stirring solution of 2-methylcyclohexane-1,3-dione-dimethylhydrazone 2.50 (0.090 g, 
0.53 mmol, 1 eq) in dry dimethylformamide, sodium hydride (60% dispersion in mineral oil, 
0.04 g, 1.00 mmol, 5.2 eq) was added under an atmosphere of argon. Upon addition of 
sodium hydride the solution turned red-brown. Prenyl bromide (0.13 mL, 1 mmol, 2 eq) was 
then added dropwise at 0 ˚C. After stirring the solution for 4 h, saturated ammonium chloride 
(10 mL) was added and the aqueous phase was extracted with ethyl acetate (2x30 mL). The 
combined organic layers were washed twice with brine, dried over MgSO4 and evaporated 
to give a crude yellow oil (0.090 g). Column chromatography (hexane:ethyl acetate, 50:50) 
afforded 2.51 (40 mg, 32%) as yellow oil which was found very unstable and used 
immediately for the subsequent step, Rf 0.57 (ethyl acetate); 1H NMR (600 MHz, CDCl3)  
ppm 4.92 (1H, t, J = 4.8 Hz, CH=C(CH3)2), 3.11 (1H, dt, J = 10.4, 3.6 Hz, 1xN=C-CH2), 
2.57−2.51 (1H, m, 1xN=C-CH2), 2.46−2.39 (10H, m, -N(CH3)2, 2xCO-CH2), 1.93 (1H, dtd, J 
= 15.2, 7.6, 3.6 Hz, CO-CH2-CH2eq), 1.75−1.68 (1H, dtd, J = 15.2, 6.8, 3.6 Hz, CO-CH2-
CH2ax), 1.64 (3H, s, -CH3), 1.59 (3H, s, -CH3), 1.24 (3H, s, -CH3); 13C NMR (150 MHz, 
CDCl3)  ppm 212.8 (CO), 169 (C=N), 134.4 (CH=C(CH3)2), 118.8 (CH=C(CH3)2), 57.9 (-C-
CH3), 47.3 (N(CH3)2), 38.5 (N=C-CH2), 37.8 (CO-CH2), 25.9 ((CH3)2C=CH-CH2), 24.9 (CO-
CH2-CH2), 20.5 (-CH3), 20.0 (-CH3), 18.0 (-CH3). 
 
143 
 
 
2-Methyl-2-(oxiran-2-ylmethyl)cyclohexanone-1,3-dione (2.53) 
 
To a stirred solution of 2-methyl-2-(3-propenyl)-cyclohexane-1,3-dione 2.49 (0.200 g, 1.2 
mmol, 1 eq) in dichloromethane (10 mL), acetone (1 mL) and saturated aqueous sodium 
hydrogen carbonate (5 mL) was added dropwise a solution of oxoneTM (0.700 g, 2.4 mmol, 
2 eq) in water (6.0 mL) over a period of 10 min at 0 °C. After stirring for 1 additional hour, 
additional OxoneTM (0.700 g, 2.4 mmol, 2 eq) was added over a period of 10 min. The mixture 
was extracted with dichloromethane (3x10 mL), the organic layers washed with brine, filtered 
and evaporated to give 2.53 (0.070 mg, 27%) as colourless liquid, Rf 0.7 (hexane:ethyl 
acetate, 80:20); IR (film): 2952, 1695, 1455, 1242, 1007 cm-1; 1H NMR (600 MHz, CDCl3)  
ppm 2.92‒2.88 (1H, m, CH2-CH-O), 2.74−2.67 (5H, m, 2xCH2, 1xCH2-O) 2.46 (1H, dd, J = 
3.2, 1.6 Hz, 1xCH2-O), 2.17‒2.10 (2H, m, -CH2), 2.08−1.97 (2H, m, -CH2), 1.31 (3H, s, C-
CH3); 13C NMR (150 MHz, CDCl3)  ppm 210.5 (CO), 210.1 (CO), 67.2, 63.0, 48.9, 48.4, 
38.0, 37.8, 37.2, 22.4, 17.8; HRMS (ESI-TOF) [M+] C10H15O3 calcd. 183.1021, found 
183.1020. 
 
2,2,4a-Trimethylhexahydro-3,8a-epoxychromen-5(6H)-one (2.54) 
O
O
O
2.54
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7
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In a flame-dried round-bottom flask, under an atmposphere of argon, alkene 2.48 (0.200 g, 
1.0 mmol, 1 eq) was dissolved in dry dichloromethane (2.5 mL) and stirred at 20 °C for 5 
min. After this period, m-CPBA (0.300 g, 2 mmol, 2 eq) was added. A white precipitate was 
observed almost immediately. After 30 min. starting material was absent and TLC showed 
a new spot with 0.42 Rf (hexane:ethyl acetate, 50:50). The mixture was then brought to −78 
°C and 2,6-lutidine (0.750 g, 0.81 mL, 7 mmol, 7 eq) and TMSOTf (0.72 mL, 4 mmol, 4 eq) 
144 
 
were added. Upon disappearance of the TLC spot at Rf 0.42 (and formation of two new spots 
at Rf 0.89 and 0.54 respectively) after approximately 1 h, sat NaHCO3 (1 mL) was added 
and the temperature was slowly raised to 20 °C. The mixture was extracted with ethyl 
acetate (3x10 mL) and the combined organic layers washed sequentially with an aqueous 
solution of hydrochloric acid (2M, 10 mL), saturated aqueous sodium bicarbonate (10 mL), 
water (10 mL) and brine (10 mL). The organic layer was dried over MgSO4, filtered and 
evaporated to give a crude yellow oil (0.060 g). Column chromatography (hexane:ethyl 
acetate, 90:10→ 70:30) afforded 2.54 (10 mg, 5%) as white crystalline microprisms, Rf  0.54 
(hexane:ethyl acetate, 50:50);  1H NMR (600 MHz, CDCl3)  ppm 3.72 (1H, dd, J = 9, 7.2 
Hz, 3-H), 2.73 (1H, dd, J = 8.4, 4.8 Hz, 8-H), 2.53 (1H, td, J = 9.6, 4.4 Hz, 6-H), 2.30 (1H, 
app d, J = 9.2 Hz, 6-H), 2.11 (1H, app d, J = 9.6 Hz, 4-H), 2.00 (1H, td, J = 9.2, 3.2 Hz, 4-
H), 1.85−1.67 (3H, m, 8-H, 2x7-H), 1.31 (3H, s, -CH3), 1.26 (3H, s, -CH3), 1.13 (3H, s, -CH3); 
13C NMR (151 MHz, CDCl3)  ppm 212.3 (C-5), 171.5, 106.4 (C-8a), 83.1 (C-2), 70.9 (C-3), 
60.4 (C-4a), 37.2 (C-6), 30.7 (C-8), 28.8 (-CH3), 25.4 (-CH3), 19.9 (C-4), 18.8 (-CH3); HRMS 
(ESI-TOF) [M+] C12H18O3  calcd. 211.1334, found 211.1333. 
 
3-(2,2-Dimethylhydrazono)-2-((3,3-dimethyloxiran-2-yl)methyl)-2-
methylcyclohexanone (2.64) 
 
Sodium hydride (60% dispersion in mineral oil, 0.04 g, 1.00 mmol, 2 eq) and dry 
dimethylformamide (5 mL) were placed in a dry flask under an atmosphere of argon and 
stirred at 20 °C for 5 min. 2-Methylcyclohexane-1,3-dione dimethylhydrazone 2.50 (0.100 g, 
0.6 mmol, 1 eq) was added to the mixture and stirred at 20 °C for 30 min. Then 1-bromoethyl-
3,3-dimethyloxirane 2.19 (0.200 g, 1.2 mmol, 2 eq) was added dropwise via a syringe pump, 
over a period of 10 min. The reaction was stirred at 20 °C for 2 h. Slow addition of water at 
0 ˚C (5 mL) gave a mixture that was extracted with diethyl ether (3x20 mL). The combined 
organic layers were washed twice with brine, dried over MgSO4, filtered and evaporated. 
Column chromatography (hexane:ethyl acetate, 70:30) afforded 2.64 (0.045 g , 30%) as a 
yellow oil, Rf 0.25 (100% ethyl acetate); 1H NMR (600 MHz, CDCl3)  ppm 3.97 (2H, dd, J = 
6.0, 3.2 Hz, CH2-CHO), 3.50 (1H, dd, J = 6.8, 4.0 Hz, CH2-CHO), 3.24 (1H, dd, J = 6.8, 4.8 
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Hz, CH2-CHO), 2.63−2.56 (2H, m, -N=C-CH2), 2.51−2.46 (6H, s, -N-(CH3)2), 2.44−2.31 (2H, 
m, CO-CH2), 1.84 (3H, s, C-CH3), 1.83−1.80 (2H, m, CO-CH2-CH2), 1.37 (3H, s, -CH3), 1.32 
(3H, s, -CH3); 13C NMR (150 MHz, CDCl3)  ppm 207.1 (CO), 158.0 (C-N), 66.7 (-C-CH3), 
61.7 (CH-O), 58.1 (-C-(CH3)2), 47.4 (2xN-(CH3)2), 30.9 (CO-CH2), 25.6 (CH2-CH(O)), 24.6 (-
C(CH3)2), 21.4 (-N=C-CH2), 18.9 (C-CH3), 9.6 (CO-CH2-CH2); HRMS (ESI-TOF) [M]+ 
C14H24N2O2 calcd. 252.1838, found 252.1833. 
 
2-Cinnamyl-2-methylcyclohexane-1,3-dione (2.74) 
O
Ph
O
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To a round bottom flask containing Pd(PPh3)4 (0.010 mg, 5 mol%) was added an aqueous 
solution of Triton X-100 (0.010 mg, 9 μL in 3.2 mL H2O) at ambient temperature. Cinnamyl 
acetate (0.253 g, 1.44 mmol, 239 μL, 1 eq) was then introduced in the same flask and the 
resulting solution stirred for 15 minutes. After this time 2-methyl-1,3-cyclohexanedione 2.47 
(0.200 g, 1.58 mmol, 1.1 eq) was added at 30 ºC followed by an aqueous solution of K2CO3 
(0.200 g, 1.44 mmol in 1.6 mL of H2O, 1.1 eq). After stirring for 10 minutes the reaction was 
quenched with sat. NH4Cl and extracted with ethyl acetate. The combined organic layers 
were dried over Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (petroleum ether:ethyl acetate, 85:15) afforded 2-cinnamyl-2-
methylcyclohexane-1,3-dione 2.74 (0.330 g, 85%) as yellow oil, Rf 0.31 (petroleum 
ether:ethyl acetate, 85:15); IR (film) 2940, 1725, 1694, 1494, 1450, 1319, 1270, 1192, 1026, 
969, 827, 734, 644, 636 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 7.34−7.20 (5H, m, aryl), 
6.43 (1H, d, J = 15.9 Hz, 10-H) 6.07−5.92 (1H, dt, J H9-10 = 15.9, J H8-9 = 7.2 Hz, 9-H), 
2.77−2.61 (6H, m, H-4,H-6, 8-H), 2.07−1.86 (2H, m, 5-H), 1.31 (3H, s, 2-CH3); 13C NMR (101 
MHz, CDCl3) δ ppm 210.0 (C-1,3), 136.9 (C-9), 134.1 (C-10), 128.5 (aryl), 127.5 (aryl), 126.2 
(aryl), 123.8 (aryl), 65.3 (C-2), 40.3 (C-4,6), 38.3 (C-8), 20.3 (C-2-CH3), 17.4 (C-5); HRMS 
(ESI-TOF) [M+H]+ C16H19O2 calcd. 243.1380, found 243.1389. 
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3-(1-Methyl-2,6-dioxocyclohexyl)propanal (2.77/3.1) 
 
To a solution of 2-methyl-1,3-cyclohexanedione 2.47 (0.080 g, 0.64 mmol, 1 eq) in dry 
CH3CN (6 mL) were added acrolein (64 L, 0.96 mmol, 1.5 eq) and DABCO (0.014 g, 0.13 
mmol) at 25 °C under an atmosphere of argon. The resulting solution was heated at 95 °C 
for 6 h. After this time the reaction was allowed to cool to 25 °C and quenched with water (6 
mL). Dichloromethane was then added and the aqueous phase was extracted three times 
(3x10 mL). The combined organic layers were dried over Na2SO4, filtered and evaporated 
under reduced pressure to give 3-(1-methyl-2,6-dioxocyclohexyl)propanal 2.77/3.1 (0.130 
g, 97%) as a yellow oil, which was used in the subsequent step without further purification, 
IR (film): 3427, 2932, 2870, 1719, 1691, 1452, 1372, 1238, 1047,  956; 1H NMR (600 MHz, 
CDCl3) δ ppm 9.69 (1H, t, J = 0.8 Hz, CH-O), 2.74−2.64 (4H, m, 2xCO-CH2), 2.35 (2H, app 
t, J = 4.8 Hz, CH2-CHO), 2.12 (2H, t, J = 5.2 Hz, CH2-CH2-CHO), 2.03−1.91 (2H, m, CO-
CH2-CH2), 1.29 (3H, s, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 209.9 (CO), 201.1 (CHO), 
64.5 (C-CH3), 39.5 (CH2-CHO), 37.9 (CO-CH2), 27.3 (CH2-CH2-CHO), 21.7 (C-CH3), 17.6 
(CO-CH2-CH2). HRMS (ESI-TOF) [M+Na]+ C10H14NaO3 calcd. 205.0835, found 205.0842. 
 
Methyl-5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enoate (2.82) 
O O
O
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A literature procedure was adapted.106b LiCl (0.030 g, 0.63 mmol, 1.2 eq) was placed in a 
25 mL round bottom flask and flame dried under vacuum at 400 ºC for 5 minutes. Trimethyl 
phosphonoacetate (0.120 g, 0.65 mmol, 1.2 eq), DBU (0.090 g, 0.6 mmol, 1.1 eq) and dry 
CH3CN (6 mL) were subsequently added to the flask under an atmosphere of argon. A 
solution of 3-(1-methyl-2,4-dioxocyclohexyl) propanal 2.77 (0.100 g, 0.54 mmol, 1 eq) 
dissolved in dry CH3CN (5 mL) was then added dropwise to the mixture. The solution was 
stirred for 3 h at 25 °C and then quenched with sat. NH4Cl. The aqueous phase was 
extracted with ethyl acetate (3x30 mL), the combined organic layers were washed with brine, 
dried over MgSO4, filtered and evaporated. Column chromatography (petroleum ether:ethyl 
acetate, 60:40) afforded 5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enoate 2.82 (0.030 g, 23%) 
as colorless oil, 1H NMR (400 MHz, CDCl3) δ ppm 6.86 (1H, dt, J H10-11 = 15.6, J H9-10  = 6.7 
Hz, 10-H), 5.79 (1H, dt, J H10-11 = 15.6, J H9-11 = 1.5 Hz, 11-H), 3.71 (3H, s, O-CH3), 2.79−2.55 
(4H, m, 4-H, 6-H), 2.12−1.89 (6H, m, 5-H, 8-H, 9-H), 1.28 (3H, s, 2-C-CH3). 13C NMR (101 
MHz, CDCl3) δ ppm 209.8 (C-1,3), 166.7 (C-12), 147.7 (C-10), 121.5 (C-11), 64.8 (C-2), 
51.4 (C-13), 37.9 (C-4.6), 34.0 (C-8), 27.5 (C-9), 21.3 (C-2-CH3), 17.5 (C-5). 
 
Ethyl-5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enoate (2.83) 
 
A literature procedure was adapted.106b To a solution of carbethoxymethylene triphenyl 
phosphorane (0.570 g, 1.64 mmol, 1.2 eq) in dry dichloromethane (4 mL) was added a 
solution of 3-(1-methyl-2,4-dioxocyclohexyl) propanal (2.77, 0.250 g, 1.37 mmol, 1 eq) 
dissolved in dry dichloromethane (2 mL). The solution was stirred at 25 °C over the course 
of the night. The aqueous phase was extracted with ethyl acetate, the combined organic 
layers were washed with brine, dried over MgSO4, filtered and evaporated. The crude 
mixture was purified by flash column chromatography (petroleum ether:ethyl acetate, 80:20) 
to afford ethyl 5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enoate 2.83 (0.25 g, 85%) as 
colorless oil, 1H NMR (400 MHz, CDCl3) δ ppm 6.85 (1H, dt, J H10-11 = 15.7, J H9-10 = 6.6, J 
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H9-10 = 6.6 Hz, 10-H), 5.78 (1H, dt, J H10-11 = 15.7, J H9-11 = 1.8, H9-9 = 1.8 Hz, 11-H), 4.14 
(2H, q, J = 7.1 Hz, 13-H), 2.73−2.59 (4H, m, 4-H, 6-H), 2.08−1.91 (6H, m, 5-H, 8-H, 9-H), 
1.27 (6H, dt, J = 7.1, 3.7 Hz, 14-H, 2-C-CH3); 13C NMR (101 MHz, CDCl3) δ ppm 209.7 (C-
1,3), 166.3 (C-12), 147.3 (C-10), 121.9 (C-11), 64.8 (C-13), 60.2 (C-2), 37.9 (C-4,6), 34.1 
(C-8), 27.4 (C-9), 21.1 (C-14), 17.5 (C-5), 14.2 (C-2-CH3). 
 
Benzyltriphenylphosphonium chloride (2.89) 
PPh3 Cl
2.89  
A literature procedure was adapted.138 Benzyl chloride (1.08 g, 8.6 mmol, 2.25 eq) was 
added to a stirring solution of PPh3 (1g, 3.81 mmol, 1 eq) in toluene (12 mL) at room 
temperature. The reaction was heated at 110 ºC for 6 hours. The white solid formed was 
collected through filtration, washed with warm toluene and dried to give benzyl 
triphenylphosponium chloride 2.89 as a white solid (370 mg, 11%), m.p. 270−275 ºC (lit.138 
m.p. >300 °C) 1H NMR (400 MHz, CDCl3) δ ppm 7.80−7.57 (15H, m, aryl) 7.24−7.06 (5H, 
m, aryl), 5.53 (2H, d, J = 14.5 Hz, CH2-PPh3); 13C NMR (101 MHz, CDCl3) δ ppm 134.6 (d, 
J = 9.8 Hz, aryl), 131.7 (d, J = 5.6 Hz, aryl), 130.3 (d, J = 12.5 Hz, aryl), 128.9 (d, J = 3.4 
Hz, aryl), 128.4 (d, J = 4.0 Hz, aryl), 127.5 (d, J = 8.5 Hz, aryl), 118.7 (aryl), 117.9 (aryl), 
31.1 (d, J = 46.5 Hz, CH2-PPh3). 
 
 
Ethyl-5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enethioate (2.92) 
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A literature procedure was adapted.141 To a solution of 3-(1-Methyl-2,6-
dioxocyclohexyl)propanal  2.77 (0.200 g, 1.09 mmol, 1 eq) in CHCl3 (20 mL) was added 
ethyl 2-(triphenyl-λ5-phosphanylidene)ethanethioate (0.520 g, 1.42 mmol, 1.3 eq.) in one 
portion at 25 °C and the reaction heated at reflux for 2 hours. After this time the mixture was 
allowed to cool to 25 °C and the solvent evaporated under reduced pressure. The crude 
residue was purified by flash column chromatography (hexane:ethyl acetate, 80:20) to afford 
ethyl-5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enethioate 2.92 (0.260 g, 89%) as a 80:20 
mixture of isomers, Rf 0.29 (hexane:ethyl acetate, 60:40), 1H NMR (400 MHz, CDCl3) δ ppm 
6.77−6.68 (m, 1H, 10-H), 6.02 (1H, m, 11-H), 2.93‒2.84 (2H, m, 13-H), 2.67−2.58 (4H, m, 
4-H, 6-H), 2.01‒1.96 (2H, m, 9-H), 1.95−1.88 (4H, m, 5-H, 8-H), 1.24 (6H, m, 2xCH3); Major 
isomer 13C NMR (101 MHz, CDCl3) δ ppm 209.8 (C-1,3), 189.9 (C-12), 143.5 (C-10), 129.3 
(C-11), 64.8 (C-2), 38.0 (C-4,6), 34.0 (C-8), 27.6 (C-9), 23.1 (C-7), 21.6 (C-13), 17.6 (C-5), 
14.8 (C-14); Minor isomer 13C NMR (101 MHz, CDCl3) δ 210.2, 189.4, 144.5, 127.2, 65.2, 
35.7, 25.5, 23.3, 19.9, 17.7, 14.8. 
 
5-(1-Methyl-2,6-dioxocyclohexyl)pent-2-enal (2.93) 
 
A literature procedure was adapted.139To a stirring solution of 3-(1-Methyl-2,6-
dioxocyclohexyl)propanal  2.77 (0.260 g, 1.42 mmol, 1 eq) in dry CHCl3 (12 mL) was added 
2-(triphenyl-λ5-phosphanylidene)acetaldehyde (0.430 g, 1.42 mmol, 1 eq) in one portion at 
25 °C and the reaction heated at reflux for 5 h. After this time the solvent was evaporated 
under reduced pressure and the crude residue purified by flash column chromatography 
(dichloromethane:ethyl acetate, 95:5) to afford 5-(1-methyl-2,6-dioxocyclohexyl)pent-2-enal 
2.93 (0.092 g, 31%) as 6.6:3.6 mixture; 1H NMR (600 MHz, CDCl3) δ ppm 9.62 (1H, s, CHO) 
9.43 (1H, d, J = 5.2 Hz, CHO), 6.73 (1H, dt, J = 10.4, 4.4 Hz, CH-CHO), 6.02 (1H, m, CH2-
CH=), 2.73−2.52 (8H, m, -CH2), 2.30 (1H, t, J = 5.6 Hz, -CH2), 2.15−2.08 (2H, m, -CH2), 2.06 
(1H, t, J = 5.2 Hz, -CH2), 1.99‒1.82 (8H, m, CH2) 1.27 (3H, s, -CH3), 1.23 (3H, s, -CH3). 
Major isomer 13C NMR (151 MHz, CDCl3) δ ppm 209.9 (CO), 201.0 (CO), 193.8 (CHO), 
157.2 (CH2-CH=), 133.1 (=CH-CHO), 64.7 (C-CH3), 37.8 (CO-CH2), 33.1 (CH2-CH=), 28.3 
(CH2-CH2-CH=CH), 22.6 (C-CH3), 17.5 (CO-CH2-CH2). Minor isomer 13C NMR (151 MHz, 
CDCl3) δ 209.9, 201.0, 193.8, 157.0, 132.9, 64.4, 39.3, 37.8, 27.2, 21.6, 17.5. 
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Ethyl 2-(triphenyl-phosphanylidene)ethanethioate (2.99) 
 
A literature procedure was adapted.140 To a solution of bromoacetic acid (5.26 g, 37.6 mmol, 
1 eq) in dry dichloromethane (170 mL) was added ethanethiol (48.9 mmol, 3.62 mL, 1.3 eq) 
and DMAP (0.450 g, 3.76 mmol) and the resulting mixture brought to 0 °C. DCC (8.15 g, 
39.5 mmol, 1.05 eq) was then added in 3 portions. The reaction was allowed to warm to 
room temperature over the course of the night and the cloudy white solution filtered through 
celite. The resulting cake was washed twice with cold dichloromethane, the filtrate 
transferred in a separating funnel and washed with sat. NaHCO3 and water. The combined 
organic layers were dried over MgSO4, filtered and evaporated under reduced pressure to 
give ethyl 2-bromoethanethioate as a yellowish solid (4.6 g, 67%). The latter was stirred in 
dry toluene (40 mL) at 25 °C in the presence of PPh3 (6.20 g, 23.7 mmol, 1 eq) for 2 days. 
The white solid obtained was filtered and washed twice with toluene. The resulting crystals 
were dissolved in dichloromethane (40 mL) and stirred for 30 minutes in the presence in a 
10% solution of Na2CO3 (30 mL). The aqueous phase was extracted with dichloromethane 
three times, and the combined organics were partially concentrated under reduced pressure, 
diluted with pentane and filtered twice to afford ethyl 2-(triphenyl-
phosphanylidene)ethanethioate 2.99 (2.00 g, 15% over 2 steps) 1H NMR (400 MHz, CDCl3) 
δ ppm 7.67−7.53 (9H, m, aryl), 7.46 (6H, tdd, J = 8.2, 2.5, 0.8 Hz, aryl), 3.65 (1H, s, P=CH), 
2.84 (2H, q, J = 7.3 Hz, S-CH2), 1.25 (3H, t, J = 7.4 Hz, S-CH2-CH3). 13C NMR (101 MHz, 
CDCl3) δ ppm 180.7 (CO), 133.2 (aryl), 133.1 (aryl), 132.3 (aryl), 129.0 (aryl), 127.5 (aryl), 
126.6 (aryl), 46.5 (P=CH), 23.3 (S-CH2), 16.5 (S-CH2-CH3). 
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2-(Triphenylphosphanylidene)acetaldehyde (2.101) 
 
A literature procedure was adapted.142To a solution of methyl triphenylphosphonium 
bromide (7.40 g, 20 mmol, 1 eq) in dry Et2O (40mL) was added t-BuOK (2.70 g, 24.0 mmol, 
1.2 eq) and the resulting bright yellow solution stirred for 30 minutes at 25 °C. The latter was 
then poured dropwise into a stirring solution of ethyl formate (2.25 mL, 28.0 mmol, 1.4 eq) 
in dry Et2O (40 mL) and the resulting cloudy solution was stirred for 2 h at the same 
temperature. After this time the reaction mixture was cooled down to 0 °C and cold aqueous 
HCl first (0.1 M, 100 mL) then (1M, 12 mL) were subsequently added. The solution was 
washed with aqueous HCl (0.1 M, 3x15mL) and the combined aqueous layers were basified 
with aqueous NaOH (2 M) until pH 10. Over the course of the night a precipitate formed 
which was washed with water and Et2O to afford 2-(triphenylphosphanylidene)acetaldehyde 
2.101 as yellow solid (60:40 mixture of trans/cis isomer, 1.50 g, 25%), 1H NMR (400 MHz, 
CDCl3) δ ppm 8.97 (1H, d, J = 38.2 Hz, CHO-trans), 8.25 (1H, dd, J = 10.7, 3.5 Hz, CHO-
cis), 7.72−7.43 (30H, m, aryl), 4.07 (1H, dd, J = 19.4, 10.8 Hz, P=CH-trans), 3.75−3.56 (1H, 
m, P=CH-cis). 13C NMR (101 MHz, CDCl3) δ ppm 181.8 (CHO), 181.7 (CHO), 133.4 (aryl), 
133.3 (aryl), 133.3(aryl), 133.1(aryl), 132.8 (aryl), 132.4 (aryl), 129.2 (aryl), 129.1 (aryl), 
127.1 (aryl), 126.2 (aryl), 55.3 (P=CH), 54.3 (P=CH). 
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1-Benzyltetrahydrothiophenium bromide (2.105) 
 
A literature procedure was adapted.143 To a solution of tetrahydrothiophene (3.57 g, 40.6 
mmol, 1 eq) in dry acetone (20 mL) benzyl bromide was added (6.94 g, 40.6 mmol, 1 eq) at 
25 °C. After overnight stirring the resulting white solid was filtered and washed twice with 
acetone to afford 1-benzyltetrahydrothiophene 2.105 (4.27 g, 23%) as a white solid, m.p. 
122‒124 °C, 1H NMR (600 MHz, D2O) δ ppm 7.57−7.50 (5H, m, aryl), 4.54 (2H, s, S-CH2), 
3.56−3.40 (4H, m, 2xCH2), 2.37−2.22 (4H, m, 2xCH2). 13C NMR (101 MHz, D2O) δ ppm 
130.4 (aryl), 130.1 (aryl), 129.7 (aryl), 128.4 (aryl), 45.7 (SH-CH2), 42.4 (2xSH-CH2), 28.2 
(2xCH2). 
 
6-Hydroxy-1-methylbicyclo[3.3.1]nonane-2,9-dione (3.2) 
 
To a stirred solution of 2-methyl-1,3-cyclohexanedione (0.100 g, 0.79 mmol, 1 eq) in 
dimethylformamide (4 mL) was added acrolein (81 μL, 1.18 mmol, 1.5 eq) at 25 °C. The 
solution was then heated at 130 °C for 24 h. After allowing the mixture to cool the solvent 
was evaporated. The residue was washed with chloroform (2x3 mL) to give exo-ketol 3.2 
(0.142 g, 97%) as a colorless oil, Rf 0.3 (dichloromethane:ethyl acetate, 60:40); IR (film): 
3405, 2936, 1727, 1697, 1454 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.35 (1H, dt, J = 3.1, 2.6 
Hz, 6-H), 2.93 (1H, dm, J = 9.7 Hz, 5-H), 2.60 (1H, m, 3-Heq), 2.32 (1H, dt, J = 16.5, 9.5 Hz, 
3-Hax), 2.22‒2.14 (1H, m, 4-Heq), 2.14‒2.06 (2H, m, 8-H), 1.84 (1H, m, 7-Heq), 1.74‒1.67 
(2H, m, 4-Hax, 7-Hax), 1.15 (3H, s, 1-C-CH3); 13C NMR (100 MHz, CDCl3) δ 211.9 (C-9), 
211.5 (C-2), 77.0 (C-6), 63.2 (C-1), 52.2 (C-5), 38.2 (C-3), 37.4 (C-8), 26.4 (C-7), 18.9 (C-
4), 16.7 (1-C-CH3); HRMS (ESI-TOF) [M+H]+ C10H15O3 calcd. 183.1016, found 183.1018. 
From the above reaction conducted in the presence of DABCO (0.2 eq) in acetonitrile at 20 
°C was obtained a 1:1 mixture of epimers at position-6. For endo-ketol 3.2: Rf 0.28 
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(dichloromethane:ethyl acetate, 60:40), 1H NMR (400 MHz, CDCl3) δ 4.10 (1H, dt, J = 11.5, 
5.0 Hz, 6-H), 3.10 (1H, m, 5-H), 2.50-2.45 (2H, m, 3-H), 2.29-2.14 (4H, m, 4-Heq, 7-Heq and 
8-H), 1.65-1.56 (1H, m, 4-Hax), 1.47-1.38 (1H, m, 7-Hax), 1.14 (3H, s, 1-C-CH3); 13C NMR 
(100 MHz, CDCl3) δ 210.2 (C-9), 209.3 (C-2), 73.2 (C-6), 61.8 (C-1), 52.5 (C-5), 38.8 (C-3), 
35.6 (C-8), 27.8 (C-7), 16.3 (C-4) 15.0 (1-C-CH3). 
6-Hydroxy-1,7-dimethylbicyclo[3.3.1]nonane-2,9-dione (3.19) 
 
To a solution of 2-methyl-1,3-cyclohexanedione (0.100 g, 0.8 mmol, 1 eq) in acetonitrile (6 
mL) were added methacrolein (98 μL, 1.19 mmol, 1.5 eq) and DABCO (0.018 g, 0.16 mmol, 
20 mol%) at 25 °C. The solution was heated at 95 °C for 16 h. After allowing to cool, water 
(5 mL) was added and the mixture extracted with dichloromethane (3x10 mL). The combined 
organic layers were dried over MgSO4, filtered and evaporated to give ketol 3.19 (0.150 g, 
96%) as an 80:20 mixture of endo-3.19:exo-3.19, IR (film): 3455, 2936, 1728, 1697 cm-1. 
endo-3.19, Rf 0.45 (dichloromethane:ethyl acetate, 60:40)  1H NMR (400 MHz,  CDCl3) δ 
ppm 3.62 (1H, dd, J = 10.5, 4.8 Hz, 6-H), 3.08 (1H, ddd, J = 8.9, 4.8, 2.1 Hz, 5-H), 2.64 (1H, 
m, 3-Heq), 2.37 (1H, m, 3-Hax), 2.24 (1H, m, 4-Heq), 2.12‒2.00 (2H, m, 7-H, 8-Heq), 1.92 
(1H, m, 8-Hax), 1.77 (1H, m, 4-Hax), 1.13 (3H, s, 1-C-CH3), 1.02 (3H, d, J = 6.3 Hz, 7-
CHCH3); 13C NMR (100 MHz, CDCl3) δ ppm 212.0 (C-9), 209.9 (C-2), 78.4 (C-6), 62.9 (C-
1), 52.0 (C-5), 44.4 (C-8), 38.4 (C-3), 32.7 (C-7), 17.7 (C-4), 16.2 (1-CCH3), 15.5 (7-CCH3); 
exo-3.19 was isolated pure in 6% yield under neutral conditions (DMF, 95 °C, 72 h), Rf 0.48 
(dichloromethane:ethyl acetate, 60:40) 1H NMR (400 MHz, CDCl3) δ ppm 3.96 (1H, m, 6-H), 
2.96 (1H, ddd, J = 10.2, 4.2, 2.0 Hz, 5-H), 2.62 (1H, ddd, J = 16.2, 7.4, 3.4 Hz, 3-Heq), 2.34 
(1H, m, 3-Hax), 2.20 (1H, m, 4-H), 2.10 (1H, m, 7-H), 2.01 (1H, m, 8-Heq), 1.82 (1H, dd, J 
= 12.9, 4.5 Hz, 8-Hax), 1.70 (1H, m, 4-Hax), 1.14 (3H, s, 1-C-CH3), 1.00 (3H, d, J = 6.6 Hz, 
7-CHCH3); 13C NMR (100 MHz, CDCl3) δ ppm 212.5 (C-9), 211.8 (C-2), 80.4 (C-6), 62.5 (C-
1), 52.1 (C-5), 44.5 (C-8), 38.4 (C-3), 29.9 (C-7), 18.6 (C-4), 16.8 (1-CHCH3), 16.7 (7-CCH3). 
HRMS (ESI-TOF) [M+H]+ C11H17O3 calcd. 197.1172, found 197.1170. 
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endo-1,8-Dimethyl-6-acetoxy-bicyclo[3.3.1]nonane-2,9-dione (3.22) 
H3C(O)CO
O O
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To a solution of 6-hydroxy-1,8-dimethylbicyclo[3.3.1]nonane-2,9-dione (crude mixture, 
0.082 g, 0.41 mmol, 1 eq) in dry dichloromethane (4 mL) were added acetic anhydride (1.64 
mmol, 155 L, 4 eq), DMAP (0.050 g, 0.41 mmol, 1 eq) and pyridine (1.23 mmol, 100 L, 3 
eq)  at 25 °C  under an atmosphere of argon. The resulting solution was stirred at the same 
temperature for 1 h, then at 45 °C for 2 days. After this time water (10 mL) was added to the 
reaction and the aqueous phase was extracted three times with dichloromethane (3x10 mL). 
The combined organic layers were washed with brine, dried over MgSO4, filtered and 
evaporated under reduced pressure. The crude residue was purified by flash column 
chromatography on neutral Al2O3 (petroleum ether:ethyl acetate, 90:10) to give 3.22 (0.031 
g, 23% over 2 steps) as a single diastereoisomer, IR (film, cm-1):  2989, 2946, 1734, 1697, 
1456, 1347, 1238, 1039 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 5.29 (1H, dd, Jeq-ax = 5.6, 
Jeq-eq = 3.2 Hz, 6-H), 2.95–2.90 (1H, m, 5-H), 2.56 (2H, ddd, Jeq-ax = 8.9, Jeq-ax 6.8, Jeq-eq 2.1 
Hz, 3-H), 2.29–2.18 (1H, sept, Jax-ax = 12.7, Jax-eq = 5.8 Hz, 8-H), 2.05 (3H, s, -OCOCH3), 
2.04–1.82 (4H, m, 4H, 7-H), 1.22 (3H, s, 1-C-CH3), 0.98 (3H, d, J = 6.8 Hz, 8-CH-CH3); 13C 
NMR (101 MHz, CDCl3) δ ppm 209.1 (C-9), 208.4 (C-2), 170.1 (6-OCOCH3), 76.8 (C-6), 
69.2 (C-1), 48.4 (C-5), 41.5 (C-8), 38.4 (C-3), 34.5 (C-7), 21.3 (6-OCOCH3), 19.9 (C-4), 16.2 
(8-CH-CH3), 14.0 (1-C-CH3). HRMS (ESI-TOF) [M+H]+ C13H18O4 calcd. 239.1205, found 
239.1283. 
 
6-Hydroxy-1-methyl-8-phenylbicyclo[3.3.1]nonane-2,9-dione (3.25) 
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To a solution of 2-methyl-1,3-cyclohexanedione 3.12 (0.100 g, 0.8 mmol, 1 eq) in CH3CN (6 
mL) at 25 °C were added cinnamaldehyde (150 L, 1.1 mmol, 1 eq) and DABCO (0.089 g, 
0.8 mmol, 1 eq). The solution was heated at 95 °C for 16 h. After allowing to cool, water (15 
mL) was added and the mixture extracted with dichloromethane (4x10 mL). The combined 
organic layers were washed with water (3x15 mL), dried over Na2SO4, filtered and 
evaporated. Column chromatography (dichloromethane:ethyl acetate, 90:10) gave 3.25 
(0.022 g, 10%) as a yellow oil, a 70:30 mixture of endo-3.25:exo-3.25; Rf 0.41 (ethyl 
acetate:dichloromethane, 40 : 60)  IR (film): 3443, 2927, 1725, 1691, 1496, 1041 cm-1. endo-
3.25: 1H NMR (400 MHz, CDCl3) δ ppm 7.32‒7.26 (3H, m, aryl), 7.03‒6.97 (2H, m, aryl), 
4.34 (1H, dt, J = 11.0, 5.5 Hz, 6-H), 3.09 (1H, app. t, J = 5.5 Hz, 5-H), 2.75 (1H, m, 3-Heq), 
2.81‒2.70 (2H, m, 3-Hax, 8-H), 2.58 (1H, m, 4-Heq), 2.44‒2.25 (2H, m, 7-H), 1.82 (1H, m, 
4-Hax), 0.95 (3H, s, 1-C-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 208.5 (C-9), 208.0 (C-2), 
138.2 (ipso-Aryl), 128.7 (Aryl), 128.6 (Aryl), 128.5 (Aryl), 71.2 (C-6), 68.9 (C-1), 52.8 (C-5), 
51.2 (C-8), 40.2 (C-3), 37.0 (C-7), 17.2 (C-4), 15.0 (1-C-CH3); exo-3.25: 1H NMR (400 MHz, 
CDCl3) δ ppm 7.32‒7.26 (3H, m, Aryl), 7.03-6.97 (2H, m, Aryl), 4.52 (1H, dd, J = 2.5, 2.2 Hz, 
6-H), 3.45 (1H, dd, J = 13.9, 4.7 Hz, 5-H), 2.96 (1H, m, 3-Heq), 2.81‒2.70 (2H, m, 3-Hax, 8-
H), 2.65‒2.62 (1H, m, 4-Heq), 2.44‒2.45 (2H, m, 7-H), 2.11 (1H, m, 4-Hax), 1.00 (3H, s, 1-
C-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 209.2 (C-9), 207.8 (C-2), 138.5 (ipso-Aryl), 128.7 
(Aryl), 128.6 (Aryl), 128.5 (Aryl), 75.0 (C-6), 70.4 (C-1), 53.0 (C-5), 52.2 (C-8), 39.0 (C-3), 
36.0 (C-7), 20.7 (C-4), 15.1 (1-C-CH3). HRMS (ESI-TOF) [M+H]+ C16H18O3 calcd. 259.1329, 
found 259.1328. 
 
 
endo-6-Benzyloxy-1-methyl-4-phenylbicyclo[3.3.1]nonane-2,9-dione (3.26) 
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To a solution of 6-hydroxy-1-methyl-8-phenylbicyclo[3.3.1]nonane-2,9-dione (crude mixture, 
0.100 g, 0.38 mmol, 1 eq) in dry Et3N (522 L), was slowly added benzoyl chloride (0.058 
g, 0.42 mmol, 50 L, 1,1 eq) at 25 °C under an atmosphere of argon. The resulting dark 
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solution was left stirring at the same temperature for 6 h. After this time the reaction was 
quenched with water (5 mL). Dichloromethane was then added and the aqueous phase 
extracted three times (3 x 8 mL). The combined organic layers were washed twice with 
water, dried over MgSO4, filtered and evaporated under reduced pressure to give endo-3.26 
(0.007 g, 5% over 2 steps) as a single diastereoisomer, IR (film, cm-1): 2393, 1721, 1697, 
1495, 1451, 1269, 1176, 1113, 767, 712 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 8.09–8.05 
(2H, m, Aryl), 7.64–7.57 (1H, m, aryl), 7.51–7.45 (2H, m, aryl),  7.32–7.27 (3H, m, aryl), 
7.04–6.98 (2H, m, aryl), 5.57 (1H, td, Jax-ax = 8.6, Jax-eq = 5.4, Jax-eq = 3.1 Hz, 6-H), 3.39 (1H, 
appt t, Jeq-ax = 5.8 Hz, 5-H), 3.08–2.97 (1H, ddd, Jgem = 18.2, Jax-ax =11.2, Jax-eq = 9.3 Hz, 1H, 
3-Hax), 2.90–2.79 (2H, m, Jax-ax = 10.2, Jax-ax = 8.6, Jax-eq = 2.36 Hz, 3-Heq, 8-H), 2.64–2.47 
(3H, m, 7-H, 4-Heq), 2.01-1.89 (1H, dddd, Jgem = 14.4, Jax-ax = 11.5, Jax-eq = 8.4, Jax-eq = 5.8 
Hz, 4-Hax), 1.03 (3H, s, 1-C-CH3); 13C NMR (101 MHz, CDCl3) δ ppm 207.42 (C-9), 206.72 
(C-2), 165.25 (6-O-COPh), 137.83 (aryl), 133.63 (aryl), 130.73 (aryl), 129.83 (aryl), 129.03 
(aryl), 128.72 (aryl), 128.63 (aryl), 128.10 (aryl), 72.61 (C-6), 69.44 (C-1), 50.90 (C-8), 49.57 
(C-5), 40.16 (C-3), 34.12 (C-7), 18.64 (C-4), 14.95 (1-C-CH3). 
2-(3-Methylbut-2-en-1-yl)cyclohexane-1,3-dione (3.31) 
 
A literature procedure was adapted.144 To a cool solution of cyclohexane-1,3-dione 3.30 
(3.00 g, 26.7 mmol, 1 eq) in water (45 mL) DIPEA was added (32.1 mmol, 5.58 mL, 1.2 eq) 
and the resulting solution stirred for 5 minutes at 25 °C. After this time prenyl bromide was 
added dropwise (26.7 mmol, 3 mL, 1 eq) over a period of 15 minutes. The ice bath was 
removed and the reaction was stirred at 25 °C for 3 days.  NaOH (1 M aqueous solution, 20 
mL) was then added to the mixture and the aqueous phase washed twice with hexane (2x40 
mL) and acidified with acetic acid until a precipitate was formed. The solid was collected and 
the filtrate extracted with ethyl acetate (2x 40 mL). Flash column chromatography (petroleum 
ether:ethyl acetate, 80:20) afforded pure 3-hydroxy-2-(3-methylbut-2-en-1-yl)cyclohex-2-en-
1-one 3.31 (2.00 g, 41%) as a white solid, IR (film) 2944, 2254, 1634, 1443, 1375, 1270, 
1039, 919 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 5.20 (1H, t, J = 4.4 Hz, CH=C(CH3)2), 
3.07 (2H, d, J = 4.8 Hz, CH2-CH=C(CH3)2), 2.40 (4H, t, J = 4.0 Hz, CO-CH2), 1.95 (2H, m, 
CO-CH2-CH2), 1.75 (3H, s, CH3), 1.74 (3H, s, CH3). 13C NMR (101 MHz, CDCl3) δ ppm 205.0 
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(CO), 136.2 (CH=C(CH3)2), 122.0 (CH=C(CH3)2), 113.8 (C=C(OH)), 68.0 (C-CH3), 39.9 (CO-
CH2), 25.9 (CH2-CH=C(CH3)2), 21.3 (CH=C(CH3)2), 20.7 (CH=C(CH3)2), 17.9 (CO-CH2-
CH2). 
 
6-Hydroxy-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,9-dione (3.32) 
 
To a solution of 2-(3-methylbut-2-en-1-yl)cyclohexane-1,3-dione 3.31 (0.200 g, 1.1 mmol, 1 
eq) in dry acetonitrile (12 mL) were added acrolein (111 μL, 1.65 mmol, 1.5 eq) and DABCO 
(0.025 g, 0.22 mmol, 20 mol %) at 25 °C. The solution was then heated at 95 °C for 48 h. 
After allowing to cool, water (20 mL) was added, and the mixture extracted with 
dichloromethane (4x20 mL). The combined organic layers were dried over Na2SO4, filtered 
and evaporated to give 6-hydroxy-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,9-dione 
(0.200 g, 80%) as a 90:10 mixture of exo-3.32: endo-3.32, IR (film): 3416, 2917, 1701, 1450 
cm-1; exo-3.32: Rf 0.5 (dichloromethane:ethyl acetate, 60:40); 1H NMR (600 MHz, CDCl3) δ 
ppm 5.05 (1H, tsept., J = 5.0, 1.0 Hz, 10-H), 4.34 (1H, m, 6-H), 2.92 (1H, dm, J = 6.8 Hz, 5-
H), 2.57 (1H, m, 3-Heq), 2.40‒2.30 (2H, m, 9-H), 2.25‒2.05 (5H, m, 3-Hax, 4-H, 8-H), 1.80 
(1H, m, 7-Heq), 1.70 (1H, m, 7-Hax), 1.61 (3H, s, 12-H), 1.59 (3H, s, 13-H); 13C NMR (100 
MHz, CDCl3) δ ppm 212.0 (C-9), 212.3 (C-2), 134.7 (C-11), 118.7 (C-10), 77.2 (C-6), 66.5 
(C-1), 52.5 (C-5), 40.4 (C-3), 36.3 (C-8), 31.0 (C-9), 26.1 (C-7), 25.8 (C-12), 18.8 (C-4), 17.9 
(C-13). endo-3.32: : Rf 0.47 (dichloromethane:ethyl acetate, 60:40);  1H NMR (400 MHz, 
CDCl3) δ ppm 5.05 (1H, m, 10-H), 4.06 (1H, dt, J = 11.5, 4.9 Hz, 6-H), 3.11 (1H, m, 5-H), 
2.55 (1H, m, 3-Heq), 2.40‒2.30 (2H, m, 9-H), 2.26‒2.15 (3H, m, 3-Hax, 4-H), 2.11‒2.05 (2H, 
m, 8-H), 1.80 (1H, m, 7-Heq), 1.70 (1H, m, 7-Hax), 1.58 (6H, m, 12,13-H); 13C NMR (150 
MHz, CDCl3) δ ppm 212.3 (C-9), 210.3 (C-2), 135.0 (C-11), 118.6 (C-10), 73.7 (C-6), 65.2 
(C-1), 52.8 (C-5), 40.6 (C-3), 34.2 (C-8), 30.6 (C-9), 27.2 (C-7), 26.1 (C-12), 18.8 (C-4), 14.6 
(C-13). HRMS (ESI-TOF) [M+H]+ C14H21O3 calcd. 237.1485, found 237.1481. 
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6-Hydroxy-7-methyl-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,9-dione (3.33) 
O O
OH
12
3 4 5
67
8
9
9
10
11
12
13
O O
OH
12
3 4 5
6
7
8
9
9
10
11
12
13
+
exo-3.33 endo-3.33  
To a solution of 2-(3-methylbut-2-en-1-yl)cyclohexane-1,3-dione 3.31 (0.100 g, 0.55 mmol, 
1 eq) in dry acetonitrile (6 mL) were added methacrolein (68 μL, 0.82 mmol, 1.5 eq) and 
DABCO (0.062 g, 0.55 mmol, 1 eq) at 25 °C. The solution was heated at 95 °C for 16 h. 
After allowing to cool, water (10 mL) was added and the mixture extracted with 
dichloromethane (4x10 mL). The combined organic layers were dried over Na2SO4, filtered 
and evaporated to give ketol 3.33 (0.118 g, 86%) as a 70:30 mixture of exo-3.33:endo-3.33, 
IR (film): 3416, 2918, 1700, 1456 cm-1; exo-3.33, Rf 0.53 (dichloromethane:ethyl acetate, 
60:40)  1H NMR (600 MHz, CDCl3) δ ppm 5.05 (1H, m, 10-H), 3.98 (1H, m, 6-H), 2.92 (1H, 
m, 5-H), 2.62‒2.51 (1H, m, 3-Heq), 2.39‒2.27 (3H, m, 9-H, 3-Hax) 2.24‒2.13 (m, 2H, 4-H), 
1.98 (1H, m, 7-H), 1.97‒1.74 (2H, m, 8-H), 1.61 (3H, s, 1-C-cis-CH3), 1.58 (3H, s, 1-C-trans-
CH3), 0.97 (3H, d, J = 7.0 Hz, 7-CH-CH3); 13C NMR (150 MHz, CDCl3) δ ppm 212.4 (C-9), 
210.3 (C-2), 134.8 (C-11), 118.6 (C-10), 80.6 (C-6), 65.8 (C-1), 52.2 (C-5), 43.3 (C-8), 40.5 
(C-3), 31.0 (C-9), 29.4 (C-7), 26.0 (1-C-cis-CH3), 18.5 (C-4), 17.9 (1-C-trans-CH3), 16.6 (7-
CH-CH3); endo-3.33, Rf 0.50 (dichloromethane:ethyl acetate, 60:40)   1H NMR (600 MHz, 
CDCl3) δ ppm 5.05 (1H, m, 10-H), 3.55 (1H, dd, J = 7.0, 4.8 Hz, 6-H), 3.07 (1H, ddd, J = 6.5, 
3.2, 1.4 Hz, 5-H), 2.62–2.51 (2H, m, 3-H), 2.39–2.27 (2H, m, 9-H), 2.13–2.06 (2H, m, 4-H), 
1.98 (1H, m, 7-H), 1.87‒1.74 (2H, m, 8-H), 1.65 (3H, s, 1-C-cis-CH3), 1.60 (3H, s, 1-C-trans-
CH3), 1.00 (3H, d, J = 7.0 Hz, 7-CH-CH3); 13C NMR (150 MHz, CDCl3) δ ppm 212.7 (C-9), 
212.5 (C-2), 135.0 (C-11), 118.5 (C-10), 78.8 (C-6), 66.1 (C-1), 52.2 (C-5), 43.0 (C-8), 40.3 
(C-3), 32.1 (C-7), 30.6 (C-9), 26.0 (1-C-cis-CH3), 17.6 (1-C-trans-CH3), 16.6 (7-CH-CH3), 
15.1 (C-4); HRMS (ESI-TOF) [M+H]+ C15H23O3 calcd. 251.1642, found 251.1639. 
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6-Hydroxy-8-methyl-1-(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,9-dione (3.34) 
 
To a solution of 2-(3-methylbut-2-en-1-yl)cyclohexane-1,3-dione 3.31 (0.100 g, 0.55 mmol, 
1 eq) in dry acetonitrile (6 mL) were added crotonaldehyde (68 μL, 0.82 mmol, 1.5 eq) and 
DABCO (0.062 g, 0.55 mmol, 1 eq) at 25 °C. The solution was heated at 95 °C for 60 h. 
After allowing to cool, water (10 mL) was added, and the mixture extracted with 
dichloromethane (4x10 mL). The combined organic layers were dried over MgSO4, filtered 
and evaporated. Column chromatography (dichloromethane:ethyl acetate, 80:20) of the 
residue gave ketol 3.34 (0.061 g, 44%) as 60:40 mixture of exo-3.34: endo-3.34, IR (film): 
3432, 2971, 2992, 1728, 1697 cm-1. Repeated column chromatography of a small fraction 
enabled the exo-isomer to be isolated, and hence NMR data for the endo-isomer to be 
deduced: exo-3.34, Rf 0.53 (silica gel, EtOAc/CH2Cl2, 4 : 6, v/v); 1H NMR (400 MHz, CDCl3) 
δ 5.06 ppm (1H, tsept., J = 7.1, 1.4 Hz, 10-H), 4.27 (1H, dt, J = 3.0, 2.5 Hz, 6-H), 2.87 (1H, 
dm, J = 8.7 Hz, 5-H), 2.60‒2.33 (5H, m, 9-H, 3-H), 2.15‒2.03 (2H, m, 4-H), 1.89‒1.74 (2H, 
m, 7-H), 1.64 (6H, s, 1-C-cis-CH3 and 1-C-trans-CH3), 0.99 (3H, d, J = 6.8 Hz, 8-CH-CH3); 
13C NMR (100 MHz, CDCl3) δ ppm 210.6 (C-9), 209.5 (C-2), 134.2 (C-11), 119.4 (C-10) 75.5 
(C-6), 71.7 (C-1), 52.6 (C-5), 39.6 (C-3), 38.3 (C-8), 36.3 (C-7), 27.1 (C-9), 26.1 (1-C-cis-
CH3), 19.7 (C-4), 18.0 (1-C-trans-CH3), 15.8 (8-CH-CH3); endo-3.34, Rf 0.51 
(dichloromethane:ethyl acetate, 60:40); 1H NMR (400 MHz, CDCl3) δ ppm 4.98 (1H, m, 10-
H), 4.10 (1H, dt, J = 11.1, 5.4 Hz, 6-H), 2.99 (1H, app. t, J = 6.0 Hz, 5-H), 2.58‒2.43 (5H, m, 
9-H, 8-H, 3-H), 2.15‒2.03 (2H, m, 4-H) 1.83‒1.71 (2H, m, 7-H), 1.64 (6H, s, 1-C-cis-CH3 and 
1-C-trans-CH3), 0.96 (3H, d, J = 6.8 Hz, 8-CH-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 
212.6 (C-9), 211.6 (C-2), 135.0 (C-11), 118.5 (C-10), 71.3 (C-6), 70.2 (C-1), 52.4 (C-5), 40.2 
(C-3), 37.5 (C-8), 37.4 (C-7), 29.8 (C-9), 26.0 (1-C-cis-CH3), 18.0 (C-4), 17.8 (1-C-trans-
CH3), 15.7 (8-CH-CH3). Traces of a third diastereoisomer were detected by 13C NMR 
spectroscopy. HRMS (ESI-TOF) [M+H]+ C15H23O3 calcd. 251.1642, found 251.1640. 
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2-Phenylcyclohexane-1,3-dione (3.37) 
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Ph
3.37
2
6
1
5
4
3
 
Literature procedure was followed.118 PhI (0.70 g, 3.47 mmol, 1 eq) was added to a solution 
of CuI (0.033 g, 0.17 mmol), L-proline (0.040 g, 0.34 mmol) K2CO3 (1.91 g, 13.81 mmol, 4 
eq) and 1,3-cyclohexanedione (1.16 g, 10.3 mmol, 3 eq) in dry DMSO (6 mL). The reaction 
was stirred at 90 °C for 24 h after which time the cooled solution was slowly transferred in a 
flask containing aqueous HCl (45 mL). The aqueous phase was extracted with ethyl acetate 
(3x50 mL) and the combined organics washed twice with brine, dried over MgSO4, filtered 
and evaporated under reduced pressure to give crude 2-phenylcyclohexane-1,3-dione 3.37 
(1.30 g, 65%) as redish oil, which was used in the subsequent step without any further 
purification, IR (film) 2952, 1583, 1404, 1345, 1232, 1184, 838, 760 cm-1; 1H NMR (600 MHz, 
CDCl3) δ ppm 7.71−7.68 (2H, m, aryl), 7.44−7.27 (1H, m, aryl), 7.24−7.07 (1H, m, aryl), 5.48 
(1H, s, 2-H), 2.63−2.56 (2H, m, 6-H), 2.38 (2H, m, 4-H), 2.03−1.95 (2H, m, 5-H); 13C NMR 
(151 MHz, CDCl3) δ ppm 199.6 (C-1,3), 134.2 (aryl), 130.3 (aryl), 128.8 (aryl), 118.0 (aryl), 
36.9 (C-2), 28.6 (C-4,6), 21.5 (C-5); HRMS (ESI-TOF) [M+H]+ C12H13O2 calcd. 189.0910, 
found 189.0910. 
 
2-Benzoylcyclohexane-1,3-dione (3.40) 
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A literature procedure was adapted.120 To a stirring solution of 1,3-cyclohexanedione (2.30 
g, 20 mmol, 1 eq) in dry CH3CN (20 mL) was added K2CO3 (1.50 g, 10.8 mmol, 0.5 eq) and 
the resulting orange suspension was stirred at 35 °C for 3 h. After this time benzoyl chloride 
(1.50 g, 1.2 mL, 0.5 eq) was added dropwise and a color change from orange to light yellow 
was observed. After 30 minutes of stirring at the same temperature more K2CO3 (2.00 g) 
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and 1,2,4-triazole (0.035 g, 0.025 mmol) were added. The resulting pink suspension was 
stirred for 5 h at the same temperature and overnight at 25 °C. The solvent was then 
removed under reduced pressure and the residue partitioned between water and CHCl3. 
The aqueous phase was extracted with CHCl3 (2x50 mL), the combined organic layers were 
dried over Na2SO4, filtered and evaporated under reduced pressure. The crude product was 
purified by flash column chromatography (petroleum ether:ethyl acetate, 80:20) to give 2-
benzoylcyclohexane-1,3-dione 3.40 (0.560 g, 11%) as red oil, IR (film) 3067, 2954, 1741, 
1676, 1644, 1601, 1452, 1369, 1247, 1238, 1123, 1060, 1021, 879, 707, 581 cm-1; 1H NMR 
(600 MHz, CDCl3) δ ppm 8.10−8.06 (2H, m, aryl), 7.64 (1H, ddt, J = 8.8, 7.3, 1.3 Hz, aryl), 
7.53−7.47 (2H, m, aryl), 6.04 (1H, s, 2-H), 2.68 (2H, td, J = 6.2, 1.3 Hz, 6-H), 2.46 (2H, dd, 
J = 7.4, 6.0 Hz, 4-H), 2.13 (2H, dq, J = 7.6, 6.3 Hz, 5-H); 13C NMR (151 MHz, CDCl3) δ ppm 
199.5 (C-1, C-3), 199.1 (C-7), 134.1 (aryl), 130.2 (aryl), 128.7 (aryl), 118 (C-2), 36.8 (C-6), 
28.4 (C-4), 21.3 (C-5); HRMS (ESI-TOF) [M+H]+  C13H13O3 calcd. 217.0859, found 217.0855. 
 
2-Isobutyrylcyclohexane-1,3-dione (3.43) 
 
A literature procedure was adapted.121 Cyclohexane-1,3-dione 3.30 (1.00 g, 8.65 mmol, 1 
eq), 2-methyl propionyl chloride (1.03 mL, 11.6 mmol, 1.3 eq) and DMAP (0.180 g, 1.60 
mmol, 18 mol %) were stirred in anhydrous toluene (30 mL) for 30 min at 25 °C and refluxed 
for 1 h. The cooled reaction mixture was then washed 3 times with water and once with 
brine, dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was 
taken up in anhydrous toluene (50 mL), combined with DMAP (0.150 g, 1.12 mmol) and 
refluxed for 3 h. The cooled reaction mixture was washed three times with water and once 
with brine, dried over Na2SO4, filtered and evaporated under reduced pressure. The crude 
residue was purified by flash column chromatography (petroleum ether:ethyl acetate, 60:40) 
to afford pure 2-isobutyrylcyclohexane-1,3-dione 3.43 as an orange oil (0.420 g, 28%), IR 
(film) 2979, 1760, 1676, 1470, 1366, 1343, 1327, 1275, 1260, 1120, 1083, 967, 922, 881, 
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764, 750 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 5.84 (1H, t, J = 1.3 Hz, 2-H), 2.71−2.60 
(1H, m, 8-H), 2.49 (2H, t, J = 6.2 Hz, 4-H), 2.36 (2H, dd, J = 7.4, 6.0 Hz, 6-H), 2.06−1.97 
(2H, m, 5-H), 1.23 (3H, s, CH3), 1.21 (3H, s, CH3) 13C NMR (101 MHz, CDCl3) δ ppm 199.4 
(C-3), 173.7 (C-7) 170.1 (C-1), 117.5 (C-2), 36.8 (C-6), 34.3 (C-8), 28.3 (C-4), 21.3 (C-5), 
18.7 (C-9,10). 
1,3-Dioxospiro[5.5]undec-8-ene-8-carbaldehyde (3.45) 
 
To a solution of 2-isobutyrylcyclohexane-1,3-dione 3.43 (0.100 g, 0.54 mmol, 1 eq) in dry 
DMF (4 mL) was added acrolein (54 μL, 0.81 mmol, 1.5 eq) at 25 °C. The resulting orange 
solution was stirred at 130 °C for 16 h. After this time, the reaction was allowed to cool and 
quenched with H2O (6 mL). The aqueous phase was extracted three times with 
dichloromethane (3x15 mL), the combined organic layers were washed with H2O, dried over 
Na2SO4, filtered and evaporated. Column chromatography (hexane:ethyl acetate, 80:20 → 
70:30 → 50:50) afforded 1,3-dioxospiro[5.5]undec-8-ene-8-carbaldehyde 3.45 (0.092 g, 
80%) as yellow oil, IR (film) 2957, 1726, 1694, 1426, 1382, 1277, 1221, 1174, 1182, 1021, 
911, 732 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 9.43 (1H, s, 12-H), 6.71 (1H, tt, J = 3.8, 
1.7 Hz, 9-H), 2.80–2.65 (4H, m, 4-H, 6-H), 2.62 (2H, m, 11-H), 2.47‒2.40 (2H, m, 10-H), 
2.05 (2H, t, J = 6.3 Hz, 7-H), 2.02–1.83 (2H, m, 5-H); 13C NMR (101 MHz, CDCl3) δ ppm 
207.71 (C-1,3), 193.11 (C-12), 148.02 (C-8), 138.94 (C-9), 64.76 (C-1), 37.12 (C-4,6)), 28.28 
(C-7), 24.69 (C-10), 24.14 (C-11), 18.26 (C-5); HRMS (ESI-TOF) [M+H]+ C12H14O3 calcd. 
207.1016, found 207.1020. 
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3-Hydroxy-2,5,5-trimethylcyclohex-2-en-1-one (3.48) 
 
A literature procedure was adapted.145 To a cooled solution of aqueous NaOH (3 M, 12.5 
mL) dimedone (3.46, 5.00 g, 35.6 mmol, 1 eq) was added in one portion. Iodomethane (4.5 
mL, 72.3 mmol, 2 eq) was then added dropwise and the mixture heated at 100 °C for 25 h. 
The reaction mixture was allowed to cool at 25 °C and water and ethyl acetate were added. 
The aqueous phase was extracted with ethyl acetate (3x25 mL), the combined organic 
layers dried over Na2SO4, filtered and evaporated under reduced pressure. The crude 
product was purified by flash column chromatography (petroleum ether:ethyl acetate, 80:20) 
to afford 3-hydroxy-2,5,5-trimethylcyclohex-2-en-1-one 3.48 (2.00 g, 36%) as white solid, 1H 
NMR (400 MHz, MeOD) δ ppm 2.28 (4H, s, 2xCH2), 1.65 (3H, s, -CH3), 1.01 (6H, br s, 
2xCH3). 13C NMR (101 MHz, MeOD) δ ppm 208.9 (CO), 110.6 (C(OH)=C(CH3)), 47.5 (-
C(CH3)2), 32.8 (2 x CH2), 28.5 (-C(CH3)2), 6.9 (=C(CH3)). 
 
3-(1,4,4-Trimethyl-2,6-dioxocyclohexyl)propanal (3.49) 
 
A literature procedure was adapted.146To a solution of 3-hydroxy-2,5,5-trimethylcyclohex-2-
en-1-one 3.48 (0.080 g, 0.64 mmol, 1 eq) in dry CH3CN (4 mL) was added acrolein (0.96 
mmol, 64 µL, 1.5 eq) and DABCO (0.014 g, 0.12 mmol) at 25 °C and the reaction was heated 
at reflux for 4 h. The reaction mixture was allowed to cool at 25 °C and water and 
dichloromethane were added. The aqueous phase was extracted with dichloromethane 
(3x15 mL), the combined organic layers dried over Na2SO4, filtered and evaporated under 
reduced pressure to afford pure 3-(1,4,4-trimethyl-2,6-dioxocyclohexyl)propanal 3.49 (0.130 
g, 97%) as a yellow oil, which was used in the subsequent step without any further 
purification, 1H NMR (400 MHz, CDCl3) δ ppm 9.71 (1H, t, J = 1.1 Hz, CHO), 2.61 (4H, s, 
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2xCO-CH2), 2.38 (2H, ddd, J = 7.9, 6.8, 1.1 Hz, CH2-CHO), 2.07 (2H, dd, J = 8.3, 6.8 Hz, 
CH2-CH2-CHO), 1.28 (3H, s, C-CH3), 0.99 (3H, s, C-(CH3)2), 0.98 (3H, s, C-(CH3)2). 13C NMR 
(101 MHz, CDCl3) δ ppm 209.7 (CO), 200.8 (CHO), 63.5 (C-CH3), 51.3 (-C(CH3)2), 39.3 (2 
x CO-CH2), 30.8 (CH2-CHO), 28.8 (CH2-CH2-CHO), 28.4 (-C(CH3)2), 27.3 (-C(CH3)2), 21.0 
(C-CH3). 
 
6-exo-Hydroxy-1,4,4-trimethylbicyclo[3.3.1]nonane-2,9-dione (3.50) 
 
To a stirred solution of 2,5,5-trimethyl-1,3-cyclohexanedione 3.48 (1.00 g, 6.5 mmol, 1 eq) 
in dry acetonitrile (25 mL) were added acrolein (650 μL, 9.72 mmol, 1.5 eq) and DABCO 
(0.145 g, 1.3 mmol, 20 mol %) at 25 °C. The mixture was heated at 95 °C for 4 h. After 
allowing to cool, crude aldehyde 3-(1,4,4-trimethyl-2,6-dioxocyclohexyl)propanal 3.49 was 
dissolved in dry DMF (20 mL) and the reaction heated at 135 °C for 24 h. After allowing to 
cool, the solvent was evaporated and the residue washed with chloroform (2x5 mL) to give 
ketol 3.50 (0.90 g, 66% over 2 steps) as a single diastereoisomer, Rf 0.42 
(dichloromethane:ethyl acetate, 60:40)  IR (film): 3455, 2958, 1728, 1694 cm-1; 1H NMR (400 
MHz, CDCl3) δ ppm 4.65 (1H, m, 6-H), 2.72 (1H, d, J = 18.0 Hz, 3-Heq), 2.49 (1H, m, 5-H), 
2.45 (1H, m, 3-Hax), 2.26‒2.09 (2H, m, 7-Heq, 8-Heq), 2.00‒1.82 (2H, m, 7-Hax, 8-Hax), 
1.22 (3H, s, 4-C(CH3)CH3), 1.17 (3H, s, 1-CCH3), 0.91 (3H, s, 4-C(CH3)CH3); 13C NMR (100 
MHz, CDCl3) δ ppm 210.5 (C-9) 209.2 (C-2), 73.4 (C-6), 65.3 (C-5), 64.3 (C-1), 52.6 (C-3), 
37.5 (C-8), 31.6 (C-4), 31.1 (4-CCH3eq), 28.1 (C-7), 27.4 (4-CCH3ax), 16.2 (1-CCH3). HRMS 
(ESI-TOF) [M+H]+ C12H19O3 calcd. 211.1329, found 211.1338. 
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2,4,4-Trimethylcyclohexane-1,3-dione (3.51) 
 
 
To a solution of 4,4-dimethyl-1,3-cyclohexanedione 3.47 (5.00 g, 35.6 mmol, 1 eq) in 
aqueous sodium hydroxide (3 M, 12.5 mL) at 0 °C was added iodomethane (4.43 mL, 71.3 
mmol, 1 eq), dropwise over 30 min. The ice-bath was then removed and the mixture heated 
at 100 °C for 24 h. After cooling, the mixture was extracted with dichloromethane (3x30 mL), 
and the combined organic layers washed with water (2x20 mL) dried over MgSO4, filtered 
and evaporated. Flash column chromatography (ethyl acetate;petroleum ether, 30:70) of the 
residue gave 2,4,4-trimethylcyclohexane-1,3-dione 3.51 (2.84 g, 52%) as a white solid, 
stable for several weeks when stored at –20 °C; m.p. 163‒165 °C, IR (film): 3005, 2988, 
1711, 1458 cm-1; 1H NMR (400 MHz, CD3OD) δ ppm 2.48 (2H, td, J = 6.5, 1.3 Hz, 6-H), 1.79 
(2H, t, J = 6.5 Hz, 5-H), 1.63 (3H, t, J = 1.3 Hz, 2-C-CH3), 1.08 (6H, s, 4-C-(CH3)2); 13C NMR 
(100 MHz, CD3OD) δ ppm 110.0 (C-1,2,3), 40.1 (C-4), 35.8 (C-5), 28.0 (C-6), 25.4 (4-C-
(CH3)2), 7.7 (2-C-CH3); HRMS (ESI-TOF) [M+H]+ C9H15O2 calcd. 155.1067, found 155.1065. 
 
 
6-Hydroxy-1,3,3-trimethylbicyclo[3.3.1]nonane-2,9-dione (3.52) 
 
To a solution of 2,4,4-trimethylcyclohexane-1,3-dione 3.51 (0.200 g, 1.28 mmol, 1 eq) in dry 
acetonitrile (12 mL) were added acrolein (128 μL, 1.98 mmol, 1.5 eq) and DABCO (0.143 g, 
1.28 mmol, 1 eq) at 25 °C. The solution was heated at 95 °C for 16 h. After allowing to cool, 
water (20 mL) was added. The mixture was extracted with dichloromethane (3x20 mL) and 
the combined organic layers washed three times with water, dried over Na2SO4, filtered and 
evaporated to give ketol 3.52 (0.264 g, 98%), as a 65:35 mixture of exo-3.52:endo-3.52, IR 
(film): 3417, 2936, 1729, 1697, 1469 cm-1. Column chromatography (ethyl acetate: 
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dichloromethane, 40:60) afforded exo-3.52: Rf 0.57 (dichloromethane:ethyl acetate, 60:40).  
1H NMR (400 MHz, CDCl3) δ ppm 4.26 (1H, dq, J = 4.5, 2.4 Hz, 6-H), 2.95 (1H, m, 5-H), 
2.20 (1H, m, 8-Heq), 2.12‒2.00 (2H, m, 4-Heq, 8-Hax), 1.70‒1.65 (2H, m, 7-H), 1.48 (1H, 
dm, J = 14.4 Hz, 4-Hax), 1.19 (3H, s, 1-C-CH3), 1.15 (3H, s, 1x3-C(CH3)2), 0.97 (3H, s, 1x3-
C(CH3)2; 13C NMR (100 MHz, CDCl3) δ ppm 216.2 (C-2), 213.7 (C-9), 78.1 (C-6), 60.4 (C-
1), 51.9 (C-5), 45.8 (C-3), 39.4 (C-8), 35.5 (C-4), 26.1 (3-CCH3eq), 25.6 (C-7), 24.6 (3-
CCH3ax), 18.7 (1-CCH3) and endo-3.52, Rf 0.55 (dichloromethane:ethyl acetate, 60:40), 1H 
NMR (400 MHz, CDCl3) δ ppm 4.02 (1H, dt, J = 11.0, 4.5 Hz, 6-H), 3.15 (1H, m, 5-H), 2.17 
(1H, m, 8-Heq), 2.05 (1H, dd, J = 14.7, 2.0 Hz, 4-Heq), 1.80–1.70 (2H, m, 4-Hax, 7-Heq), 
1.41–1.26 (2H, m, 7-Hax, 8-Hax), 1.22 (3H, 1-C-CH3), 1.20 (3H, 3-C(CH3)2),  0.97 (3H, s, 3-
C(CH3)2); 13C NMR (100 MHz, CDCl3) δ ppm 216.1 (C-2), 211.9 (C-9), 74.3 (C-6), 58.9 (C-
1), 52.5 (C-5), 45.7 (C-3), 37.0 (C-8), 30.9 (C-4), 27.1 (C-7), 26.0 (3-CCH3eq), 24.1 (3-
CCH3ax), 18.3 (1-CCH3). HRMS (ESI-TOF) [M+H]+ C12H19O3 calcd. 211.1329, found 
211.1333. 
 
2-Hydroxy-5-methylbicyclo[3.2.1]octane-6,8-dione (3.55) 
 
To a solution of 2-methyl-1,3-cyclopentanedione 3.54 (0.100 g, 0.89 mmol, 1 eq) in dry DMF 
(4 mL) was added acrolein (90 μL, 1.3 mmol, 1 eq) at 25 °C. The solution was heated at 
reflux at 130 °C for 16 h. After allowing to cool, water (15 mL) was added and the mixture 
was extracted with dichloromethane (4x15 mL). The combined organic layers were washed 
with water (3x15 mL), dried over Na2SO4, filtered and evaporated to give ketol 3.55 (0.090 
g, 60%) as an 80:20 mixture of exo-3.55:endo-3.55, Rf 0.4 (dichloromethane:ethyl acetate, 
60:40)  IR (film): 3450, 2933, 1765, 1723, 1453 cm-1; exo-3.55: 1H NMR (400 MHz, CDCl3) 
δ ppm 4.57 (1H, m, 2-H), 3.03 (1H, app. t, J = 5.4 Hz, 1-H), 2.70–2.52 (2H, m, 7-H), 2.25 
(1H, m, 4-Heq), 1.95–1.87 (2H, m, 3-H), 1.81–1.77 (1H, m, 4-Hax), 1.07 (3H, s, 5-CCH3); 
13C NMR (100 MHz, CDCl3) δ ppm 214.5 (C-8), 211.1 (C-6), 77.5 (C-2), 59.3 (C-5), 52.7 (C-
1), 42.1 (C-7), 40.1 (C-4), 26.6 (C-3), 12.2 (5-CCH3); endo-3.55: 1H NMR (400 MHz, CDCl3) 
δ ppm 4.25 (1H, m, 2-H), 3.08 (1H, dd, J = 7.5, 3.3 Hz, 1-H), 2.50-2.43 (2H, m, 7-H), 2.25 
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(1H, m, 4-Heq), 1.95–1.75 (3H, m, 3-H, 4-Hax), 1.06 (3H, s, 5-CCH3); 13C NMR (100 MHz, 
CDCl3) δ ppm 213.5 (C-8), 211.6 (C-6), 73.6 (C-2), 58.3 (C-5), 54.4 (C-1), 38.7 (C-7), 35.9 
(C-4), 27.1 (C-3), 11.6 (5-CCH3). HRMS (ESI-TOF) [M+H]+ C9H13O3 calcd. 169.0859, found 
169.0861. 
 
 2-Hydroxy-3,5-dimethylbicyclo[3.2.1]octane-6,8-dione (3.57)  
 
To a solution of 2-methyl-1,3-cyclopentanedione 3.54 (0.100 g, 0.9 mmol, 1 eq) in dry 
acetonitrile (6 mL) were added methacrolein (73 μL, 1.3 mmol, 1.5 eq) and DABCO (0.020 
g, 0.18 mmol, 20 mol %) at 25 °C. The solution was heated at reflux at 130 °C for 16 h. After 
allowing to cool, water (15 mL) was added and the mixture extracted with dichloromethane 
(4x15 mL). The combined organic layers were washed with water (3x15 mL), dried over 
Na2SO4, filtered and evaporated to give ketol 3.57 (0.080 g, 50%) as a 70:30 mixture of 
endo-3.57: exo-3.57, Rf 0.53 (dichloromethane:ethyl acetate, 60:40)  IR (film): 3499, 2933, 
1767, 1724, 1455 cm-1; endo-3.57: 1H NMR (400 MHz, CDCl3) δ ppm 3.69 (1H, dd, J = 9.6, 
3.2 Hz, 2-H), 3.03 (1H, dd, J = 7.5, 3.3 Hz, 1-H), 2.96 (1H, d, J = 19.4 Hz, 7-Hax), 2.48 (1H, 
dd, J = 19.4, 7.5 Hz, 7-Heq), 1.92‒1.67 (3H, m, 3-H, 4-H), 1.02 (3H, s, 5-CCH3), 1.01 (3H, 
d, J = 6.6 Hz, 3-CHCH3); 13C NMR (100 MHz, CDCl3) δ ppm 213.4 (C-8), 211.6 (C-6), 78.9 
(C-2), 59.4 (C-5), 53.7 (C-1), 44.5 (C-7), 39.1 (C-4), 32.9 (C-3), 17.3 (3-CH-CH3), 11.6 (5-
CCH3) (400 MHz, CDCl3); exo-3.57: 1H NMR (400 MHz, CDCl3) δ ppm 4.25 (1H, ddd, J = 
5.1, 3.4, 2.3 Hz, 2-H), 3.01 (1H, m, 1-H), 2.60‒2.58 (2H, m, 7-H), 2.08 (1H, m, 3-Heq), 1.92‒
1.67 (2H, m, 3-Hax, 4-Hax), 1.03 (3H, s, 5-CCH3), 0.97 (3H, d, J = 6.7 Hz, 3-CH-CH3); 13C 
NMR (100 MHz, CDCl3) δ ppm 215.1 (C-8), 211.4 (C-6), 79.6 (C-2), 58.8 (C-5), 52.5 (C-1), 
46.7 (C-7), 41.8 (C-4), 30.2 (C-3), 15.4 (3-CH-CH3), 12.0 (5-C-CH3). HRMS (ESI-TOF) 
[M+H]+ C10H15O3 calcd. 183.1016, found 183.1014.   
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2-Hydroxy-5-methyl-4-phenylbicyclo[3.2.1]octane-6,8-dione (3.58) 
 
To a solution of 2-methyl-1,3-cyclopentanedione 3.54 (0.100 g, 0.9 mmol, 1 eq) in dry 
acetonitrile (6 mL) were added cinnamaldehyde (168 μL, 1.3 mmol, 1.5 eq) and DABCO 
(0.101 g, 0.9 mmol, 1 eq) at 25 °C. The solution was heated at 95 °C for 16 h. After allowing 
to cool, water (15 mL) was added and the mixture extracted with dichloromethane (4x15 
mL). The combined organic layers were washed with water (3x15 mL), dried over MgSO4, 
filtered and evaporated. Column chromatography (dichloromethane:ethyl acetate, 80:20) 
gave ketol 16 (0.020 g, 10%) as a 60:40 mixture of mixture of endo-3.58:exo-3.58; Rf 0.3 
(silica gel, EtOAc/CH2Cl2, 2 : 8, v/v)  IR (film): 3488, 2988, 1763, 1721, 1455, 1046 cm-1; 
endo-3.58: 1H NMR (400 MHz, CDCl3) δ ppm 7.34‒7.26 (3H, m, m- and p-aryl), 7.03 (2H, 
dd, J = 7.8, 2.4 Hz, o-aryl), 4.38 (1H, ddd, J = 10.4, 5.9, 3.5 Hz, 2-H), 3.19 (1H, dd, J = 7.5, 
3.5 Hz, 1-H), 3.16 (1H, d, J = 19.0 Hz, 7-Hax), 2.65 (1H, dd, J = 14.0, 4.8 Hz, 4-H), 2.60 (1H, 
dd, J = 19.0, 7.5 Hz, 7-Heq), 2.29‒2.23 (1H, m, 3-Heq), 2.05 (1H, m, 3-Hax), 0.77 (3H, s, 5-
C-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 212.5 (C-6), 210.3 (C-8), 137.6 (ipso-aryl), 128.7 
(aryl), 128.6 (aryl), 128.1 (aryl), 71.7 (C-2), 61.7 (C-5), 54.3 (C-1), 50.6 (C-4), 38.8 (C-7), 
35.3 (C-3), 10.7 (5-CCH3); exo-3.58: 1H NMR (400 MHz, CDCl3) δ ppm 7.34‒7.26 (3H, m, 
m- and p-aryl), 7.07 (2H, dd, J = 7.8, 2.4 Hz, o-aryl), 4.63 (1H, ddd, J = 5.2, 3.5, 1.7 Hz, 2-
H), 3.41 (1H, dd, J = 13.7, 4.8 Hz, 4-H), 3.13 (1H, dd, J = 8.0, 4.5 Hz, 1-H), 2.68‒2.56 (2H, 
m, 7-H), 2.26 (1H, m, 3-Heq), 2.04 (1H, m, 3-Hax), 0.79 (3H, s, 5-C-CH3); 13C NMR (100 
MHz, CDCl3) δ ppm 213.1 (C-8), 212.5 (C-6), 138.0 (ipso-aryl), 128.7 (aryl), 128.6 (aryl), 
128.1 (aryl), 75.1 (C-2), 62.7 (C-5), 54.1 (C-1), 52.6 (C-4), 42.0 (C-7), 34.8 (C-3), 11.0 (5-C-
CH3); HRMS (ESI-TOF) [M+H]+ C15H17O3 calcd. 245.1172, found 245.1172.  
 
2-Hydroxy-4,5-dimethylbicyclo[3.2.1]octane-6,8-dione (3.59) 
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To a solution of 2-methyl-1,3-cyclopentanedione 3.54 (0.100 g, 0.9 mmol, 1 eq) in dry 
acetonitrile (6 mL) were added crotonaldehyde (73 μL, 1.3 mmol, 1.5 eq) and DABCO (0.101 
g, 0.9 mmol, 1 eq) at 25 °C. The resulting solution was heated at 95 °C for 16 h. After 
allowing to cool, water (15 mL) was added and the mixture extracted with dichloromethane 
(4x15 mL). The combined organic layers were washed with water (3x15 mL), dried over 
MgSO4, filtered and evaporated to give ketol 3.59 (0.109 g, 61%) as a 37:50 mixture of 
mixture of endo-3.59: exo-3.59, Rf 0.46 (dichloromethane:ethyl acetate, 60:40), IR (film): 
3441, 2936, 1763, 1719, 1455, 1041 cm-1; endo-3.59: 1H NMR (400 MHz, CDCl3) δ ppm 
4.20 (1H, ddd, J = 11.1, 5.9, 3.4 Hz, 2-H), 3.04 (1H, dd, J = 7.0, 3.4 Hz, 1-H), 2.88 (1H, d, J 
= 19.5 Hz, 7-Hax), 2.56 (1H, dd, J = 19.5, 7.0 Hz, 7-Heq), 2.05 (1H, dt, J = 14.4, 5.5 Hz, 3-
Heq), 1.65 (1H, m, 4-H), 1.27 (1H, m, 3-Hax), 0.98 (3H, d, J = 5.0 Hz, 4-CH-CH3), 0.88 (3H, 
s, 5-C-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 210.4 (C-8), 209.9 (C-6), 71.8 (C-2), 61.3 
(C-5), 53.8 (C-1), 39.7 (C-4), 38.6 (C-7), 36.3 (C-3), 15.0 (4-CH-CH3), 9.79 (5-C-CH3); exo-
3.59: 1H NMR (400 MHz, CDCl3) δ ppm 4.48 (1H, ddd, J = 5.1, 4.1, 1.6 Hz, 2-H), 2.98 (1H, 
m, 1-H), 2.55‒2.45 (2H, m, 7-H), 2.36 (1H, m, 4-H), 1.82 (1H, ddt, J = 15.8, 5.6, 1.3 Hz, 3-
Heq), 1.55 (1H, ddd, J = 15.8, 13.1, 3.9 Hz, 3-Hax), 0.99 (3H, d, J = 5.0 Hz, 4-CH-CH3), 0.90 
(3H, s, 5-C-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 215.5 (C-8), 214.3 (C-6), 75.8 (C-2), 
62.4 (C-5), 52.1 (C-1), 44.0 (C-4), 42.0 (C-7), 35.6 (C-3), 15.1 (4-CH-CH3), 10.0 (5-C-CH3). 
The 1H NMR spectrum showed the presence of third diastereoisomer (13%).  HRMS (ESI-
TOF) [M+H]+ C10H15O3 calcd. 183.1016, found 183.1012.  
 
5-exo-Methyl-6,9-dioxobicyclo[3.3.1]nonan-2-yl 3,5-dinitrobenzoate (3.60) 
 
To a solution of 6-exo-hydroxy-1-methylbicyclo[3.3.1]nonane-2,9-dione exo-3.2 (0.170 g, 
0.93 mmol, 1 eq) in dry dichloromethane were added triethylamine (400 μL, 2.79 mmol, 3 
eq) and 3,5-dinitrobenzoyl chloride (0.235 g, 1.02 mmol, 1.1 eq) at 25 °C. The mixture was 
then stirred at 25 °C for 16 h. Water (20 mL) was then added, and the mixture extracted with 
dichloromethane (4x20 mL). The combined organic layers were washed with water (3x10 
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mL), dried over MgSO4, filtered and evaporated. Flash column chromatography 
(dichloromethane:ethyl acetate, 80:20) of the residue gave 3.60 (0.030 g, 8%) which was 
recrystallized by slow diffusion of hexane into a nearly sat. solution in dichloromethane, Rf 
0.3 (ethyl acetate:petroleum ether, 30:70), IR (film): 2936, 1731, 1704, 1629, 1545, 1050 
cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 9.24 (1H, t, J = 2.1 Hz, 14-aryl), 9.05 (2H, d, J = 2.1 
Hz, 12,16-aryl), 5.62 (1H, m, 2-H), 3.21 (1H, m, 1-H), 2.69 (1H, ddd, J = 16.5, 7.5, 4.5 Hz, 
7-Heq), 2.47 (1H, dt, J = 16.5, 9.5 Hz, 7-Hax), 2.39‒2.27 (2H, m, 3-Heq, 8-Heq), 2.15-2.02 
(3H, m, 3-Hax, 4-H), 1.86 (1H, m, 8-Hax), 1.26 (3H, s, -5-C-CH3); 13C NMR (100 MHz, CDCl3) 
δ ppm 210.8 (C-9), 209.4 (C-6), 161.6 (C-10), 148.9 (C-13,15), 133.6 (C-11), 129.5 (C-
12,16), 122.9 (C-14), 81.1 (C-2), 63.2 (C-5), 48.4 (C-1), 38.1 (C-7), 37.7 (C-4), 24.4 (C-3), 
18.9 (C-8), 16.8 (5-C-CH3); m/z (EI+, %) 395 (20), 394 (M+, 100), 364 (17); HRMS (ESI-TOF) 
[M+H]+ C17H17N2O8 calcd. 377.0979, found 377.0981. 
 
6-Hydroxy-1,3,3,7-tetramethylbicyclo[3.3.1]nonane-2,9-dione (3.61) 
 
To a solution of 2,4,4-trimethylcyclohexane-1,3-dione 3.51 (0.200 g, 1.28 mmol, 1 eq) in dry 
acetonitrile (10 mL) were added methacrolein (160 μL, 1.92 mmol, 1.5 eq) and DABCO 
(0.143 g, 1.28 mmol, 1 eq) at 25 °C. The solution was heated at 95 °C for 16 h. After this 
time the reaction was allowed to cool to 25 °C then evaporated. Water (15 mL) was then 
added and the mixture extracted with dichloromethane (2x15 mL). The combined organic 
layers were washed with water (2x15 mL) and then with brine, dried over Na2SO4, filtered 
and evaporated to give ketol 3.61 (0.186 g, 65%) as a colourless oil (mixture of 
diastereoisomers approx. 43:41:14:2 and confirmed by oxidation to 3.62); Rf 0.7 
(dichloromethane:ethyl acetate, 60:40); IR (film): 3405, 2972, 2937, 1726, 1694, 1496, 1061, 
1034 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 3.93 and 3.78 (1H, m, 6-H), 3.50 (1H, dd, J = 
10.5, 4.5 Hz, 5-H), 3.15‒2.63 (2H, m), 2.40‒0.90 (16H, m); 13C NMR (100 MHz, CDCl3) δ 
ppm 216.4, 216.1, 215.2, 213.8, 213.40, 212.1, 211.7, 207.5, 83.9, 83.1, 81.2, 79.3, 77.4, 
59.9, 59.8, 59.3, 53.0, 51.9, 51.7, 46.2, 45.8, 45.72, 45.4, 45.3, 44.1, 43.4, 37.1, 35.3, 33.4, 
31.9, 31.5, 31.4, 29.4, 27.4, 26.3, 26.1, 26.1, 25.8, 25.5, 25.3, 24.6, 24.1, 19.2, 18.6, 18.5, 
18.3, 17.2, 16.5; m/z (EI+, %) 225 (3), 224 (M+, 17), 196 (6), 138 (52), 123 (100); HRMS 
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(ESI-TOF) [M+] C13H20O3 calcd. 224.1407, found 224.1408. 
 
1,3,3,7-exo-Tetramethylbicyclo[3.3.1]nonane-2,6,9-trione (3.62) 
 
To a solution of 6-hydroxy-1,3,3,7-tetramethylbicyclo[3.3.1]nonane-2,9-dione 3.61 (0.200 g, 
0.90 mmol, 1 eq) in dry dichloromethane (10 mL) was added pyridinium chlorochromate 
(0.230 g, 1.08 mmol, 1.2 eq) and the resulting dark solution was stirred at 25 °C for 16 h. 
After allowing to cool, the solution was filtered through a pad of Celite® and the filtrate was 
evaporated. The residue was dissolved in ethyl acetate, the mixture filtered through a pad 
of silica, and the filtrate evaporated to give an 85:15 mixture of epimers. On standing for 2 
weeks, the mixture afforded trione 3.62 (0.191 g, 94%) as pale green needles, Rf 0.73 
(petroleum ether:ethyl acetate, 70:30), m.p. 94‒95 °C; IR (film): 2262, 1716, 1699, 1270, 
1037 cm-1; 1H NMR (400 MHz, CD3CN) δ ppm 3.69 (dd, J = 10.8, 1.7 Hz, 5-H), 2.51 (1H, m, 
7-H), 2.31 (1H, dd, J = 14.5, 10.8 Hz, 4-Heq), 2.32‒2.22 (2H, m, 8-H), 1.75 (1H, d (br), J = 
14.5 Hz, 4-Hax), 1.25 (3H, s, 3-C-CH3eq), 1.13 (3H, s, 1-C-CH3), 1.00 (3H, s, 3-C-CH3ax), 
0.98 (3H, d, J = 6.3 Hz 7-CH-CH3); 13C NMR (100 MHz, CD3CN) δ ppm 215.6 (C-2), 206.7 
(C-9), 205.4 (C-6), 64.8 (C-5), 60.6 (C-1), 45.6 (C-3), 41.7 (C-8), 38.9 (7-CH-CH3), 36.4 (C-
4), 26.3 (2-C-CH3eq), 24.3 (2-C-CH3ax), 18.7 (1-C-CH3), 13.7 (7-CH-CH3); m/z (EI+, %) 223 
(9), 222 (M+, 66), 194 (36), 138 (100), 123 (97); HRMS (ESI-TOF) [M+] C13H18O3 calcd. 
222.1251, found 222.1251. 
 
6-Hydroxy-1,3,3,8-tetramethylbicyclo[3.3.1]nonane-2,9-dione (3.63) 
 
To a solution of 2,4,4-trimethylcyclohexane-1,3-dione 3.51 (0.100 g, 0.64 mmol, 1 eq) in dry 
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acetonitrile (6 mL) were added crotonaldehyde (80 μL, 0.96 mmol, 1.5 eq) and DABCO 
(0.072 g, 0.64 mmol, 1 eq) at 25 °C. The resulting solution was heated at 95 °C for 16 h. 
After allowing to cool, water (15 mL) was added and the mixture extracted with 
dichloromethane (4 x 15 mL). The combined organic layers were washed with water (3x10 
mL), dried over MgSO4, filtered and evaporated to give 3.63 (71 mg, 49%) as a pale yellow 
oil, (mixture of 4 diastereoisomers approx. 40:27:19:14 and confirmed by oxidation to 3.63); 
Rf 0.6 (dichloromethane:ethyl acetate, 60:40) ; IR (film): 3405, 2972, 2937, 1726, 1694, 
1496, 1061, 1034 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 4.25 and 4.00 (1H, m, 6-H), 3.20 
and 2.90 (1H, m, 5-H), 2.70‒1.20 (m, 5H), 1.25‒0.80 (m, 12H); 13C NMR (100 MHz, CDCl3) 
δ ppm 216.9, 216.8, 214.9, 214.0, 213.6, 212.5, 211.5, 80.9, 76.3, 72.6, 70.6, 63.8, 63.6, 
62.5, 61.9, 52.4, 52.2, 51.7, 51.2, 46.0, 45.7, 45.6, 45.4, 45.3, 42.6, 41.1, 39.8, 36.2, 36.1, 
36.0, 34.6, 34.2, 31.9, 30.9, 30.7, 27.3, 27.1, 26.6, 26.5, 24.7, 24.6, 24.3, 24.1, 17.1, 17.0 
(2 lines), 16.9, 16.4, 15.7, 15.6, 14.6; m/z (EI+, %) 225 (8), 224 (M+, 58), 196 (14), 178 (22), 
138 (88), 123 (100); HRMS (ESI-TOF) [M]+ calcd. 224.1407, found 224.1408. 
 
1,3,3,8-Tetramethylbicyclo[3.3.1]nonane-2,6,9-trione (3.64) 
 
To a solution of 6-hydroxy-1,3,3,8-tetramethylbicyclo[3.3.1]nonane-2,9-dione 3.63 (0.050 g, 
0.2 mmol, 1 eq) in dry dichloromethane (3 mL) was added pyridinium chlorochromate (0.057 
g, 0.26 mmol, 1.2 eq) and the mixture was stirred at 25 °C for 16 h. The mixture was then 
filtered through a pad of Celite® and the filtrate was evaporated. The residue was dissolved 
in ethyl acetate, filtered through a pad of silica and the filtrate evaporated. The residue was 
purified by flash column chromatography (dichloromethane:ethyl acetate, 90:10) to give 
trione 3.64 (0.015 g, 30%) as a 70:30 mixture of 8-endo-3.64:8-exo-3.64; Rf 0.66 (silica gel, 
EtOAc/petroleum ether, 3 : 7, v/v); IR (film): 2975, 1741, 1716, 1698, 1455 cm-1; 8-endo-
3.64: 1H NMR (400 MHz, CDCl3) δ ppm 3.71 (1H, dt, J = 10.7, 1.5 Hz, 5-H), 2.57 (1H, dd, J 
= 15.5, 6.3 Hz, 7-Hax), 2.47 (1H, m, 8-H), 2.35‒2.21 (2H, m, 7-Heq, 4-Heq), 1.68 (1H, m, 4-
Hax), 1.31 (3H, s, 3-C-CH3eq), 1.18 (3H, s, 1-C-CH3), 1.08 (3H, s, 3-C-CH3ax), 0.82 (3H, d, 
J = 7.2 Hz, 8-CH-CH3); 13C NMR (100 MHz, CDCl3) δ ppm 215.2 (C-2), 205.0 (C-9), 204.2 
(C-6), 64.4 (C-5), 63.0 (C-1), 45.2 (C-3), 42.6 (C-7), 37.4 (C-8), 36.9 (C-4), 27.0 (3-C-
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CH3eq), 24.8 (3-C-CH3ax), 16.6 (1-C-CH3), 15.3 (8-CH-CH3); 8-exo-3-64: 1H NMR (400 
MHz, CDCl3) δ ppm 3.73 (1H, dt, J = 10.8, 1.8 Hz, 5-H), 2.41 (1H, dd, J = 4.7, 1.8 Hz, 7-
Heq), 2.32‒2.05 (3H, m, 7-Hax, 4-Heq, 8-H), 1.75 (1H, m, 4-Hax), 1.36 (3H, s, 3-C-CH3eq), 
1.22 (3H, d, J = 6.7 Hz, 8-CH-CH3), 1.17 (3H, s, 1-C-CH3), 1.02 (3H, s, 3-C-CH3ax); 13C 
NMR (100 MHz, CDCl3) δ ppm 213.6 (C-2), 205.5 (C-9), 203.8 (C-6), 63.1 (C-5), 62.0 (C-1), 
45.1 (C-3), 43.8 (C-7), 37.2 (C-4), 35.8 (C-8), 27.4 (3-C-CH3eq), 24.7 (3-C-CH3ax), 17.3 (1-
C-CH3), 15.1 (8-CHCH3); m/z (EI+, %) 223 (7), 222 (M+, 49), 194 (19), 179 (62); HRMS (ESI-
TOF) [M+] C13H18O3 calcd. 222.1251, found 222.1251. 
 
 
1-Methylbicyclo[3.3.1]nonane-2,6,9-trione (3.65) 
 
To a solution of 6-hydroxy-1-methylbicyclo[3.3.1]nonane-2,9-dione 3.2 (0.040 g, 0.22 mmol, 
1 eq) in dry dichloromethane was added pyridinium chlorochromate (0.056 g, 0.26 mmol, 
1.2 eq) in one portion at 25 °C and stirred for 16 h. The mixture was then filtered through a 
pad of Celite® and evaporated. The residue was dissolved in ethyl acetate, the solution 
passed through a pad of silica and the filtrate evaporated to give trione 3.65 (0.030 g, 76%) 
as a pale green powder, Rf 0.58 (petroleum ether:ethyl acetate 70:30), m.p. 97‒99 °C. IR 
(film): 1711, 1453, 1246, 1036, 1029 cm-1; 1H NMR (400 MHz, CD3CN) δ ppm 3.45 (1H, t, J 
= 5.0 Hz, 5-H), 2.70‒2.55 (4H, m, 7-H, 8-H), 2.53 (1H, m, 3-Heq), 2.12‒2.03 (2H, m, 4-H), 
1.75 (1H, m, 3-Hax), 1.22 (3H, s, -CH3); 13C NMR (100 MHz, CD3CN) δ ppm 209.9 (C-9), 
208.0 (C-2), 204.6 (C-6), 64.5 (C-5), 63.9 (C-1), 37.9 (C-3), 37.5 (C-7), 32.1 (C-8), 23.4 (C-
4), 16.5 (1-C-CH3); HRMS (ESI-TOF) [M+H]+ C10H13O3 calcd. 181.0859, found 181.0857. 
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1,7-exo-Dimethylbicyclo[3.3.1]nonane-2,6,9-trione (3.66) 
 
To a solution of 6-hydroxy-1,7-dimethylbicyclo[3.3.1]nonane-2,9-dione 3.19 (0.050 g, 0.25 
mmol, 1 eq) in dry dichloromethane was added pyridinium chlorochromate (0.066 g, 0.30 
mmol, 1.2 eq) in one portion at 25 °C, and the mixture was stirred for 16 h. The mixture was 
then filtered through a pad of Celite® and the filtrate was evaporated. The residue was 
dissolved in ethyl acetate and the solution passed through a pad of silica. The filtrate was 
evaporated to give trione 3.66 (0.037 g, 77%) as a light green oil; Rf 0.23 (petroleum 
ether:ethyl acetate 70:30); IR (film): 2983, 2988, 1740, 1709, 1457, 1038 cm -1; 1H NMR 
(400 MHz, CD3CN) δ ppm 3.54 (1H, dd, J = 7.2, 2.6 Hz, 5-H), 2.75-2.52 (3H, m, 7-H, 3-H), 
2.25‒2.15 (3H, m, 8-H, 4-Heq) 2.04 (1H, m, 4-Hax), 1.20 (3H, s, 1-C-CH3), 1.04 (3H, d, J = 
6.3 Hz, 7-CH-CH3); 13C NMR (100 MHz, CD3CN) δ ppm 210.7 (C-9), 208.1 (C-2), 204.2 (C-
6), 64.8 (C-5), 64.6 (C-1), 41.6 (C-7), 41.1 (C-8), 37.6 (C-3), 22.5 (C-4), 16.5 (1-C-CH3), 14.5 
(7-CH-CH3); m/z (EI+, %) 194 (M+, 34), 166 (19), 152 (20), 140 (30), 69 (100); HRMS (ESI-
TOF) [M+] C11H14O3 calcd. 194.0937, found 194.0938. 
1,4,4-Trimethylbicyclo[3.3.1]nonane-2,6,9-trione (3.67) 
 
To a solution of 6-exo-hydroxy-1,4,4-trimethylbicyclo[3.3.1]nonane-2,9-dione 3.50 (0.500 g, 
2.37 mmol, 1 eq) in dry dichloromethane was added pyridinium chlorochromate (0.610 g, 
2.85 mmol, 1.2 eq) in one portion at 25 °C and stirred for 16 h. The mixture was then filtered 
through a pad of Celite® and evaporated. The residue was dissolved in ethyl acetate, the 
solution passed through a pad of silica and the filtrate evaporated to give trione 3.67 (0.290 
g, 59%), Rf 0.23 (petroleum ether:ethyl acetate, 80:20). IR (film): 2955, 2023, 2851, 1734, 
1709, 1697, 1453, 1375, 1265, 1236, 1158, 1095, 1010, 736, 703 cm-1; 1H NMR (400 MHz, 
CDCl3) δ ppm 3.27 (1H, s, 5-H), 2.73 (1H, ddt, Jgem =  18.5, Jeq-ax = 7.6, Jeq-eq = 1.7 Hz, 7-
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Heq), 2.64–2.51 (1H, m, 7-Hax), 2.56 (s, 2H, 3-H), 2.09–2.01 (1H, m, 8-Heq), 1.72 (1H, ddd, 
Jgem = 14.0, Jax-ax = 12.3, Jax-eq = 7.7 Hz, 8-Hax), 1.30 (3H, s, 1-C-CH3), 1.12 (3H, s, 4-C-
CH3)2), 0.95 (3H, s, 4-C-CH3)2). 13C NMR (101 MHz, CDCl3) δ ppm 207.4 (C-9), 205.3 (C-
6), 203.2 (C-2), 76.5 (C-5), 62.4 (C-1), 52.2 (C-3), 38.1 (C-7), 33.9 (C-4), 31.4 (C-8), 29.5 
(4-C-CH3)2), 27.4(4-C-CH3)2), 15.9 (1-C-CH3). HRMS (ESI-TOF) [M+H]+ C12H17O3 calcd. 
209.1172, found 209.1179. 
 
1,3,3-Trimethylbicyclo[3.3.1]nonane-2,6,9-trione (3.68) 
 
To a solution of 6-hydroxy-1,3,3-trimethylbicyclo[3.3.1]nonane-2,9-dione 3.52 (0.075 g, 0.36 
mmol, 1 eq) in dry dichloromethane (3 mL) was added pyridinium chlorochromate (0.092 g, 
0.43 mmol, 1 eq) and the dark solution was stirred at 25 °C for 16 h. The mixture was then 
filtered through a pad of Celite® and the filtrate was evaporated. The residue was dissolved 
in ethyl acetate, the solution filtered through a pad of silica and the filtrate was evaporated 
to give trione 3.68 (0.050 g, 67%) as a white solid, Rf 0.31 (petroleum ether:ethyl acetate, 
70:30), m.p. 99‒104 °C; IR (film) 2977, 2934, 1742, 1715, 1694, 1470, 1373, 1276, 1087, 
1045, 764, 740 cm-1; 1H NMR (400 MHz, CD3CN) δ ppm 3.65 (1H, d, J = 10.8 Hz, 5-H), 2.45 
(1H, m, 7-Heq), 2.37‒2.25 (2H, m, 4-Heq, 7-Hax),  2.21 (1H, app. dd, J = 13.3, 7.6 Hz, 8-
Heq), 1.72 (1H, m, 4-Hax), 1.47 (1H, td, J = 13.3, 5.3 Hz, 8-Hax), 1.26 (3H, s, 3-C-CH3eq), 
1.13 (3H, s, 1-C-CH3), 1.01 (3H, s, 3-C-CH3ax); 13C NMR (100 MHz, CD3CN) δ ppm 215.5 
(C-2), 206.0 (C-9), 205.8 (C-6), 65.1 (C-5), 59.8 (C-1), 45.7 (C-3), 36.3 (C-7), 35.3 (C-4), 
33.1 (C-8), 26.2 (3-C-CH3), 24.4 (3-C-CH3), 18.9 (1-C-CH3); m/z (EI+, %) 209 (8), 208 (M+, 
62), 180 (53), 138 (68), 123 (100), 110 (52); HRMS (ESI-TOF) [M+] C12H16O3 calcd. 
208.1094, found 208.1094. 
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3-(5-Methyl-6-oxocyclohex-1-en-1-yl)propanoic acid (3.72) 
 
To a solution of 2-methyl-1,3-cyclohexanedione 2.47 (0.100 g, 0.8 mmol, 1 eq) in water (13 
mL) was added acrolein (80 μL, 1.2 mmol, 1.5 eq) at 25 °C. The resulting solution was stirred 
at 95 °C for 72 h. After this time, the reaction was allowed to cool and the aqueous phase 
was extracted three times in dichloromethane (3x15 mL). The combined organic layers were 
washed with H2O, dried over Na2SO4, filtered and evaporated to give 3.72 (0.142 g, 97%) 
as colorless oil, IR (film) 2933, 1710, 1668, 1381, 1197, 911, 732, 646, 610 cm-1; 1H NMR 
(400 MHz, CDCl3) δ ppm 6.74 (1H, t, J = 3.7 Hz, 2’-H), 2.49 (4H, m, 2-CH2, 3-CH2), 2.41–
2.34 (3H, m, 3’-H, 5’-H), 2.08‒1.99 (1H, dqd, J = 13.5, 4.6, 1.1 Hz, 4’-Heq), 1.77‒1.65 (1H, 
dddd, J = 13.2, 11.8, 8.6, 6.5 Hz, 4’-Hax), 1.14 (3H, d, J = 6.8 Hz, 5’-CH3); 13C NMR (101 
MHz, CDCl3) δ ppm 202.0 (C-6’), 177.9 (C-1), 145.7 (C-2’), 137.5 (C-1’), 41.8 (C-5’), 33.1 
(C-2), 31.0 (C-4’), 25.6 (C-3), 25.5 (C-3’), 15.2 (5’-CH3); HRMS (ESI-TOF) [M+H]+ C10H14O3 
calcd. 183.0999, found 183.1021. 
 
Ethyl-2-hydroxy-5-methyl-6,8-dioxo-4-phenylbicyclo[3.2.1]octane-2-carboxylate 
(3.89) 
 
To a solution of 2-methyl-1,3-cyclopentanedione 3.54 (0.100 g, 0.9 mmol, 1 eq) in dry 
acetonitrile (6 mL) were added ethyl 2-oxo-4-phenylbut-3-enoate 3.88 (0.181 g, 0.9 mmol, 1 
eq) and DABCO (0.099 g, 0.9 mmol, 1 eq) at 25 °C. The resulting solution was heated at 95 
°C for 16 h. After allowing to cool down to room temperature, water (15 mL) was added and 
the mixture extracted with dichloromethane (4 x 20 mL). The combined organic layers were 
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washed with water, dried over MgSO4, filtered and evaporated. Column chromatography 
(petroleum ether:ethyl acetate, 85 : 15 → 75 : 25 → 70 : 30) afforded 3.89 (0.050 g, 35%) 
as a 57:43 mixture of diastereoisomers, IR (film): 3450, 2931, 1770, 1731, 1455, 1258, 1217, 
1084, 1055, 758, 701 cm-1; Major diastereoisomer 1H NMR (400 MHz, CDCl3) δ ppm 7.32–
7.28 (3H, m, Aryl), 7.10 (2H, dd, J = 7.5, 2.1 Hz, Aryl), 4.35–4.29 (2H, m, -OCH2CH3), 3.36–
3.30 (1H, dd, Jax-ax = 13.7, Jax-eq = 4.7 Hz, 4-H), 3.23–3.15 (1H, m, 7-Hax), 3.07 (1H, d, Jeq-ax 
= 7.9 Hz, 1-H), 2.72–2.56 (2H, m, 7-Heq, 3-Hax), 2.09–2.04 (1H, m, 3-Heq), 1.36 (3H, t, J = 
7.2 Hz, -OCH2CH3), 0.82 (3H, s, 5-C-CH3) 13C NMR (101 MHz, CDCl3) δ ppm 209.7 (C-8), 
209.4 (C-6), 172.57 (-CO2Et), 137.6 (Aryl), 128.8 (Aryl), 128.7 (Aryl), 128.3 (Aryl), 79.7 (C-
2), 63.3 (-OCH2CH3), 62.4 (C-5), 54.4 (C-1), 51.7 (C-4), 42.1 (C-7), 36.31 (C-3), 14.40 (-
OCH2CH3), 11.10 (5-C-CH3) Minor diastereoisomer; 1H NMR (400 MHz, CDCl3) δ ppm 7.32–
7.28  (3H, m, aryl), 7.06 (2H, dd, J = 7.4, 2.1 Hz, 2H, Aryl), 4.35–4.29 (2H, m, -OCH2CH3), 
3.36–3.30 (1H, m, 7-Hax)  3.23–3.15 (1H, m, 4-H), 2.72–2.56 (2H, m, 7-Heq, 3-Hax), 2.35–
2.19 (1H, m, 3-Heq), 1.36 (3H, t, J = 7.2 Hz, OCH2CH3), 0.81 (3H, 5-C-CH3).13C NMR (101 
MHz, CDCl3) δ ppm 209.7 (C-8), 209.0 (C-6),  173.8 (CO2Et), 137.6 (Aryl), 128.8 (Aryl), 
128.6 (Aryl), 128.2(Aryl), 78.0 (C-2), 61.2 (-OCH2CH3), 60.5 (C-5), 55.6 (C-1), 50.2 (C-4), 
40.9 (C-7), 36.7 (C-3), 14.2 (-OCH2CH3), 10.9 (5-C-CH3). HRMS (ESI-TOF) [M+H]+ C18H21O5 
calcd. 317.1384, found 317.1375. 
1-Methylbicyclo[3.3.1]non-6-ene-2,9-dione (4.1) 
6-Fluoro-1-methylbicyclo[3.3.1]nonane-2,9-dione (4.4) 
 
To a stirring solution of 6-exo-hydroxy-1-methylbicyclo[3.3.1]nonane-2,9-dione (3.2) (0.073 
g, 0.40 mmol) in dry dichloromethane (6 mL) at -78 °C DAST (0.322 g, 2.0 mmol) was added 
dropwise. The mixture was stirred at -78 °C for 1 h then quenched with water (5 mL); the 
aqueous phase was extracted with dichloromethane (3x20 mL). The combined organic 
layers were washed with water (10 mL), dried over Na2SO4, filtered and evaporated. Column 
chromatography (95:5 then 93:7 hexane:ethyl acetate) of the residue gave 4.1 (0.036 g, 
60%) as a colourless oil; IR (film) νmax 3005, 2989, 1733, 1691, 1455, 1376, 1350, 1275, 
1260, 1195, 1095 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.87 (1H, ddd, J = 9.2, 3.6, 2.5, 7-H), 
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5.77 (1H, dm, J = 9.2 Hz, 6-H), 3.23–3.18 (1H, m, 5-H), 2.88–2.77 (1H, m, 3-Heq), 2.69 (1H, 
dd, 2JHH = 18.0 Hz, J = 4.0 Hz, 1x8-CH2), 2.57–2.49 (2H, m, 3-Hax, 1x8-CH2), 2.02–1.94 
(1H, m, 4-Heq), 1.89–1.79 (1H, m, 4-Hax), 1.22 (3H, s); 13C NMR (101 MHz, CDCl3) δ 209.6 
(C-9), 208.5 (C-2), 128.4 (C-6), 127.7 (C-7), 64.6 (C-1), 46.5 (C-5), 44.8 (C-8), 34.9 (C-3), 
24.6 (C-4), 15.8 (CH3). HRMS (ESI-TOF) [M+H]+ C10H13O2 calcd. 165.0910, found 165.0913; 
and 4.4 (0.015 g, 20%) as a colourless oil; IR (film) νmax 3000, 2968, 2925, 1720, 1700, 1275, 
1260 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.82 (1H, ddt, J = 48.3, Jax-ax = 11.2, Jax-eq = 5.6 Hz, 
6-H), 3.42–3.33 (1H, m, 5-H), 2.62 (1H, ddd, 2JHH = 16.3, Jax-ax = 7.5, Jax-eq = 4.6 Hz, 3-Heq) 
2.37 (1H, dtm, 2JHH = 16.3, Jax-ax = 9.5 Hz, 3-Hax), 2.21–2.09 (3H, m, 7-Heq, 4-Heq, 8-Hax), 
2.04–1.94 (1H, m, 4-Hax), 1.85–1.69 (1H, m, 7-Hax), 1.37 (1H, tdm, 2JHH = 14.0, J = 4.8 Hz, 
8-Heq), 1.15 (3H, s, 1-CH3); 13C NMR (101 MHz, CDCl3) δ 211. 2 (C-2), 207.7 (d, 3JCF = 10.6 
Hz, (C-9), 92.2 (d, JCF = 188.2 Hz, C-6), 61.9 (C-1), 50.8 (d, 2JCF = 19.4 Hz, C-5), 38.5 (C-
3), 33.5 (d, 3JCF = 11.6 Hz, C-8), 25.7 (d, 2JCF = 19.8 Hz, C-7), 16.2 (1-CH3), 15.3 (d, 3JCF = 
4.3 Hz, C-4). 19F NMR (565 MHz, CDCl3) δ -176.3. HRMS (ESI-TOF) [M+H]+ C10H14FO2 
calcd. 185.0972, found 185.0967. 
 
1-Methyl-9-oxabicyclo[3.3.2]decane-2,6,10-trione (4.6) 
 
To a stirring solution of 1-methylbicyclo[3.3.1]non-6-ene-2,9-dione 4.1 (0.020 g, 0.12 mmol, 
1 eq) in dry dichloromethane (3 mL) m-CPBA (0.042 g, 0.24 mmol, 2 eq) and NaHCO3 (0.020 
g, 0.24 mmol, 2 eq) were added in one portion at 0 °C. The reaction was kept at 0 °C for 1 
hour, the ice bath removed and stir for additional 16 h. After this time, the reaction was 
quenched with H2O (5 mL) and the aqueous phase extracted three times in dichloromethane 
(3x20 mL). The combined organic layers were washed with H2O, dried over Na2SO4, filtered 
and evaporated. Column chromatography (hexane:ethyl acetate, 85:15) afforded 4.6 
(0.0050 g, 23%), IR (film): 3009, 2978, 1445, 1270, 1263, 760, 748 cm-1; 1H NMR (400 MHz, 
CDCl3) δ ppm 5.70 (1H, ddd, J = 11.4, 6.4, 1.9 Hz, 7-H), 5.60–5.50 (1H, m, 6-H), 3.71 (1H, 
t, J = 8.3 Hz, 5-H), 3.06 (1H, td, Jgem = 12.1, 9.3 Hz, 3-Heq), 2.85 (1H, dd, Jgem = 18.5, 6.5 
Hz, 8-Heq), 2.53–2.37 (3H, m, 8-Hax, 3-Hax, 4-Heq), 1.87–1.77 (1H, m, 4-Hax), 1.26 (3H, 
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s, 1-C-CH3); 13C NMR (101 MHz, CDCl3) δ ppm 203.9 (C-2), 171.0 (C-9), 128 (C-7), 124.0 
(C-6), 87.6 (C-1), 44.0 (C-5), 37.0 (C-8), 35.0 (C-3), 26.0 (1-C-CH3), 25.0 (C-4). 
6-(tert-Butyldimethylsilyl)oxy)-1,3,3-trimethylbicyclo[3.3.1]non-6-ene-2,9-dione (4.7) 
 
A stirring solution of 1,3,3-trimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.68 (0.045 g, 0.21 
mmol, 1 eq) in dry dichloromethane (6 mL) was brought to 0 °C. Et3N (132.0 μL, 0.095 g, 
0.94 mmol, 4.5 eq) was then added and the mixture stirred for 5 minutes. TBSOTf (0.199 g, 
173.7 μL, 0.75 mmol, 3.6 eq) was added at last and the reaction kept at 0 °C for 10 minutes. 
After this time, the ice bath was removed, the mixture was slowly warmed up to room 
temperature and then heated at 45 °C for 1 hour. After allowing to cool down to room 
temperature the solution was quenched with sat. NaHCO3 (5 ml) and the aqueous phase 
extracted three times with dichloromethane (3x15 mL). The combined organic layers were 
washed with H2O, dried over Na2SO4, filtered and evaporated to afford 4.7 (0.051 g, 72%) 
as colorless oil, IR (film): 2933, 1741, 1705, 1662, 1471, 1254, 1194, 870, 839, 783 cm-1; 1H 
NMR (400 MHz, CDCl3) δ ppm 4.72 (1H, dd J =  5.5, 1.8 Hz, 7-H), 3.04 (1H, dt, J = 7.4, 1.4 
Hz, 5-H), 2.71 (1H, dd, Jgem = 16.0, J = 5.5 Hz, 8-Hax), 2.11–2.04 (2H, m, 8-Heq, 4-Hax), 
1.96 (1H, dd, Jgem = 13.5, 7.5 Hz, 4-Heq), 1.24 (3H, s, 1-C-CH3), 1.17 (3H, s, 3-C-(CH3)2), 
1.03 (3H, s, 3-C-(CH3)2), 0.90 (9H, s, Si(CH3)2-C(CH3)3), 0.14 (3H, s, Si(CH3)2-C(CH3)3), 0.12 
(3H, s, Si(CH3)2-C(CH3)3). 13C NMR (101 MHz, CDCl3) δ ppm 216.8 (C-2), 209.3 (C-9), 150.6 
(C-6), 101.2 (C-7), 59.1 (C-1), 51.7 (C-5), 44.4 (C-3), 39.1 (C-4), 38.0 (C-8), 28.7 (3-C-
(CH3)2), 26.5 (3-C(CH3)2), 25.6 (Si(CH3)2-C(CH3)3), 18.1 (Si(CH3)2-C(CH3)3), 17.7 (1-C-CH3), 
-4.4 (Si(CH3)2-C(CH3)3), -4.6 (Si(CH3)2-C(CH3)3). HRMS (ESI-TOF) [M+H]+ C18H31O3Si 
calcd. 324.2063, found 324.2036. 
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1,3,3-Trimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione (4.8) 
 
To a stirring solution of 1,3,3-trimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.68 (0.050 g, 0.24 
mmol) in dry dichloromethane (6 mL) at 0 °C was added Et3N (0.109 g, 1.08 mmol). The 
mixture was stirred for 5 min, then TMSOTf (0.192 g, 0.86 mmol) was added and the mixture 
was stirred at 0 °C for a further 10 min. The ice-bath was then removed, and the mixture 
was allowed to warm to 20 °C, then heated at 45 °C for 3 h. After allowing to cool to 20 °C 
a saturated aqueous solution of NaHCO3 (5 mL) was added, and the aqueous layer 
extracted with dichloromethane (3x15 mL). The combined organic layers were washed with 
water (10 mL), dried over Na2SO4, filtered and evaporated to give 4.8 (0.064 g, 95%) as 
colourless oil; IR (film) νmax 2965, 2925, 1706, 1470, 1277, 1051 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 4.72 (1H, dd, J = 5.5, 2.0 Hz, 7-H), 3.03 (1H, d, J = 7.5 Hz, 5-H), 2.72 (1H, dd, J = 
16.0, 5.6 Hz, 8-Heq/ax), 2.11–2.03 (2H, m, 8-Hax/eq, 4-Hax), 1.96 (1H, dd, J = 13.5, 7.5 Hz, 
4-Heq), 1.26 (3H, s, 1-CH3), 1.18 (3H, s, 3-CH3), 1.04 (3H, s, 3-CH3), 0.20 (9H, s, OSi(CH3)3). 
HRMS (ESI-TOF) [M+H]+ C15H25O3Si calcd. 281.1567, found 281.1567. 
 
7-Fluoro-1,3,3-trimethylbicyclo[3.3.1]nonane-2,6,9-trione (4.10) 
 
To a stirring solution of 1,3,3-trimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-
dione 4.8 (0.037 g, 0.13 mmol) in dry acetonitrile (2 mL) was added selectfluor in one portion 
(0.093 g, 0.26 mmol) at 25 °C. After stirring the mixture for 16 h, water (2 mL) was added 
and the aqueous phase extracted with dichloromethane (3x10 mL). The combined organic 
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layers were washed with water (10 mL), dried over Na2SO4, filtered and evaporated to give 
4.10 (0.018 g, 58%) as a colourless oil; IR (film) νmax 2918, 1850, 1729, 1703, 1462, 1270, 
1239, 1048 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.96 (1H, ddd, JHF = 46.5, Jax-ax = 12.4, Jax-eq 
= 7.6 Hz, 7-H), 3.92 (1H, ddd, J = 11.0, 4.5, 1.2 Hz, 5-H), 2.75 (1H, ddd, 2JHH = 12.4, 3JHF = 
7.6, Jeq-ax = 2.5 Hz, 8-Heq), 2.33 (1H, dd, 2JHH = 15.2, Jeq-eq = 11.0 Hz, 4-Heq), 1.76 (1H, m, 
4-Hax), 1.63 (1H, apparent q, 2JHH = Jax-ax = 3JHF = 12.4 Hz, 8-Hax), 1.39 (3H, s, 1-CH3), 1.20 
(3H, s, 3-CH3), 1.08 (3H, s, 3-CH3); 13C NMR (101 MHz, CDCl3) δ 213.0 (C-2), 201.9 (C-9), 
198.0 (d, 2JFC = 15.0 Hz, C-6), 86.9 (d, JFC = 195.4 Hz, C-7), 62.0 (C-5), 58.5 (3JFC = 8.5 Hz, 
C-1), 45.1 (C-3), 37.9 (d, 3JFC = 20.5 Hz, C-8), 35.5 (C-4), 26.1 (3-CH3), 24.6 (3-CH3), 18.6 
(1-CH3); 19F NMR (565 MHz, CDCl3) δ -198.0. HRMS (ESI-TOF) [M]+ C12H15FO3 calcd. 
226.1005, found 226.1007. 
 
7-Fluoro-1,3,3,7-tetramethylbicyclo[3.3.1]nonane-2,6,9-trione (4.11) 
 
To a stirring solution of 1,3,3-trimethylbicyclo[3.3.1]non-6-ene-2,6,9-trione (3.62) (0.050 g, 
0.22 mmol) in dry dichloromethane (3 mL) at 0 °C was added Et3N (0.101 g, 1.0 mmol, 4.54 
eq). The mixture was stirred for 5 min, then TMSOTf (0.177 g, 0.80 mmol, 3.63 eq) was 
added and the mixture was stirred at 0 °C for a further 10 min. The ice-bath was then 
removed and the mixture allowed to warm to 20 °C, then heated at 45 °C for 16 h. After 
allowing to cool to 20 °C, sat. aqueous NaHCO3 (5 mL) was added, and the aqueous layer 
extracted with dichloromethane (3x15 mL). The combined organic layers were washed with 
water (10 mL), dried over Na2SO4, filtered and evaporated. Column chromatography 
(petroleum ether then 97:3 petroleum ether:ethyl acetate) of the residue gave 1,3,3,7-
tetramethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione 4.9 (0.030 g, 46%) as a 
colourless oil of which 0.025 g (0.08 mmol) were immediately placed in a flame-dried round-
bottom flask containing dry acetonitrile (3 mL) to which Selectfluor (0.060 g, 0.16 mmol, 2 
eq) was added at 25 °C. The resulting solution was stirred at 25 °C for 3 days after which 
water (2 mL) was added and the aqueous layer extracted with dichloromethane (3x10 mL). 
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The combined organic layers were washed with water (10 mL), dried over Na2SO4, filtered 
and evaporated to give 4.11 (0.011 g, 57%) as a colourless oil; IR (film) νmax 2925, 2845, 
1732, 1707, 1455, 1383 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.60 (1H, dt, Jeq-eq = 8.4, Jeq-eq = 
2.4 Hz, 5-H), 2.60–2.45 (1H, dm, 3JHF = 36.0, J = 14.8 Hz, 8-Heq), 2.44–2.38 (1H, dd, J = 
13.6 Hz, 1.6 Hz, 4-Hax), 2.14–2.03 (2H, m, 4-Heq, 8-Hax), 1.46 (3H, d, 3JHF = 22.1 Hz, 7-
CH3), 1.35 (3H, s, 1-CH3), 1.12 (3H, s, 3-CH3), 1.09 (3H, s, 3-CH3); 13C NMR (101 MHz, 
CDCl3) δ 214.3 (C-2), 204.2 (C-9), 202.3 (d, 2JFC = 25.8 Hz, C-6), 95.5 (d, JFC = 170.8 Hz, 
C-7), 60.0 (C-1), 57.5 (C-5), 45.9 (C-3), 45.6 (d, 2JFC = 3.7 Hz, C-8), 36.6 (C-4), 28.5 (3-
CH3), 26.6 (3-CH3), 20.1 (1-CH3), 19.7 (d, JFC = 23.4 Hz, 7-CH3); 19F NMR (565 MHz, CDCl3) 
δ -141.0. 
 
5,7,7-Trimethylbicyclo[3.3.1]non-3-ene-2,6,9-trione (4.15) 
 
To a mixture of DMSO and dichloromethane (2:1 by volume, 1 mL) were added IBX (0.201 
g, 0.72 mmol, 3 eq) and MPO hydrate (0.090 g, 0.72 mmol, 3 eq). The resulting cloudy 
solution was stirred at 25 °C for 90 min, the colour becoming yellow. 1,3,3-
Trimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.68 (0.050 g, 0.24 mmol, 1 eq) was then added 
and the mixture stirred at 25 °C overnight. 5% aqueous NaHCO3 (10 mL) was then added 
and the mixture was extracted with diethyl ether (3x10 mL). The combined organic layers 
were filtered through a pad of celite. The filtrate was washed with 5% aqueous NaHCO3 (10 
mL), then with water (10 mL) and lastly with brine (10 mL). The organic layer was dried over 
Na2SO4, filtered and evaporated to give 4.15 (0.015 g, 30%) as a colourless oil; IR (film) νmax 
2928, 1748, 1718, 1275 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.75 (1H, d, J = 9.6 Hz, 8-H), 
6.21 (1H, d, J = 9.6, 7-H), 3.76 (1H, dd, J = 7.6, 4.0 Hz, 5-H), 2.24–2.13 (2H, m, 4-H), 1.50 
(3H, s, 1-CH3), 1.25 (3H, s, 3-CH3), 1.10 (3H, s, 3-CH3); 13C NMR (101 MHz, CDCl3) δ 206.1 
(C-2), 201.9 (C-9), 197.6 (C-6), 150.4 (C-8), 128.9 (C-7), 65.5 (C-1), 60.5 (C-5), 45.9 (C-3), 
38.6 (C-4), 29.3 (3-CH3), 28.1 (3-CH3), 15.3 (1-CH3). HRMS (ESI-TOF) [M+H]+ C12H15O3 
calcd. 207.1016, found 207.1025. 
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6-Fluoro-1,3,3-trimethylbicyclo[3.3.1]nonane-2,9-dione (4.19) 
 
To a stirring solution of 6-hydroxy-1,3,3-trimethylbicyclo[3.3.1]nonane-2,9-dione (3.52) 
(0.030 g, 0.14 mmol, 1 eq) in dry dichloromethane (4 mL) at -78 °C DAST (0.115 g, 0.71 
mmol, 5 eq) was added dropwise. The mixture was stirred at -78 °C for 1 h then quenched 
with water (5 mL) and the aqueous phase extracted with dichloromethane (3x15 mL). The 
combined organic layers were washed with water (10 mL), dried over Na2SO4, filtered and 
evaporated. Column chromatography (95:5 then 93:7 hexane:ethyl acetate) of the residue 
gave 4.19 (0.011 g, 38%) as a 65:35 mixture of exo-4.19:endo-4.19; IR (film) νmax 3018, 
1643, 1603, 1379, 1275, 1260, 1226, 1187 cm-1; exo-4.19: 1H NMR (400 MHz, CDCl3) δ 
4.94 (1H, ddq, 2JHF = 47.4, Jeq-ax = 4.5, Jeq-eq = 1.6 Hz, 6-H), 3.25–3.17 (1H, m, 5-H), 2.25–
2.18 (1H, m, 7-Heq), 2.11–1.91 (3H, m, 4-Heq, 7-Hax, 8Heq), 1.65–1.45 (1H, m, 4-Hax), 
1.29–1.24 (1H, m, 8-Hax), 1.22 (3H, s, 3-CH3), 1.15 (3H, s, 3-CH3), 0.99 (3H, s, 1-CH3); 13C 
NMR (101 MHz, CDCl3) δ 215.7 (C-2), 210.9 (C-9), 97.6 (d, JCF = 177.7 Hz, C-6), 60.2 (C-
1), 49.1 (d, 2JCF = 22.7 Hz, C-5), 45.5 (C-3), 38.4 (C-7), 34.1 (d, 3JCF = 9.4 Hz, C-8), 26.2 (3-
CH3), 24.7 (3-CH3), 24.65 (C-4), 18.7 (1-CH3); 19F NMR (565 MHz, CDCl3) δ ˗174.9; endo-
4.19: 1H NMR (400 MHz, CDCl3) δ 4.16 (1H, dm, JHF = 58.0 Hz, 6-H), 3.33–3.30 (1H, m, 5-
H), 2.25–2.18 (1H, m, 7-Heq), 2.11–1.91 (3H, m, 4-Heq, 7-Hax, 8-Heq), 1.91–1.85 (1H, m, 
4-Hax), 1.22 (3H, s, 3-CH3), 1.15 (3H, s, 3-CH3), 0.99 (3H, s, 1-CH3); 13C NMR (101 MHz, 
CDCl3, part assignments) δ 215.7 (C-2), 210.9 (C-9), 97.6 (d, JCF = 177.7 Hz, C-6), 19F NMR 
(565 MHz, CDCl3) δ ˗163.8. HRMS (ESI-TOF) [M+H]+ C12H18FO2 calcd. 213.1285, found 
213.1288. 
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5-Methyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione (4.25)  
1-Methyl-2,6-bis((trimethylsilyl)oxy)bicyclo[3.3.1]nona-2,6-dien-9-one (4.22) 
 
To a stirring solution of 1-methylbicyclo[3.3.1]nonane-2,6,9-trione 3.65 (0.040 g, 0.22 mmol, 
1 eq) in dry dichloromethane (3 mL) at 0 °C was added Et3N (0.066 g, 0.66 mmol, 3 eq) was 
then added. The mixture was stirred for 5 min, then TMSOTf (0.120 g, 0.54 mmol, 2.4 eq) 
was added and the mixture was stirred at 0 °C for a further 10 min. The ice-bath was then 
removed, and the mixture was allowed to warm to 20 °C, then heated at 45 °C for 2 h. After 
allowing to cool to 20 °C, sat. aqueous NaHCO3 (5 mL) was added, and the aqueous layer 
extracted with dichloromethane (3x12 mL). The combined organic layers were washed with 
water (10 mL), dried over Na2SO4, filtered and evaporated. Column chromatography of the 
residue (hexane then 95:5 hexane:ethyl acetate) gave 4.22 (0.020 g, 28%) as an oil; IR (film) 
νmax 2959, 1734, 1658, 1253, 1181, 1051 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.81–4.77 (2H, 
m, 3-H, 7-H), 2.80 (1H, d, J = 4.8 Hz, 5-H), 2.50–2.41 (2H, m, 4-Heq, 8-Heq), 2.35 (1H, dm, 
J = 16.4 Hz, 4-Hax), 2.00 (1H, m, 8-Hax), 1.53 (3H, s, 1-CH3), 0.18 (9H, OSi(CH3)3), 0.17 
(9H, OSi(CH3)3); 13C NMR (101 MHz, CDCl3) δ  209.1 (C-9), 152.4 (C-2), 150.2 (C-6), 101.7 
(C-3/C-7), 99.8 (C-7/C-3), 51.3 (C-5), 50.5 (C-1), 36.4 (C-8), 28.2 (C-4), 16.3 (1-CH3), 0.38 
(OSi(CH3)3), 0.35 (OSi(CH3)3). HRMS (ESI-TOF) [M+H]+ C16H29O3Si2 calcd. 325.1650, found 
325.1658; and 4.25 (0.005 g, 10%) as an oil; IR (film) νmax 3003, 2978, 1709, 1270 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 4.94 (1H, dd, J = 5.2, 2.4 Hz, 3-H), 3.38 (apparent d, Jeq-ax = 6.4 
Hz, 5-H), 2.69–2.61 (2H, m, 4-Heq, 7-Heq), 2.51 (1H, ddt, 2JHH = 17.0 Hz, Jax-eq = 5.6, Jeq-eq 
= 1.6 Hz, 7-Hax), 2.39 (1H, ddd, 2JHH = 17.1, Jax-ax = 5.1, Jax-eq = 1.6 Hz, 4-Hax), 2.10 (1H, 
ddd, 2JHH = 13.7, Jax-ax = 8.0 Hz, J =1.7 Hz, 8-Hax), 1.47 (1H, m, 8-Heq), 1.24 (3H, s, 1-CH3), 
0.24 (9H, s, (OSi(CH3)3); 13C NMR (101 MHz, CDCl3) δ 208.8 (C-9), 205.3 (C-6), 150.7 (C-
2), 100.2 (C-3), 63.6 (C-5), 51.0 (C-1), 36.8 (C-7), 30.4 (C-8), 29.4 (C-4), 16.5 (1-CH3), 0.32 
(OSi(CH3)3). HRMS (ESI-TOF) [M+H]+ C13H21O3Si calcd. 253.1254, found 253.1259. 
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3-Fluoro-1-methylbicyclo[3.3.1]nonane-2,6,9-trione (4.27) 
 
To a stirring solution of 5-methyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione 
4.25 (0.005 g, 0.02 mmol, 1 eq) in dry acetonitrile (2 mL) was added selectfluor (0.014 g, 
0.04 mmol, 2 eq) at 25 °C. After stirring the mixture for 16 h water (3 mL) was added and 
the aqueous layer extracted with dichloromethane (3x10 mL). The combined organic layers 
were dried over Na2SO4, filtered and evaporated to give 4.27 (0.0035 g, 90%) as a colourless 
oil; IR (film) νmax 2919, 1719, 1456, 1270, 1109, 1020 cm-1; 1H NMR (400 MHz, CDCl3) δ 
5.11 (1H, dtd, JHF = 47.7, Jax-eq = 7.5, 4J = 1.6 Hz, 3-H), 3.64 (1H, dd, J = 6.8, 3.3 Hz, 5-H), 
2.64–2.50 (2H, m, 7-CH2), 2.46–2.36 (2H, m, 4-CH2), 2.25 (1H, ddd, 2JHH = 14.0 Hz, Jax-eq = 
7.3, Jeq-eq = 5.0 Hz, 8-Heq), 1.74 (1H, ddd, 2JHH = 13.9, Jax-ax = 9.7, Jax-eq = 7.7 Hz, 8-Hax), 
1.40 (3H, s, 1-CH3); 13C NMR (101 MHz, CDCl3) δ 204.8 (C-6), 202.5 (d, 2JCF = 17.6 Hz, C-
2), 200.9 (C-9), 89.0 (d, JCF = 184.5 Hz, C-3), 61.5 (C-1), 60.9 (d, 3JCF = 4.6 Hz, C-5), 36.4 
(C-7), 30.2 (C-8), 29.0 (d, 2JCF = 22.5 Hz, C-4), 16.9 (1-CH3); 19F NMR (565 MHz, CDCl3) δ 
-187.13. HRMS (ESI-TOF) [M+H]+ C10H11FO3 calcd. 199.0765, found 199.0771. 
 
1,7-Dimethyl-2-((trimethylsilyl)oxy)bicyclo[3.3.1]non-2-ene-6,9-dione (4.35) 
1,7-Dimethyl-2,6-bis((trimethylsilyl)oxy)bicyclo[3.3.1]nona-2,6-dien-9-one (4.36) 
4.364.35
+ 12
3
4
5
6
7
8
9
OTMSOOTMSO
O OTMS
12
3
4
5
67
8
9
 
To a stirring solution of 1,7-exo-dimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.66 (0.090 g, 
0.46 mmol, 1 eq) in dry dichloromethane (5 mL) at 0 °C was added Et3N (0.140 g, 1.38 
mmol, 3 eq). The mixture was stirred for 5 min, then TMSOTf (0.245 g, 1.1 mmol, 2.4 eq) 
was added and the mixture was stirred at 0 °C for a further 10 min. Then the ice-bath was 
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then removed and the mixture heated at 45 °C for 3 h. After allowing to cool to 20 °C, sat. 
aqueous NaHCO3 (5 mL) was added, and the aqueous layer was extracted with 
dichloromethane (3x20 mL). The combined organic layers were washed with water (10 mL), 
dried over Na2SO4, filtered and evaporated. Column chromatography (petroleum ether then 
95:5 petroleum ether:ethyl acetate) of the residue gave 1,7-dimethyl-2-
((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione 4.35 (0.045 g, 36%) as a colourless 
oil; Rf 0.6 (petroleum ether:ethyl acetate, 80:20); IR (film) νmax 2955, 2931, 2849, 1728, 1702, 
1653, 1452, 1252, 1225, 1048, 1027 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.92 (1H, dd, J = 
4.8, 2.4 Hz, 3-H), 3.47 (1H, apparent d, Jeq-endo  = 6.4 Hz, 5-H), 2.80–2.72 (1H, m, 7-CH), 
2.71–2.62 (1H, ddd, 2JHH = 17.2, Jax-eq = 6.8, Jeq-eq = 2.0 Hz, 4-Hax), 2.53–2.40 (1H, m, 8-
Heq), 2.34 (1H, ddd, 2JHH = 17.2, Jeq-eq = 4.8, Jeq-eq = 0.8 Hz, 4-Heq), 2.20 (1H, dd, 2JHH = 
13.2, Jax-eq = 7.2 Hz, 8-Hax), 1.20 (3H, s, 1-CH3), 1.12 (3H, d, J = 6.8 Hz, 7-CH3), 0.24 (9H, 
s, OSi(CH3)3); 13C NMR (101 MHz, CDCl3) δ 208.9 (C-9), 204.8 (C-6), 151.3 (C-2), 100.0 
(C-3), 63.5 (C-5), 51.7 (C-1), 40.6 (C-7), 39.9 (C-8), 29.1 (C-4), 16.4 (1-CH3), 13.4 (7-CH3), 
0.3 (OSi(CH3)3). HRMS (ESI-TOF) [M+H]+ C14H23O3Si calcd. 267.1411, found 267.1413; and 
1,7-dimethyl-2,6-bis((trimethylsilyl)oxy)bicyclo[3.3.1]nona-2,6-dien-9-one 4.36 (0.018 g, 
11%) as a colourless oil; Rf 0.76 (petroleum ether:ethyl acetate, 80:20); IR (film) νmax 1723, 
1420, 1262, 1175 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.74 (1H, dd, J = 5.6, 2.0 Hz, 3-H), 
2.83 (1H, d, Jeq-ax = 4.8 Hz, 5-H), 2.47 (1H, ddd, 2JHH = 16.4, Jax-eq = 5.2, Jax-eq = 1.6 Hz, 4-
Heq), 2.41–2.34 (2H, m, 4-Hax, 8-Heq), 2.01 (1H, dd, 2JHH = 16.4, Jeq-eq = 1.2, 8-Hax), 1.56 
(3H, s, 7-CH3), 1.12 (3H, s, 1-CH3), 0.18 (18H, s, 2xOSi(CH3)3); 13C NMR (101 MHz, CDCl3) 
δ 208.9 (C-9), 152.4 (C-2), 141.9 (C-6), 111.5 (C-7), 99.5 (C-3), 64.2 (C-1), 50.9 (C-5), 42.8 
(C-8), 28.2 (C-4), 16.2 (1-CH3), 15.7 (7-CH3), 0.8 (OSi(CH3)3), 0.3 (OSi(CH3)3); HRMS (ESI-
TOF) [M+H]+ C17H31O3Si2 calcd. 339.1806, found 339.1807. 
3-Fluoro-1,7-dimethylbicyclo[3.3.1]nonane-2,6,9-trione (4.37) 
 
To a stirring solution of 3,5-dimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione 
(4.36) (0.020 g, 0.08 mmol, 1 eq) in dry acetonitrile (2 mL) was added Selectfluor in one 
portion (0.056 g, 0.16 mmol, 2 eq) at 25 °C. After stirring the mixture for 16 h water (2 mL) 
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was added and the aqueous layer extracted with dichloromethane (3x10 mL). The combined 
organic layers were washed with water (3 x10 mL), dried over Na2SO4, filtered and 
evaporated to give 24 (0.013 g, 81%) as a 75:25 mixture of exo-4.37:endo-4.37, Rf 0.23 
(petroleum ether: ethyl acetate, 80:20); IR (film) νmax 2916, 1721, 1642, 1452, 1218, 1022, 
995 cm-1; exo-4.37: 1H NMR (400 MHz, CDCl3) δ 5.05 (1H, dt, JHF = 48.4, Jeq-eq = 4.8 Hz, 3-
H), 3.74 (1H, td, J = 9.2, 2.0 Hz, 5-H), 2.70–2.50 (2H, m, 8-CH2), 2.51–2.36 (2H, m, 4-CH2), 
2.35–2.25 (1H, m, 7-H), 1.38 (3H, s, 1-CH3), 1.13 (3H, d, J = 6.5 Hz, 7-CH3); 13C NMR (101 
MHz, CDCl3) δ  205.0 (C-9), 203.9 (d, 2JFC = 19.7 Hz, C-2), 200.2 (C-6), 89.7 (d, JFC = 180.4 
Hz, C-3), 63.3 (C-1), 61.4 (C-5), 40.4 (C-7), 39.6 (d, 2JFC = 4.6 Hz, C-4), 37.2 (C-8), 17.1 (1-
CH3), 14.2 (7-CH3); 19F NMR (565 MHz, CDCl3) δ -183.0; endo-4.37: 1H NMR (400 MHz, 
CDCl3) δ 5.15 (1H, ddd, JHF = 46.7, Jax-ax = 11.8, Jax-eq = 7.6 Hz, 3-H), 3.70 (1H, m, 5-H), 
2.51–2.36 (2H, m, 4-CH2), 2.35-2.25 (1H, m, 7-H), 2.18 (1H, tdd, Jgem = 17.2, Jax-ax = 6.8, Jax-
eq = 2.0 Hz, 8-Heq), 2.05-1.96 (1H, m, 8-Hax), (3H, s, 1-CH3), 1.11 (3H, d, J = 6.8 Hz, 7-
CH3); 13C NMR (101 MHz, CDCl3) δ 209.8 (C-9), 206.8 (C-2), 203.4 (C-6), 87.1 (d, JFC = 
192.2 Hz, C-3), 77.4 (C-1), 63.4 (d, 3JFC = 26.8 Hz, C-5), 40.6 (C-7), 28.7 (d, 2JFC = 22.8 Hz, 
C-4), 21.6 (C-8), 16.3 (1-CH3), 14.4 (7-CH3); 19F NMR (565 MHz, CDCl3) δ -195.8; HRMS 
(ESI-TOF) [M+H]+ C11H14FO3 calcd. 213.0921, found 213.0930. 
 
3-Iodo-1,7-dimethylbicyclo[3.3.1]nonane-2,6,9-trione (4.38) 
 
To a stirring solution of 3,5-dimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione 
(4.36) (0.018 g, 0.06 mmol, 1 eq) in dry acetonitrile (2 mL) was added N-iodosuccinimide in 
one portion (0.022 g, 0.10 mmol, 1.6 eq) at 25 °C, and the mixture stirred at 25 °C for 48 h. 
Then, sat. aqueous NH4Cl (5 mL) was added and the aqueous layer extracted with 
dichloromethane (3x10 mL). The combined organic layers were washed with water (10 mL), 
dried over Na2SO4, filtered and evaporated to give 4.36 (0.015 g, 80%) as a 80:20 mixture 
of endo-4.36:exo-4.36; IR (film) νmax 2939, 1715, 1452, 1230, 1108 cm-1; endo-4.36: 1H 
NMR (400 MHz, CDCl3) δ 4.84 (1H, dd, Jeq-ax = 6.3, Jeq-eq = 2.2 Hz, 3-H), 3.87 (1H, dd, Jeq-ax 
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= 10.2, Jeq-eq = 2.0 Hz, 1H, 5-H), 2.85 (1H, dd, Jgem = 16.8, Jax-eq = 10.2 Hz, 4-Hax), 2.66 (1H, 
ddd, Jgem = 16.8, Jeq-ax = 6.3, Jeq-eq = 2.0 Hz, 4-Heq), 2.56–2.45 (2H, m, 7-H), 2.40 (1H, dd, 
Jgem = 13.1, Jeq-ax = 7.0 Hz, 8-Heq), 1.61 (3H, s, 1-CH3), 1.33–1.22 (1H, m, 8-Hax), 1.07 (3H, 
d, J = 6.4 Hz, 7-CH3); 13C NMR (101 MHz, CDCl3) δ 204.6 (C-2), 204.2 (C-6), 201.0 (C-9), 
62.0 (C-5), 61.2 (C-1), 41.0 (C-8), 38.6 (C-7), 31.5 (C-4), 21.8 (C-3), 21.2 (1-CH3), 13.7 (7-
CH3); exo-4.36: 1H NMR (400 MHz, CDCl3) δ 4.67 (1H, dd, Jeq-ax = 12.0, Jeq-eq = 3.6 Hz, 3-
H), 3.73 (1H, dd, Jeq-ax = 8.4, Jeq-eq = 2.0 Hz, 1H, 5-H). 
(1S,5R,6R,7R)-6-Fluoro-1,7-dimethylbicyclo[3.3.1]nonane-2,9-dione (4.43) 
 1,7-dimethylbicyclo[3.3.1]non-6-ene-2,9-dione (4.44) 
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A stirring solution of 6-hydroxy-1,7-dimethylbicyclo[3.3.1]nonane-2,9-dione 3.19 (0.050 g, 
0.25 mmol, 1 eq) in dry dichloromethane (4 mL) was brought to –78 °C and DAST (0.080 g, 
0.5 mmol, 70 μL, 2 eq) was added dropwise. The reaction was kept at –78 °C for 3 hours 
until completion. After this time, the reaction was quenched with H2O (5 mL) and the aqueous 
phase extracted three times in dichloromethane (3x20 mL). The combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and evaporated. Column 
chromatography (hexane:ethyl acetate, 90:10) afforded 4.43 (0.012 g, 24%) and 4.44 (0.020 
g, 45%) as colorless oils; 4.43: IR (film):1733, 1705, 1451, 1263, 1043, 845, 732, 702 cm-1; 
1H NMR (400 MHz, CDCl3) δ ppm 4.75 (1H, ddd, 1JHF-gem = 47.8, Jeq-ax = 4.0, Jeq-eq = 2.0 Hz, 
6-H), 3.18 (1H, m, 5-H), 2.60 (1H, dddd, Jgem = 16.4, Jeq-ax = 7.5, Jeq-eq = 3.9, wJ = 1.3 Hz, 3-
Heq), 2.38 (1H, dt, Jgem = 16.4, Jax-ax = 9.6, Jax-ax = 6.8 Hz, 3-Hax), 2.25–1.99 (4H, m, 4-Heq, 
7-H, 8-H), 1.67 (1H, m, 4-Hax), 1.15 (3H, s, 1-C-CH3), 1.06 (3H, d, J = 6.6 Hz, 7-CH-CH3). 
13C NMR (101 MHz, CDCl3) δ ppm 211.6 (C-2), 209.3 (C-9), 99.8 (d, JCF  = 178.7 Hz, C-6), 
62.1 (C-1), 48.9 (d, 2JFC  = 24.0 Hz, C-5), 43.7 (C-8), 37.6, (C-3), 29.7 (d, 3JCF = 20.1 Hz, C-
7), 17.4 (d, 3JFC  = 11.0 Hz, C-4), 16.5 (1-C-CH3), 15.9 (d, J = 5.1 Hz, 7-CH3). 19F NMR (376 
MHz, CDCl3) δ -189.01. HRMS (ESI-TOF) [M+H]+ C11H16FO2 calcd. 199.1129, found 
199.1123. 4.44: IR (film): 1732, 1693, 1444, 1232, 1193, 1085, 1017, 847, 711 cm-1; 1H NMR 
(400 MHz, CDCl3) δ ppm 5.47 (1H, d, J = 6.0 Hz, 6-H), 3.11 (1H, m, 5-H), 2.80 (1H, m, 3-
Heq), 2.59–2.42 (3H, m, 3-Hax, 8-H), 1.95 (1H, m, 4-Heq), 1.86–1.75 (1H, m, 4-Hax), 1.72 
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(3H, s, 7-CH3), 1.20 (3H, s, 1-CH3). 13C NMR (101 MHz, CDCl3) δ ppm 209.7 (C-2), 209.3 
(C-9), 135.7 (C-7), 123.0 (C-6), 63.9 (C-1), 49.0 (C-8), 46.0 (C-5), 34.9 (C-3), 25.2 (C-4), 
21.7 (7-CH3), 15.7 (1-C-CH3). HRMS (ESI-TOF) [M+H]+ C11H15O2 calcd.179.1067, found 
179.1058. 
 
1,7-Dimethyl-9-oxabicyclo[3.3.2]decane-2,6,10-trione (4.41) 
 
To a stirring solution of 1,7-exo-dimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.66 (0.040 g, 0.5 
mmol, 1 eq) in dry dichloromethane (2 mL) were added m-CPBA (0.070 g, 0.4 mmol, 2 eq) 
and NaHCO3 (0.034 g, 0.4 mmol, 2 eq) in one portion at 0 °C. The reaction was kept at 0 °C 
for 6 h, the ice bath removed and stir for additional 16 h. After this time, the reaction was 
quenched with H2O (5 mL) and the aqueous phase extracted with dichloromethane (3x20 
mL). The combined organic layers were washed with H2O, dried over Na2SO4, filtered and 
evaporated. Column chromatography (hexane:ethyl acetate, 90:10) afforded 4.41 (0.006 g, 
14%), IR (film): 2923, 1717, 1698, 1277, 760, 751 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 
4.79–4.70 (1H, sext., Jax-ax = 12.2, Jax-eq = 6.2 Hz, 7-H), 4.16–4.09 (1H, m, 5-H), 2.76–2.69 
(1H, m, CO-3-Hax), 2.69–2.58 (m, 1H, 4-Hax), 2.43–2.28 (3H, m, 3-Heq, 4-Heq, 8-Heq), 
1.90 (1H, dd, Jgem  = 14.9, Jax-ax = 11.0 Hz, 8-Hax), 1.36 (3H, d, J = 6.1 Hz, 7-CH-CH3), 1.25 
(3H, s, 1-C-CH3). 13C NMR (101 MHz, CDCl3) δ ppm 209.63 (C-6), 202.68 (C-2), 166.37 (C-
9), 73.84 (C-7), 62.53 (C-1), 56.38 (C-5), 47.63 (C-8), 38.58 (C-3), 23.44 (C-7-CH3), 19.01 
(1-C-CH3), 18.90 (C-4). HRMS (ESI-TOF) [M+H]+ C11H15O4 calcd. 211.0965, found 
211.0969.  
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1,4,4-Trimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-dione (4.45) 
 
To a stirring solution of 1,4,4-trimethylbicyclo[3.3.1]nonane-2,6,9-trione 3.67 (0.050 g, 0.24 
mmol, 1 eq) in dry dichloromethane (4 mL) at 0 °C was added Et3N (0.036 g, 0.36 mmol, 
1.38 eq). The mixture was stirred for 5 min, then TMSOTf (0.064 g, 0.29 mmol, 5.8 eq) was 
added and the mixture was stirred at 0 °C for a further 10 min. Then the ice bath was then 
removed and the mixture heated at 45 °C for 2 h. After allowing to cool to 20 °C, sat. aqueous 
NaHCO3 (5 mL) was added, and the aqueous layer was extracted with dichloromethane 
(3x15 mL). The combined organic layers were washed with water (10 mL), dried over 
Na2SO4, filtered and evaporated to give 4.45 (0.043 g, 60%); IR (film) νmax 1731, 1701, 1449, 
1249, 1177 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.96 (1H, t, J = 3.2 Hz, 7-H), 2.92 (1H, m, 3-
Heq), 2.68 (1H, s, 5-H), 2.39 (1H, dd, Jgem = 17.6, Jeq-ax = 3.6 Hz, 8-Heq), 2.30–2.22 (2H, m, 
8-Hax, 3-Hax), 1.21 (3H, s, 1-CH3), 1.17 (3H, s, 4-CH3), 0.85 (3H, s, 4-CH3), 0.23 (9H, s, 
O(SiCH3)3); 13C NMR (101 MHz, CDCl3) δ 208.4 (C-2), 205.9 (C-9), 149.1 (C-6), 102.4 (C-
7), 63.6 (C-5), 61.8 (C-1), 49.6 (C-3), 37.9 (C-8), 35.7 (C-4), 27.7 (4-CH3), 27.4 (4-CH3), 15.3 
(1-CH3), 0.3 O(SiCH3)3); HRMS (ESI-TOF) [M+H]+ C15H25O3Si calcd. 281.1567, found 
281.1566. 
 
5,8,8-Trimethylbicyclo[3.3.1]non-3-ene-2,6,9-trione (4.47) 
 
To a stirring solution of 1,4,4-trimethyl-6-((trimethylsilyl)oxy)bicyclo[3.3.1]non-6-ene-2,9-
dione 4.45 (0.043 g, 0.15 mmol, 1 eq) in dry acetonitrile (4 mL) was added Pd(OAc)2 in one 
portion (0.124 g, 0.18 mmol, 1.2 eq) at 25 °C. The mixture was stirred at 25 °C for 16 h, then 
at 80 °C for 3 h. After allowing to cool, water (2 mL) was added and the aqueous layer 
extracted with diethyl ether (3x10 mL). The combined organic layers were washed with water 
(10 mL), dried over Na2SO4, filtered and evaporated to give 4.47 (0.014 g, 46%) as a 
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colourless oil; IR (film) νmax 1710, 1678, 1447, 1374, 1250, 1218, 1174, 1055 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 6.79 (1H, d, J = 6.4 Hz, 7-H), 6.42 (1H, d, J = 6.4 Hz, 8-H), 3.35 (1H, s, 
5-H), 3.06 (1H, d, Jgem= 9.6 Hz, 3-Heq), 2.25 (1H, d, Jgem= 10.4, 3-Hax), 1.43 (3H, s, 1-CH3) 
1.18 (3H, s, 4-CH3), 0.95 (3H, s, 4-CH3); 13C NMR (151 MHz, CDCl3) δ 201.1 (C-9), 200.2 
(C-6), 196.4 (C-2), 151.4 (C-7), 131.8 (C-8), 73.3 (C-5), 69.3 (C-1), 46.5 (C-3), 33.9 (C-4), 
28.5 (4-C-CH3eq), 27.1 (4-C-CH3ax), 13.2 (1-C-CH3); HRMS (ESI-TOF) [M+H]+ C12H15O3 
calcd. 207.1016, found 207.1009. 
 
1,4,4-Trimethylbicyclo[3.3.1]non-7-ene-2,9-dione (4.49) 
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A stirring solution of 6-exo-hydroxy-1-methylbicyclo[3.3.1]nonane-2,9-dione 3.50 (0.100 g, 
0.55 mmol, 1 eq) in dry dichloromethane was brought to –78 °C and DAST (0.354 g, 2.2 
mmol, 295 μL, 4 eq) was added dropwise. The reaction was kept at the same temperature 
and stirred for 1 hour. After this time, the reaction was quenched with H2O (5 mL) and the 
aqueous phase extracted with dichloromethane (3x20 mL). The combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and evaporated to afford 4.49 (0.103 g, 
98%) as colorless oil, IR (film): 2961, 1927, 1734, 1700, 1452, 1275, 1260, 764, 749 cm-1; 
1H NMR (400 MHz, CDCl3) δ ppm 5.94–5.84 (2H, m, 6-H, 7-H), 2.83 (1H, dd, Jgem = 15.4, J 
= 1.1 Hz, 3-Heq), 2.77–2.74 (1H, m, 5-H), 2.63 (1H, dd, Jeq-eq = 3.5, J = 1.0 Hz, 8-Heq), 2.50 
(1H, ddt, Jgem = 18.5, J = 2.6, 1.4 Hz, 8-Hax), 2.24 (1H, dd, Jgem = 15.4, J = 1.5 Hz, 3-Hax), 
1.20 (3H, s, 1-C-CH3), 1.10 (3H, s, 4-C-(CH3)2), 0.86 (3H, s, 4-C-(CH3)2). 13C NMR (101 
MHz, CDCl3) δ ppm 209.0 (C-9), 208.9 (C-2-), 128.3 (C-6), 128.1 (C-7), 62.9 (C-1), 57.8 (C-
5), 49.2 (C-3), 44.9 (C-8), 35.7 (C-4), 27.3 (4-C(CH3)2), 26.2 (4-C(CH3)2), 15.6 (1-C-CH3). 
HRMS (ESI-TOF) [M+H]+ C12H17O2 calcd. 193.1223, found 193.1227.  
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X-ray crystallographic data 
 
An X-ray quality crystal was obtained by slow diffusion of hexane into a nearly sat. solution 
in dichloromethane. 
A colorless block-like specimen of C17H16N2O8, approximate dimensions 0.220 mm x 0.400 
mm x 0.420 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured.  
The total exposure time was 1.02 hours. The frames were integrated with the Bruker SAINT 
software package using a narrow-frame algorithm. The integration of the data using an 
orthorhombic unit cell yielded a total of 24863 reflections to a maximum θ angle of 36.39° 
(0.60 Å resolution), of which 7597 were independent (average redundancy 3.273, 
completeness = 99.8%, Rint = 4.59%, Rsig = 4.71%) and 6529 (85.94%) were greater than 
2σ(F2). The final cell constants of a = 10.6964(11) Å, b = 25.365(3) Å, c = 6.2244(6) Å, 
volume = 1688.8(3) Å3, are based upon the refinement of the XYZ-centroids of 4917 
reflections above 20 σ(I) with 4.981° < 2θ < 67.90°. Data were corrected for absorption 
effects using the Multi-Scan method (SADABS). The ratio of minimum to maximum apparent 
transmission was 0.861. The calculated minimum and maximum transmission coefficients 
(based on crystal size) are 0.9520 and 0.9740. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, using 
the space group P n a 21, with Z = 4 for the formula unit, C17H16N2O8. The final anisotropic 
full-matrix least-squares refinement on F2 with 245 variables converged at R1 = 4.46%, for 
the observed data and wR2 = 10.94% for all data. The goodness-of-fit was 1.009. The 
largest peak in the final difference electron density synthesis was 0.453 e-/Å3 and the largest 
hole was -0.241 e-/Å3 with an RMS deviation of 0.058 e-/Å3. On the basis of the final model, 
the calculated density was 1.480 g/cm3 and F(000), 784 e-. 
Crystal data, data collection and structure refinement. 
Identification code ices15 
Chemical formula C17H16N2O8 
Formula weight 376.32 g/mol 
Temperature 103(2) K 
Wavelength 0.71073 Å 
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Crystal size 0.220 x 0.400 x 0.420 mm 
Crystal habit colorless block 
Crystal system orthorhombic 
Space group P n a 21 
Unit cell dimensions a = 10.6964(11) Å α = 90° 
 b = 25.365(3) Å β = 90° 
 c = 6.2244(6) Å γ = 90° 
Volume 1688.8(3) Å3  
Z 4 
Density (calculated) 1.480 g/cm3 
Absorption coefficient 0.120 mm-1 
F(000) 784 
Theta range for data 
collection 2.49 to 36.39° 
Index ranges -17<=h<=17, -42<=k<=40, -10<=l<=9 
Reflections collected 24863 
Independent reflections 7597 [R(int) = 0.0459] 
Coverage of independent 
reflections 99.8% 
Absorption correction Multi-Scan 
Max. and min. 
transmission 0.9740 and 0.9520 
Structure solution 
technique direct methods 
Structure solution 
program XT, VERSION 2014/4 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-2014/7 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / 
parameters 7597 / 1 / 245 
Goodness-of-fit on F2 1.009 
 
 
Final R indices 
 
 
6529 data; I>2σ(I) 
 
 
R1 = 0.0446, wR2 = 0.1037 
 all data R1 = 0.0542, wR2 = 0.1094 
Weighting scheme w=1/[σ2(Fo2)+(0.0599P)2] 
where P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 0.453 and -0.241 eÅ-3 
R.M.S. deviation from mean 0.058 eÅ-3 
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Table S1. Bond lengths (Å).  
C1-C2 1.3913(19) C1-C6 1.392(2) 
C2-C3 1.382(2) C2-N1 1.477(2) 
C3-C4 1.387(2) C4-C5 1.3846(19) 
C4-N2 1.471(2) C5-C6 1.396(2) 
C6-C7 1.4942(18) C7-O5 1.2117(17) 
C7-O6 1.3371(18) C8-O6 1.4717(17) 
C8-C14 1.522(2) C8-C9 1.524(2) 
C9-C10 1.513(2) C9-C15 1.545(2) 
C10-O7 1.2156(18) C10-C11 1.525(2) 
C11-C12 1.523(2) C11-C17 1.545(2) 
C11-C13 1.559(3) C13-C14 1.529(2) 
C15-C16 1.539(2) C16-C17 1.512(2) 
C17-O8 1.2144(19) N1-O1 1.224(2) 
N1-O2 1.2250(18) N2-O4 1.2288(19) 
N2-O3 1.2325(16)   
 
Table S2. Bond angles (°). 
C2-C1-C6 118.14(14) C3-C2-C1 123.37(14) 
C3-C2-N1 118.36(13) C1-C2-N1 118.27(15) 
C2-C3-C4 116.32(13) C5-C4-C3 123.15(15) 
C5-C4-N2 118.34(14) C3-C4-N2 118.51(12) 
C4-C5-C6 118.44(14) C1-C6-C5 120.57(12) 
C1-C6-C7 121.53(13) C5-C6-C7 117.89(12) 
O5-C7-O6 125.12(13) O5-C7-C6 123.28(14) 
O6-C7-C6 111.60(12) O6-C8-C14 107.96(12) 
O6-C8-C9 104.62(12) C14-C8-C9 113.86(12) 
C10-C9-C8 109.63(13) C10-C9-C15 108.87(12) 
C8-C9-C15 113.04(12) O7-C10-C9 123.62(13) 
O7-C10-C11 122.72(13) C9-C10-C11 113.65(12) 
C12-C11-C10 112.20(13) C12-C11-C17 110.79(13) 
C10-C11-C17 108.69(13) C12-C11-C13 109.74(15) 
C10-C11-C13 106.98(13) C17-C11-C13 108.29(13) 
C14-C13-C11 114.75(14) C8-C14-C13 112.22(13) 
C16-C15-C9 115.38(12) C17-C16-C15 117.49(12) 
O8-C17-C16 120.78(14) O8-C17-C11 119.44(14) 
C16-C17-C11 119.65(12) O1-N1-O2 124.56(14) 
O1-N1-C2 117.86(13) O2-N1-C2 117.58(15) 
195 
 
O4-N2-O3 123.93(15) O4-N2-C4 117.75(12) 
O3-N2-C4 118.33(13) C7-O6-C8 116.95(11) 
 
 
X-ray crystallographic data 
 
 
An X-ray quality crystal was obtained by slow diffusion of hexane into a nearly sat. solution 
of 7-exo-20 in dichloromethane. 
A colorless block-like specimen of C13H18O3, approximate dimensions 0.100 mm x 0.220 
mm x 0.420 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured. 
The total exposure time was 0.99 hours. The frames were integrated with the Bruker SAINT 
software package using a narrow-frame algorithm. The integration of the data using a 
monoclinic unit cell yielded a total of 21935 reflections to a maximum θ angle of 29.70° (0.72 
Å resolution), of which 6533 were independent (average redundancy 3.358, completeness 
= 99.2%, Rint = 8.68%, Rsig = 9.08%) and 4743 (72.60%) were greater than 2σ(F2). The final 
cell constants of a = 12.6185(16) Å, b = 6.4539(8) Å, c = 28.975(4) Å, β = 100.150(2)°, 
volume = 2322.8(5) Å3, are based upon the refinement of the XYZ-centroids of 4832 
reflections above 20 σ(I) with 5.713° < 2θ < 59.23°. Data were corrected for absorption 
effects using the Multi-Scan method (SADABS). The ratio of minimum to maximum apparent 
transmission was 0.815. The calculated minimum and maximum transmission coefficients 
(based on crystal size) are 0.9640 and 0.9910. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, using 
the space group P 1 21/n 1, with Z = 8 for the formula unit, C13H18O3. The final anisotropic 
full-matrix least-squares refinement on F2 with 297 variables converged at R1 = 6.23%, for 
the observed data and wR2 = 17.86% for all data. The goodness-of-fit was 1.029. The 
largest peak in the final difference electron density synthesis was 0.447 e-/Å3 and the largest 
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hole was -0.329 e-/Å3 with an RMS deviation of 0.073 e-/Å3. On the basis of the final model, 
the calculated density was 1.271 g/cm3 and F(000), 960 e-. 
 
Crystal data, data collection and structure refinement for 7-exo-20: 
 
Identification 
code ices7 
Chemical 
formula C13H18O3 
Formula weight 222.27 g/mol 
Temperature 103(2) K 
Wavelength 0.71073 Å 
Crystal size 0.100 x 0.220 x 0.420 mm 
Crystal habit colorless block 
Crystal system monoclinic 
Space group P 1 21/n 1 
Unit cell 
dimensions a = 12.6185(16) Å α = 90° 
 b = 6.4539(8) Å β = 100.150(2)° 
 c = 28.975(4) Å γ = 90° 
Volume 2322.8(5) Å3  
Z 8 
Density 
(calculated) 1.271 g/cm
3 
Absorption 
coefficient 0.089 mm
-1 
F(000) 960 
Theta range for 
data collection 1.43 to 29.70° 
Index ranges -17<=h<=13, -8<=k<=8, -40<=l<=40 
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Reflections 
collected 21935 
Independent 
reflections 6533 [R(int) = 0.0868] 
Coverage of 
independent 
reflections 
99.2% 
Absorption 
correction Multi-Scan 
Max. and min. 
transmission 0.9910 and 0.9640 
Structure 
solution 
technique 
direct methods 
Structure 
solution 
program 
XS, VERSION 2013/1 
Refinement 
method Full-matrix least-squares on F2 
Refinement 
program SHELXL-2014/7 (Sheldrick, 2014) 
Function 
minimized Σ w(Fo
2 - Fc2)2 
Data / 
restraints / 
parameters 
6533 / 0 / 297 
Goodness-of-
fit on F2 1.029 
Δ/σmax 0.001 
 Final R indices 4743 data; I>2σ(I)        R1 = 0.0623, wR2 = 0.1622 
 all data        R1 = 0.0846, wR2 = 0.1786 
Weighting 
scheme 
w=1/[σ2(Fo2)+(0.0843P)2+0.3771P] 
where P=(Fo2+2Fc2)/3 
Largest diff. 
peak and hole 0.447 and -0.329 eÅ
-3 
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R.M.S. 
deviation from 
mean 
0.073 eÅ-3 
 
Table S3. Bond lengths (Å). 
 
C1-O1 1.2128(16) C1-C2 1.523(2) 
C1-C8 1.5468(19) C2-C11 1.530(2) 
C2-C10 1.543(2) C2-C3 1.5487(18) 
C3-C4 1.5669(19) C4-C9 1.5140(19) 
C4-C5 1.5314(19) C5-O2 1.2099(16) 
C5-C6 1.5146(19) C6-C12 1.522(2) 
C6-C7 1.5395(19) C7-C8 1.5506(19) 
C8-C9 1.5187(19) C8-C13 1.5267(19) 
C9-O3 1.2113(17) C14-O4 1.2083(17) 
C14-C15 1.525(2) C14-C21 1.547(2) 
C15-C24 1.526(2) C15-C23 1.546(2) 
C15-C16 1.5481(19) C16-C17 1.5617(19) 
C17-C22 1.5122(18) C17-C18 1.5314(19) 
C18-O5 1.2106(16) C18-C19 1.5158(19) 
C19-C25 1.523(2) C19-C20 1.5367(19) 
C20-C21 1.5529(19) C21-C22 1.5145(19) 
C21-C26 1.5277(19) C22-O6 1.2121(17) 
 
Table S4. Bond angles (°). 
 
O1-C1-C2 123.11(13) O1-C1-C8 119.31(13) 
C2-C1-C8 117.56(11) C1-C2-C11 111.24(12) 
C1-C2-C10 106.98(11) C11-C2-C10 109.45(12) 
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C1-C2-C3 109.71(11) C11-C2-C3 108.84(12) 
C10-C2-C3 110.61(11) C2-C3-C4 115.91(11) 
C9-C4-C5 109.28(11) C9-C4-C3 110.18(10) 
C5-C4-C3 108.76(11) O2-C5-C6 124.09(13) 
O2-C5-C4 120.25(12) C6-C5-C4 115.65(11) 
C5-C6-C12 112.53(11) C5-C6-C7 109.74(11) 
C12-C6-C7 112.36(12) C6-C7-C8 113.88(11) 
C9-C8-C13 112.28(12) C9-C8-C1 110.24(11) 
C13-C8-C1 110.30(11) C9-C8-C7 105.43(10) 
C13-C8-C7 110.70(12) C1-C8-C7 107.69(11) 
O3-C9-C4 123.46(13) O3-C9-C8 124.35(13) 
C4-C9-C8 112.15(11) O4-C14-C15 122.52(13) 
O4-C14-C21 119.45(13) C15-C14-C21 117.98(11) 
C14-C15-C24 110.86(12) C14-C15-C23 106.69(12) 
C24-C15-C23 109.59(12) C14-C15-C16 110.95(11) 
C24-C15-C16 108.53(12) C23-C15-C16 110.22(11) 
C15-C16-C17 116.38(11) C22-C17-C18 109.57(11) 
C22-C17-C16 110.16(11) C18-C17-C16 108.54(11) 
O5-C18-C19 123.96(13) O5-C18-C17 120.39(12) 
C19-C18-C17 115.61(11) C18-C19-C25 112.58(11) 
C18-C19-C20 109.54(11) C25-C19-C20 112.40(12) 
C19-C20-C21 113.93(11) C22-C21-C26 112.48(12) 
C22-C21-C14 110.29(11) C26-C21-C14 110.51(11) 
C22-C21-C20 105.63(10) C26-C21-C20 110.30(12) 
C14-C21-C20 107.39(11) O6-C22-C17 123.41(13) 
O6-C22-C21 124.10(13) C17-C22-C21 112.47(11) 
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